data_6x4x_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6x4x _Structure_validation_residue.Date_analyzed 2020-07-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 121.868 0.842 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 -40.14 79.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.457 0.646 . . . . 0.0 110.58 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.2 -54.07 16.74 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.448 -0.782 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.8 mt-30 -61.06 -33.87 73.98 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.234 -0.916 . . . . 0.0 111.72 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 m -96.17 -30.63 13.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.691 -1.256 . . . . 0.0 112.372 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 t -91.65 -58.2 2.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.625 -1.297 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -66.22 -11.17 48.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -161.22 166.31 27.96 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.217 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.4 mt -82.29 137.65 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.877 -1.139 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 5.9 m -98.93 171.64 7.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.416 -0.803 . . . . 0.0 110.041 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 m -118.6 144.9 45.81 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -44.19 -35.09 2.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 110.135 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -61.24 -36.83 81.03 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.621 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.497 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 16.3 mt-30 -74.21 -41.62 61.09 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.35 -49.59 71.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -63.06 -25.31 68.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.943 0.878 . . . . 0.0 108.745 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.12 -32.31 73.68 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.75 -0.34 56.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.686 -1.259 . . . . 0.0 109.119 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -94.33 146.3 24.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' B' ' 44' ' ' GLY . 38.7 t-20 . . . . . 0 C--N 1.299 -1.594 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.778 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.31 159.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.987 . . . . 0.0 109.797 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.1 92.78 4.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -139.55 144.64 37.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.425 -0.797 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -68.59 109.59 3.84 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.343 -0.848 . . . . 0.0 109.133 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.2 mt -92.01 149.23 21.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.928 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.0 m -156.4 -178.13 7.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.9 -143.87 18.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.49 -20.37 54.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.831 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -47.28 -59.03 3.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.087 -1.008 . . . . 0.0 108.732 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.96 -54.72 14.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 34' ' ' GLU . 31.1 t -52.63 -59.02 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.212 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -40.99 -41.79 1.73 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.78 -60.5 3.6 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.79 -46.17 64.11 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.646 -1.284 . . . . 0.0 108.359 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -55.73 -25.57 41.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.4 tp -85.25 -63.3 1.35 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.48 -56.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.603 0.716 . . . . 0.0 110.004 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.4 t -71.71 -30.36 65.56 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 110.665 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -120.58 6.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' B' ' 42' ' ' GLU . 1.3 pm0 -84.36 -12.56 54.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -1.142 . . . . 0.0 110.959 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -54.91 -33.36 62.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.85 -1.156 . . . . 0.0 109.989 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.76 126.86 4.18 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.25 172.93 10.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.058 -1.26 . . . . 0.0 108.761 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.61 119.77 28.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.631 -0.668 . . . . 0.0 109.437 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.606 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.518 0.675 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 t -58.84 -38.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.47 -0.769 . . . . 0.0 110.037 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.94 -45.18 75.0 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.679 -0.638 . . . . 0.0 110.821 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -75.97 -31.81 59.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.139 -0.976 . . . . 0.0 111.598 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 12.0 m -94.27 -28.17 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.62 -1.3 . . . . 0.0 112.104 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.481 ' C ' ' H ' ' A' ' 9' ' ' SER . 15.1 t -90.49 -62.38 1.47 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.0 109.598 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.38 -9.75 0.77 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.5 m -160.11 -147.18 0.15 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.335 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.09 141.88 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.901 . . . . 0.0 108.931 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.56 174.12 6.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 15' ' ' GLN . 54.0 m -118.31 146.69 44.14 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.8 -34.64 1.63 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.481 -0.762 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.06 -35.46 80.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 108.521 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.9 mt-30 -76.73 -35.73 57.6 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.49 -50.29 39.51 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.644 -0.66 . . . . 0.0 109.288 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -60.81 -26.85 67.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -61.89 -34.29 75.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.235 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.01 -4.4 58.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.602 -1.311 . . . . 0.0 109.334 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 t -100.69 146.47 27.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.407 -0.808 . . . . 0.0 109.691 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 3.7 p30 . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.54 157.37 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.699 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -106.32 88.94 2.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.04 151.8 48.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.524 -0.735 . . . . 0.0 109.539 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -74.59 110.42 8.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.183 -0.948 . . . . 0.0 109.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -92.03 148.69 22.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.784 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.3 m -155.81 -177.87 6.88 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.14 -142.77 16.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.84 -18.58 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -1.134 . . . . 0.0 109.792 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.82 -57.8 5.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.0 108.814 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -49.29 -55.2 13.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 23.3 t -51.61 -59.49 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.115 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 29.0 mt-10 -41.31 -39.97 1.54 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.87 -60.49 3.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.1 mt -51.64 -46.45 63.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.547 -1.345 . . . . 0.0 108.186 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -55.03 -25.72 32.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -85.24 -63.07 1.39 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.15 -56.72 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.627 0.727 . . . . 0.0 109.943 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -71.47 -29.29 64.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.624 -0.672 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.55 -130.2 41.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -82.83 -6.91 59.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.213 -1.169 . . . . 0.0 110.152 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -56.95 -39.46 74.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.479 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 98.4 127.7 5.9 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -124.03 176.85 6.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -1.048 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.1 116.89 24.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 81.3 t80 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.892 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 t -49.72 -40.06 15.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.49 -61.33 2.05 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.377 -0.827 . . . . 0.0 111.056 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.66 -27.96 69.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 111.037 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 m -88.42 -31.55 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.698 -1.251 . . . . 0.0 110.866 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.6 t -101.89 -58.77 1.82 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -60.49 -7.04 1.86 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 7' ' ' CYS . 37.3 t -163.12 -144.28 0.09 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.626 0.727 . . . . 0.0 109.53 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.02 156.46 42.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.52 147.33 50.68 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.264 -0.897 . . . . 0.0 109.486 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.6 m -90.84 148.0 22.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -43.41 -34.31 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.533 -0.73 . . . . 0.0 110.145 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.88 -34.71 78.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 108.584 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' SER . 17.0 mt-30 -77.96 -28.04 49.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tp -78.17 -49.08 14.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.99 -23.03 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.481 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -62.85 -35.18 79.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.12 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.64 -2.73 57.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.685 -1.259 . . . . 0.0 109.232 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 t -101.42 145.92 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.425 -0.797 . . . . 0.0 109.892 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.649 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -47.99 159.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.04 90.05 3.25 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -126.09 151.97 46.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -75.45 110.3 9.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 16.2 mt -91.58 151.0 20.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.002 -1.061 . . . . 0.0 109.43 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 86.1 m -156.11 -177.95 6.95 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.33 -145.22 12.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.87 -17.67 57.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.31 -1.112 . . . . 0.0 109.714 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.71 -58.02 4.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.064 -1.022 . . . . 0.0 108.859 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -48.49 -54.38 14.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.28 -46.5 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.123 -0.986 . . . . 0.0 108.91 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -41.25 29.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -61.63 -60.11 4.17 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 24.0 mt -52.17 -42.54 63.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.301 -1.5 . . . . 0.0 108.39 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -60.45 -25.01 65.67 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.5 -63.04 1.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.18 -56.31 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.529 0.68 . . . . 0.0 110.207 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.78 -30.52 61.47 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 110.925 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.86 -117.52 4.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -84.06 -15.13 48.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -1.12 . . . . 0.0 111.035 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -57.25 -23.92 51.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.912 -1.118 . . . . 0.0 109.835 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 77.36 128.62 0.39 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.424 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 25.0 p90 -121.71 177.37 5.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.464 -1.021 . . . . 0.0 109.28 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 8.0 m-85 -125.19 120.23 30.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.4 t80 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 tt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.465 0.65 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 6.1 t -49.77 -43.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.849 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.24 -59.23 3.93 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.341 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -49.79 -50.2 45.79 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.772 . . . . 0.0 110.838 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 m -81.36 -30.68 33.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.022 -1.049 . . . . 0.0 112.27 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 8.5 t -92.58 -60.53 1.8 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.542 -1.349 . . . . 0.0 109.521 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 m -55.38 -17.22 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.131 -0.981 . . . . 0.0 108.566 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.9 m -157.85 -147.99 0.19 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.5 mt -123.17 137.09 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.87 . . . . 0.0 109.087 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 58.4 m -98.68 170.33 8.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 110.349 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 15' ' ' GLN . 73.2 m -118.06 145.89 44.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 tp -43.4 -33.43 1.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 110.205 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.68 -36.59 84.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.727 -1.233 . . . . 0.0 108.699 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.0 mt-30 -76.11 -36.06 59.03 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.5 -50.3 39.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.588 -0.695 . . . . 0.0 109.383 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -61.6 -23.23 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.22 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.37 -3.8 59.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.659 -1.276 . . . . 0.0 109.269 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.3 t -99.06 145.67 26.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.426 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.59 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -77.71 153.86 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.106 -0.997 . . . . 0.0 110.037 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -99.96 93.12 5.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -138.05 146.27 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.302 -0.873 . . . . 0.0 109.839 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.432 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.8 m-70 -71.08 109.54 5.22 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 11.8 mt -92.39 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.14 -0.975 . . . . 0.0 109.698 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.4 m -156.48 -177.75 6.83 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.25 -142.42 14.27 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.56 -18.63 54.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -1.081 . . . . 0.0 109.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -48.64 -59.07 3.82 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.966 -1.084 . . . . 0.0 108.509 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.7 -56.79 7.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.9 t -50.05 -59.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 20.4 mt-10 -41.56 -42.23 2.37 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.69 -60.44 3.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.04 -48.68 61.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.729 -1.232 . . . . 0.0 108.083 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -53.14 -25.97 15.21 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.31 -63.06 1.39 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -53.59 -57.07 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.693 0.758 . . . . 0.0 109.592 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.2 t -70.24 -29.49 66.31 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.758 -0.589 . . . . 0.0 110.594 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.86 -124.67 16.93 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.603 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -83.35 -8.23 59.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.303 -1.116 . . . . 0.0 110.733 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -59.16 -33.03 70.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.884 -1.135 . . . . 0.0 109.717 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.67 125.66 2.52 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.415 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.6 p90 -119.86 177.66 4.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.395 -1.062 . . . . 0.0 109.341 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -125.13 115.27 20.2 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 t80 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.66 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.41 0.624 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 t -48.54 -40.09 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -76.09 -23.82 55.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.993 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 21.9 mt-30 -91.16 -18.48 24.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.845 -1.159 . . . . 0.0 110.109 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -109.57 -30.6 7.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.819 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.33 -63.04 1.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.996 -1.065 . . . . 0.0 109.417 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 m -62.95 -11.03 15.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -163.73 159.86 21.92 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.576 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 55.8 mt -83.57 140.64 15.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 109.677 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.13 156.96 18.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.473 -0.767 . . . . 0.0 109.621 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . 50.2 m -100.49 147.48 25.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.47 -34.39 1.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.433 -0.792 . . . . 0.0 110.118 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.13 -34.88 79.07 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.763 -1.211 . . . . 0.0 108.555 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.6 mt-30 -78.07 -30.98 49.95 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.53 -49.16 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.535 -0.728 . . . . 0.0 109.122 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.53 -22.95 66.69 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.456 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -65.06 -34.42 78.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.386 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.65 -0.71 51.8 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.585 -1.322 . . . . 0.0 109.384 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -103.48 146.41 28.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.71 . . . . 0.0 109.838 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.486 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 21.9 m-20 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.614 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.19 151.27 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.088 -1.008 . . . . 0.0 109.518 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -101.3 85.56 2.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.822 . . . . 0.0 109.354 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.36 147.65 49.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.691 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.2 m80 -69.05 111.01 4.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.312 -0.867 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.1 mt -90.59 150.93 21.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.6 m -155.96 -178.15 7.09 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.78 -143.47 10.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -78.91 -18.47 53.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 0.0 109.856 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -47.95 -49.57 29.99 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.045 -1.034 . . . . 0.0 108.49 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.43 -56.63 19.7 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 16.4 t -51.15 -59.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 108.877 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 13.3 mm-40 -41.87 -42.94 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.43 -60.55 3.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.8 mt -51.67 -48.75 63.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.572 -1.33 . . . . 0.0 108.141 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -53.61 -25.73 18.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.8 tp -85.13 -63.01 1.4 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 41.8 t -53.09 -58.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.67 0.747 . . . . 0.0 109.579 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 2.0 t -69.57 -29.74 67.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.721 -0.612 . . . . 0.0 110.648 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.62 -125.57 26.48 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.487 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' B' ' 42' ' ' GLU . 1.5 pm0 -83.81 -6.28 59.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -1.12 . . . . 0.0 110.853 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.62 -28.51 69.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 85.88 128.01 2.08 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.458 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.6 p90 -124.62 177.12 6.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.441 -1.035 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 18.7 m-85 -122.91 114.6 20.67 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 t80 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.439 0.638 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.88 -39.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 109.818 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -75.66 -20.12 58.68 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.255 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.452 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 tp-100 -91.28 -35.04 14.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.942 -1.099 . . . . 0.0 110.744 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.529 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 6.1 m -96.24 -24.32 16.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.0 111.593 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.1 t -97.44 -67.97 0.82 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.857 -1.152 . . . . 0.0 109.66 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -56.69 -12.29 1.78 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -155.87 -163.41 1.49 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 62.4 mt -116.7 146.81 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.119 -0.988 . . . . 0.0 109.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 97.9 m -111.32 169.87 8.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.536 -0.728 . . . . 0.0 110.007 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.1 m -118.4 146.36 44.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.4 -34.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.339 -0.851 . . . . 0.0 110.28 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -35.84 81.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.822 -1.174 . . . . 0.0 108.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 18.7 mt-30 -76.28 -34.86 59.1 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tp -70.89 -50.51 34.19 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.623 -0.673 . . . . 0.0 109.263 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -60.31 -27.55 67.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.427 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.5 m-20 -61.99 -34.28 75.87 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -84.13 -5.03 59.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.627 -1.295 . . . . 0.0 109.496 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -98.42 145.9 26.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.638 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.05 148.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.041 -1.037 . . . . 0.0 109.567 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -98.7 80.95 2.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.423 -0.798 . . . . 0.0 109.465 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -120.27 148.89 43.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 110.204 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.719 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.2 m80 -68.4 111.18 4.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -90.19 150.6 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 67.9 m -155.75 -178.3 7.19 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.86 -143.24 11.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.32 -18.61 54.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.303 -1.116 . . . . 0.0 109.905 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -47.68 -53.3 15.38 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.017 -1.052 . . . . 0.0 108.695 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 tp -53.55 -55.62 24.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.6 t -53.36 -58.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.26 -0.9 . . . . 0.0 109.085 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.3 mt-10 -41.11 -40.4 1.49 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.81 -60.59 3.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -51.54 -45.94 63.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.597 -1.315 . . . . 0.0 108.366 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.27 -25.4 48.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.24 -62.88 1.43 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.7 t -54.17 -57.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.583 0.706 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -70.05 -28.46 65.47 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.596 -0.69 . . . . 0.0 110.327 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.58 -131.3 46.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 -7.33 59.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -1.13 . . . . 0.0 110.136 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -55.63 -44.28 76.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.007 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 102.98 128.08 6.28 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.1 p90 -122.88 177.6 5.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.51 -0.994 . . . . 0.0 109.178 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.35 114.39 20.12 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 80.0 t80 . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 -179.656 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.411 0.624 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 t -55.2 -40.94 58.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 110.044 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 111.011 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.446 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.2 mt-30 -59.73 -33.36 71.54 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 111.499 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.6 m -93.86 -30.34 14.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.68 -1.263 . . . . 0.0 112.062 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.498 ' C ' ' H ' ' A' ' 9' ' ' SER . 12.2 t -93.45 -62.75 1.31 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.669 -1.27 . . . . 0.0 109.429 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.12 -10.37 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.8 m -161.46 -150.5 0.2 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.2 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.487 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 72.1 mt -124.07 136.79 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 57.2 m -101.5 173.96 6.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -0.786 . . . . 0.0 110.158 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.3 m -118.82 146.67 44.65 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.55 -34.03 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 110.266 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.29 -35.19 80.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.737 -1.227 . . . . 0.0 108.83 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.7 mt-30 -77.14 -32.68 56.52 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -74.06 -50.31 20.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -61.72 -22.75 65.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.428 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.07 -33.69 76.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.267 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -86.55 -1.27 57.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.622 -1.299 . . . . 0.0 109.204 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -104.22 146.56 28.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.827 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.276 179.721 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.54 151.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -101.84 91.87 4.57 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -136.61 147.62 47.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.423 -0.798 . . . . 0.0 110.014 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.487 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.9 m-70 -71.2 109.52 5.29 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.365 -0.834 . . . . 0.0 108.793 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.04 149.9 20.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.88 -178.39 7.26 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.34 -144.74 10.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.01 -19.9 58.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -1.118 . . . . 0.0 109.87 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -47.53 -58.3 4.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.077 -1.015 . . . . 0.0 108.654 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 tp -50.08 -55.2 15.82 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' B' ' 34' ' ' GLU . 20.1 t -51.54 -60.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 109.079 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 33' ' ' VAL . 42.7 mt-10 -41.23 -42.43 2.11 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.7 -60.63 3.27 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.92 -48.85 60.61 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.8 -1.188 . . . . 0.0 108.177 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -53.69 -25.68 19.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.7 tp -85.1 -62.83 1.44 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.2 -55.95 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.555 0.693 . . . . 0.0 109.921 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 0.9 OUTLIER -73.55 -30.12 62.86 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 110.594 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.37 -119.78 7.65 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.633 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.6 -15.9 47.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.124 . . . . 0.0 110.954 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -52.94 -45.59 67.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.513 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.473 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 100.68 127.71 6.14 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.401 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 29.5 p90 -122.76 177.22 5.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.511 -0.993 . . . . 0.0 108.8 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 46' ' ' PHE . 24.1 m-85 -126.35 114.15 17.84 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.552 0.692 . . . . 0.0 109.388 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 71.7 t80 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.405 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.529 0.68 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -58.8 -37.67 67.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.712 0.768 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.1 -47.48 74.04 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.692 -0.63 . . . . 0.0 111.092 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -77.23 -39.7 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.103 -0.998 . . . . 0.0 111.727 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' SER . 16.7 m -83.12 -27.3 30.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.535 -1.353 . . . . 0.0 112.23 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.9 -55.92 3.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.497 -1.377 . . . . 0.0 109.428 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -157.32 169.85 23.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.405 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 62.9 mt -85.75 140.32 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 110.072 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' SG ' ' NE2' ' A' ' 15' ' ' GLN . 12.4 m -102.61 174.87 5.7 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.492 -0.755 . . . . 0.0 109.517 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 55.5 m -118.54 144.97 45.7 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.62 -34.73 1.52 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.451 -0.781 . . . . 0.0 110.199 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -62.76 -35.25 79.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.841 -1.162 . . . . 0.0 108.703 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.419 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 15.9 mt-30 -76.05 -34.15 59.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 tp -72.4 -50.07 29.16 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.575 -0.703 . . . . 0.0 109.324 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.3 -21.4 65.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' ND2' ' CE2' ' A' ' 14' ' ' TYR . 1.8 m-20 -66.89 -33.47 75.66 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.077 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.53 -2.96 58.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.669 -1.269 . . . . 0.0 109.408 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.5 t -101.47 145.68 28.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -0.781 . . . . 0.0 109.55 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.4 p30 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.43 153.75 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 109.675 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.81 91.13 4.03 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -137.09 146.44 45.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 109.933 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.518 ' N ' ' OE1' ' B' ' 25' ' ' GLN . 15.0 m-70 -68.78 110.03 4.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.369 -0.832 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.515 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -92.66 149.3 21.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.053 -1.03 . . . . 0.0 109.804 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.51 -178.02 7.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.75 -144.1 12.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -76.68 -19.99 57.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -1.096 . . . . 0.0 109.851 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.75 -57.96 4.93 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.027 -1.046 . . . . 0.0 108.73 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 tp -50.67 -55.21 17.53 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.62 -60.02 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.213 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 25.4 mt-10 -41.12 -43.51 2.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -55.37 -60.83 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.37 -48.9 62.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.711 -1.243 . . . . 0.0 108.256 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.16 -25.87 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.3 tp -85.56 -63.14 1.37 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.72 -55.26 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.543 0.687 . . . . 0.0 110.129 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -74.03 -30.37 62.39 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.468 -0.77 . . . . 0.0 110.475 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.92 -117.62 4.28 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.702 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.85 -13.44 53.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.267 -1.137 . . . . 0.0 111.081 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 69.6 mtt180 -58.77 -29.35 66.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.847 -1.158 . . . . 0.0 109.858 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 83.34 128.02 1.33 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.7 p90 -121.98 175.83 6.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.335 -1.097 . . . . 0.0 109.406 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -123.02 116.85 24.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.6 t80 . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.576 -0.703 . . . . 0.0 109.644 -179.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.6 tt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.385 0.612 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.05 -36.94 65.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.496 -0.753 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.57 -23.21 60.94 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.54 -0.725 . . . . 0.0 110.92 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 8.0 tt0 -92.58 -53.56 4.14 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.758 -1.213 . . . . 0.0 110.89 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -72.4 -29.94 64.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 112.266 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.0 t -89.53 -66.71 0.9 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.49 -1.381 . . . . 0.0 109.887 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 m -51.49 -14.84 0.34 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.913 -1.117 . . . . 0.0 108.538 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 7' ' ' CYS . 3.2 t -154.91 -138.73 0.07 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.3 mt -130.44 150.98 35.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.3 m -116.5 169.31 9.43 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.363 -0.836 . . . . 0.0 109.661 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.7 m -117.52 145.59 44.13 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -42.98 -33.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.509 -0.745 . . . . 0.0 110.245 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.75 -35.74 82.04 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.683 -1.26 . . . . 0.0 108.857 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.7 mt-30 -76.54 -32.49 58.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 tp -74.0 -51.0 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.3 -24.59 65.09 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -62.97 -34.86 78.42 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.071 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.62 -2.52 57.57 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.646 -1.284 . . . . 0.0 109.411 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 t -101.86 145.81 28.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.59 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 3.0 m-20 . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.82 142.41 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.9 OUTLIER -92.33 75.6 5.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.411 -0.806 . . . . 0.0 109.568 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -115.92 158.69 22.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.42 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 6.3 m-70 -77.28 110.79 12.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 109.91 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.509 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.8 mt -92.72 150.83 20.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.808 -1.182 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 68.6 m -156.28 -177.98 6.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.05 -144.22 10.55 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -76.99 -19.65 57.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -1.104 . . . . 0.0 109.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -47.28 -56.05 7.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.064 -1.023 . . . . 0.0 108.781 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -51.19 -55.2 19.17 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.8 t -52.18 -58.8 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.137 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.7 mt-10 -41.17 -40.09 1.46 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -59.27 -60.53 3.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.8 -44.73 63.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.607 -1.308 . . . . 0.0 108.372 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -57.12 -25.5 58.93 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.06 1.39 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.34 -55.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.522 0.677 . . . . 0.0 110.215 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.74 -30.54 61.54 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.536 -0.727 . . . . 0.0 110.87 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 -115.23 2.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.327 -1.415 . . . . 0.0 109.759 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -83.68 -21.26 32.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.38 -1.071 . . . . 0.0 110.962 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -52.2 -28.69 19.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.869 -1.145 . . . . 0.0 109.901 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 80.58 129.34 0.86 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.5 p90 -123.54 177.16 5.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.463 -1.022 . . . . 0.0 109.118 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.06 120.25 29.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 tt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.48 0.657 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -54.34 -39.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.49 -0.756 . . . . 0.0 109.778 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -73.2 -20.44 60.88 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.533 -0.729 . . . . 0.0 110.339 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.582 HE22 ' HH ' ' A' ' 19' ' ' TYR . 20.9 mt-30 -91.29 -36.89 13.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 110.622 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 m -94.85 -27.36 15.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.02 . . . . 0.0 111.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 t -91.0 -59.57 2.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.753 -1.217 . . . . 0.0 109.715 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -65.61 -13.47 59.13 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.115 -0.991 . . . . 0.0 108.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -158.49 164.52 36.1 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.9 mt -81.94 137.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.162 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 9.7 m -96.83 168.25 10.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 15' ' ' GLN . 75.4 m -118.46 144.68 45.81 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tp -43.45 -33.65 1.13 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.347 -0.846 . . . . 0.0 110.272 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.77 -35.58 81.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.719 -1.238 . . . . 0.0 108.776 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.1 mt-30 -76.84 -32.55 57.63 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -74.26 -50.14 20.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.66 -0.65 . . . . 0.0 109.292 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -61.65 -23.39 66.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -63.57 -34.71 78.4 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.945 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' HH ' HE22 ' A' ' 5' ' ' GLN . 98.4 m-85 -84.83 -6.63 59.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.7 -1.25 . . . . 0.0 109.263 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -98.99 145.89 26.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.1 p30 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -78.55 152.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.049 -1.032 . . . . 0.0 110.067 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -97.78 93.92 6.64 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -141.89 144.98 34.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 109.975 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -68.92 109.86 4.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.991 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.27 150.5 20.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.019 . . . . 0.0 109.949 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.92 -178.24 7.16 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.9 -145.3 8.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -75.22 -19.52 59.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -1.162 . . . . 0.0 109.95 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.09 -57.65 5.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.039 -1.038 . . . . 0.0 108.751 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 tp -49.99 -55.77 13.33 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.24 -59.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.312 -0.868 . . . . 0.0 109.39 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 23.1 mt-10 -41.24 -42.15 2.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.69 -60.78 3.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.2 -48.37 62.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.685 -1.259 . . . . 0.0 108.228 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.95 -25.58 21.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.41 -63.0 1.4 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -52.58 -56.45 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.505 0.669 . . . . 0.0 110.022 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 0.7 OUTLIER -73.28 -30.37 63.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.527 -0.733 . . . . 0.0 110.585 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.76 -118.71 5.15 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.279 -1.439 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.72 -11.55 57.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.274 -1.133 . . . . 0.0 110.894 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -59.8 -34.65 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.927 -1.108 . . . . 0.0 109.806 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.497 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.75 127.16 2.85 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.3 p90 -119.62 177.2 5.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.8 114.58 19.43 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 tt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.394 0.616 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -55.8 -38.96 53.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -75.34 -20.32 59.1 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.507 -0.745 . . . . 0.0 110.294 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -91.38 -36.99 13.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.944 -1.098 . . . . 0.0 110.771 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 4.8 m -95.76 -26.07 15.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.084 . . . . 0.0 111.882 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -90.19 -58.78 2.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.614 -1.304 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 m -65.22 -12.34 50.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.3 m -159.67 172.83 17.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 75.2 mt -89.91 135.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.735 -1.228 . . . . 0.0 109.558 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.2 m -96.8 171.48 8.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 109.846 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 60.5 m -118.53 144.83 45.79 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tp -44.18 -33.64 1.59 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.43 -34.87 78.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.702 -1.248 . . . . 0.0 108.66 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -76.92 -34.27 57.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.54 -50.41 25.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.631 -0.668 . . . . 0.0 109.241 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.44 -22.18 64.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -66.56 -33.64 76.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.104 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -85.62 -2.57 58.31 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.694 -1.253 . . . . 0.0 109.433 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -99.35 145.76 27.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.623 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.17 155.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.65 92.94 5.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.92 144.07 41.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.44 -0.787 . . . . 0.0 109.737 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.409 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 13.7 m-70 -69.67 109.75 4.51 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.01 150.12 20.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.814 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -155.81 -178.08 7.03 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.12 -144.04 11.0 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -76.36 -19.8 57.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -1.073 . . . . 0.0 109.928 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.88 -58.92 3.76 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.035 -1.041 . . . . 0.0 108.675 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -48.8 -56.23 9.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' B' ' 34' ' ' GLU . 28.6 t -50.09 -58.94 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.2 mt-10 -41.2 -40.98 1.71 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.97 -60.77 3.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.48 -46.08 63.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.596 -1.315 . . . . 0.0 108.361 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.36 -25.28 48.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.07 1.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.7 t -53.16 -55.86 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.593 0.711 . . . . 0.0 110.099 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -73.34 -30.67 63.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.595 -0.69 . . . . 0.0 110.701 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.76 -115.27 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.634 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -84.08 -15.65 46.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.333 -1.098 . . . . 0.0 111.004 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -58.97 -18.22 31.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.851 -1.155 . . . . 0.0 109.779 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 69.18 128.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.8 p90 -121.14 177.43 5.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.454 -1.027 . . . . 0.0 109.199 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.491 ' CE1' ' OD1' ' A' ' 21' ' ' ASN . 36.2 m-85 -125.52 119.85 29.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.2 t80 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.782 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.527 0.679 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.66 -39.75 56.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.622 -0.674 . . . . 0.0 109.904 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.96 -20.16 60.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.483 -0.76 . . . . 0.0 110.344 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -91.11 -37.98 13.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.993 -1.067 . . . . 0.0 110.705 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.2 m -96.59 -24.15 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.99 -1.069 . . . . 0.0 111.929 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.23 -55.57 3.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.518 -1.364 . . . . 0.0 109.25 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -65.61 -18.66 65.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.2 m -154.6 173.21 16.66 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.572 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 66.5 mt -91.13 133.4 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.738 -1.226 . . . . 0.0 109.407 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 33.5 m -92.72 172.97 8.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.9 m -118.49 145.98 44.87 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tp -43.54 -34.38 1.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 110.12 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.441 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.59 80.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.0 108.928 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -76.56 -36.81 57.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.71 -50.95 38.75 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.616 -0.678 . . . . 0.0 109.257 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.37 -25.51 65.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.4 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.19 -33.99 77.05 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.962 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.443 ' O ' ' CE2' ' B' ' 46' ' ' PHE . 91.9 m-85 -84.44 2.15 42.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.725 -1.234 . . . . 0.0 109.105 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.1 t -106.34 146.04 30.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.17 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.383 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -75.93 156.77 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.617 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.23 92.87 4.92 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.17 141.69 47.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.666 ' ND1' ' H ' ' B' ' 26' ' ' HIS . 1.8 m80 -69.23 109.85 4.3 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.408 -0.807 . . . . 0.0 109.512 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.1 mt -92.64 150.18 20.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 110.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.7 m -156.65 177.37 11.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.51 -145.54 18.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -74.17 -21.21 59.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.084 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.91 -53.19 16.64 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 0.0 108.62 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.36 -56.48 20.54 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 34' ' ' GLU . 24.1 t -47.82 -60.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.26 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 33' ' ' VAL . 38.6 mt-10 -41.1 -42.93 2.11 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -54.74 -61.02 2.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 26.6 mt -52.67 -47.58 67.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.473 -1.392 . . . . 0.0 108.146 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -53.57 -26.1 20.03 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.5 tp -85.07 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.24 -56.91 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.716 0.77 . . . . 0.0 109.721 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.8 t -70.34 -29.96 66.79 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.724 -0.61 . . . . 0.0 110.662 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.56 -125.67 22.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.6 -9.04 59.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -1.14 . . . . 0.0 110.804 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -55.46 -42.15 73.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.903 -1.123 . . . . 0.0 109.587 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 101.64 126.62 5.88 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -130.84 165.65 22.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.567 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -120.5 114.29 21.55 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.932 0.873 . . . . 0.0 109.584 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 85.4 t80 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.5 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.445 0.64 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.4 t -56.05 -38.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 110.581 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 6.9 tp-100 -91.42 -33.13 15.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 0.0 110.543 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 m -96.78 -29.76 13.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.938 -1.101 . . . . 0.0 111.404 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.8 t -92.83 -63.33 1.24 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.758 -1.214 . . . . 0.0 109.584 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -4.84 1.09 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 7' ' ' CYS . 39.7 t -161.07 -148.92 0.16 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.51 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.5 mt -127.71 140.96 47.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 69.4 m -109.31 164.71 12.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.37 -0.832 . . . . 0.0 110.417 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 15' ' ' GLN . 61.1 m -114.68 146.33 41.01 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -43.13 -34.16 1.03 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.758 . . . . 0.0 110.315 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.54 -33.92 77.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.746 -1.221 . . . . 0.0 108.706 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.4 mt-30 -79.22 -30.56 43.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.3 -49.83 17.96 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.67 -23.26 65.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.6 m-20 -64.78 -34.56 78.63 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.0 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.51 -4.57 59.02 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.678 -1.264 . . . . 0.0 109.151 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.9 t -100.23 145.95 27.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 109.566 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 3.6 p30 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.3 157.95 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.789 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.6 93.18 5.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.06 144.68 45.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.782 . . . . 0.0 110.04 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.51 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.3 m-70 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.482 -0.761 . . . . 0.0 109.666 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.6 mt -92.52 150.78 20.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 109.347 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.4 m -155.7 -177.85 6.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.3 -144.11 11.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -77.23 -18.82 57.37 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.47 -58.48 4.14 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.086 -1.009 . . . . 0.0 108.715 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.67 -55.91 10.0 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.6 t -52.19 -58.96 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.012 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 33' ' ' VAL . 15.4 mt-10 -41.47 -41.87 2.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.87 -60.8 3.04 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.74 -48.87 58.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.0 108.318 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.84 -24.42 22.97 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.3 tp -85.25 -55.78 3.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 37.6 t -61.51 -59.58 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.605 0.716 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.1 t -70.11 -30.22 67.37 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.649 -0.657 . . . . 0.0 110.711 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.52 -119.32 5.54 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.347 -1.406 . . . . 0.0 109.856 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.68 -12.64 55.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -1.133 . . . . 0.0 110.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 74.8 mtt180 -58.14 -31.87 67.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 87.52 126.49 2.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -119.22 177.23 4.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -1.091 . . . . 0.0 109.341 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -125.66 115.48 20.18 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.853 -0.529 . . . . 0.0 109.715 -179.63 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.594 0.711 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -61.26 -38.8 80.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.591 0.71 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.93 -20.07 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 109.995 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -90.71 -27.98 18.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.987 -1.071 . . . . 0.0 110.708 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' SER . 59.1 m -103.4 -30.45 10.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.043 -1.036 . . . . 0.0 111.082 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.0 t -93.65 -63.78 1.16 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.879 -1.138 . . . . 0.0 109.777 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -62.03 -10.05 8.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -162.93 164.15 25.95 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.358 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 67.0 mt -85.59 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 0.0 109.049 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.47 160.32 17.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.46 -0.775 . . . . 0.0 110.053 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' GLN . 44.9 m -103.39 147.71 26.78 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.46 -35.1 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.494 -0.754 . . . . 0.0 110.242 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.1 -35.3 79.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.768 -1.208 . . . . 0.0 108.566 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.1 mt-30 -77.85 -26.96 49.72 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.81 -47.97 15.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.446 -0.784 . . . . 0.0 108.947 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -62.59 -21.39 65.58 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.476 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 4.0 m-20 -65.43 -34.53 78.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.145 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' O ' ' CE2' ' B' ' 46' ' ' PHE . 83.7 m-85 -84.76 1.78 45.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.562 -1.336 . . . . 0.0 109.044 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -109.67 146.1 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 2.9 p30 . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.318 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.53 157.34 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.83 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.85 92.62 4.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -137.39 144.19 42.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 109.809 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 15.2 m-70 -69.1 109.51 4.06 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.149 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.0 mt -90.89 149.51 21.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.133 -0.98 . . . . 0.0 109.708 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 47.3 m -155.91 -178.08 7.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.12 -145.55 16.4 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.15 -19.99 57.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -47.43 -60.62 2.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.074 -1.016 . . . . 0.0 108.658 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -47.29 -56.46 6.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' B' ' 34' ' ' GLU . 35.2 t -50.78 -59.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.261 -0.899 . . . . 0.0 108.903 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.9 mt-10 -41.43 -39.58 1.53 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -59.68 -59.88 4.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -45.41 66.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.5 -1.375 . . . . 0.0 108.069 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -56.27 -25.93 49.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -84.77 -58.32 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.36 -56.73 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -72.83 -31.03 64.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.652 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -112.94 1.3 Allowed Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.794 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.03 -20.35 32.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 111.226 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -52.41 -50.81 61.78 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.799 -1.188 . . . . 0.0 109.665 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.57 127.73 6.15 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -125.3 170.23 11.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.556 ' N ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.86 114.09 19.38 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.948 0.88 . . . . 0.0 109.544 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 73.3 t80 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.407 0.622 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -50.69 -40.58 19.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.735 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -75.4 -19.65 59.39 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.769 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -88.89 -41.17 12.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.144 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.5 m -91.2 -30.41 16.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 111.75 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.5 t -92.91 -66.72 0.9 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.647 -1.283 . . . . 0.0 110.508 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -57.21 -10.17 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.976 -1.077 . . . . 0.0 108.498 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -163.12 176.64 9.83 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.113 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.0 mt -97.09 135.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.997 -1.064 . . . . 0.0 108.901 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 p -103.06 158.29 16.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.487 -0.758 . . . . 0.0 110.275 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.8 m -100.25 146.54 26.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -43.45 -34.4 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.25 79.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 108.702 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.8 mt-30 -77.58 -29.47 52.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.9 -49.09 16.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.509 -0.745 . . . . 0.0 109.068 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.44 -23.53 66.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.478 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.7 m-20 -61.62 -35.56 78.24 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.149 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.5 -3.84 58.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.716 -1.24 . . . . 0.0 109.395 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.5 t -100.55 146.37 27.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.442 -0.786 . . . . 0.0 109.671 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' B' ' 43' ' ' ARG . 2.2 p30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.42 152.19 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 93.68 7.31 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.17 144.46 42.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.434 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.3 m-70 -73.87 109.97 7.8 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.0 mt -92.26 148.77 21.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 109.773 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.8 m -155.41 -177.79 6.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.24 -143.57 15.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.73 -18.17 54.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -1.173 . . . . 0.0 109.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -48.18 -57.07 6.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.002 -1.061 . . . . 0.0 108.447 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 tp -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.5 t -51.32 -59.03 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.898 . . . . 0.0 108.972 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.1 mt-10 -42.49 -40.19 2.52 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -59.48 -60.18 4.27 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -51.65 -45.95 63.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.675 -1.265 . . . . 0.0 108.103 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.44 -24.95 48.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.08 -62.98 1.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.41 -57.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.748 0.785 . . . . 0.0 109.749 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.477 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.7 t -70.13 -29.53 66.49 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.662 -0.649 . . . . 0.0 110.564 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.75 -126.3 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.369 -1.396 . . . . 0.0 109.758 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -83.18 -5.96 59.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.244 -1.151 . . . . 0.0 110.649 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.45 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.6 mtt180 -61.63 -37.21 83.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.943 -1.098 . . . . 0.0 109.666 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.477 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 95.19 126.07 4.74 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.417 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.4 p90 -121.53 177.6 5.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.472 -1.016 . . . . 0.0 109.181 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -127.03 118.59 24.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 t80 . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.5 tt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.366 0.603 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 t -54.51 -38.89 43.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.869 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -76.31 -25.87 55.23 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.467 -0.77 . . . . 0.0 110.261 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.523 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.2 tt0 -91.35 -29.69 16.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.888 -1.132 . . . . 0.0 110.441 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.6 m -93.39 -30.96 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 111.187 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.535 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.9 t -94.57 -63.74 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.859 -1.15 . . . . 0.0 110.174 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 m -57.68 -7.42 0.67 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 108.248 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.535 ' H ' ' C ' ' A' ' 7' ' ' CYS . 35.7 t -156.65 -148.89 0.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.856 0.836 . . . . 0.0 109.44 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.588 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 80.1 mt -130.95 144.97 36.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.69 154.91 29.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.242 -0.911 . . . . 0.0 110.064 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -98.75 149.4 22.9 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tp -44.22 -33.41 1.55 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.84 -34.67 78.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.706 -1.246 . . . . 0.0 108.752 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.523 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.3 mt-30 -78.82 -30.34 45.31 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.53 -50.17 16.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.54 -26.18 66.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -61.35 -35.03 76.32 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.161 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -83.62 -4.5 58.64 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.652 -1.28 . . . . 0.0 109.322 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -100.23 146.28 27.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 0.0 109.58 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 4.0 p30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.381 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.86 155.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.97 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -99.62 91.33 4.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 26' ' ' HIS . 0.3 OUTLIER -133.83 142.6 47.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.531 -0.731 . . . . 0.0 109.863 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.689 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.7 m80 -67.8 109.75 3.5 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.509 -0.744 . . . . 0.0 110.491 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.522 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -92.96 149.06 21.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.802 . . . . 0.0 109.339 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.3 m -155.71 -178.12 7.06 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.71 -143.37 18.59 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -78.77 -18.62 53.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -1.114 . . . . 0.0 109.815 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -47.64 -58.37 4.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.06 -1.025 . . . . 0.0 108.636 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -48.84 -55.71 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' B' ' 34' ' ' GLU . 19.9 t -52.2 -59.07 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.257 -0.902 . . . . 0.0 108.839 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' B' ' 33' ' ' VAL . 18.0 mt-10 -42.36 -41.63 2.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.59 -60.39 3.74 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.69 -47.67 63.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.618 -1.301 . . . . 0.0 108.194 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -54.68 -25.46 27.3 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -84.89 -62.83 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.24 -58.43 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.703 0.763 . . . . 0.0 109.706 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.69 -28.69 66.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.682 -0.636 . . . . 0.0 110.585 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.19 -132.49 48.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.75 -4.91 58.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -57.65 -43.26 84.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 127.09 6.0 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.444 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.2 p90 -122.98 177.36 5.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.484 -1.01 . . . . 0.0 108.87 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -122.54 113.48 19.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 72.5 t80 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.27 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.351 0.596 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -50.39 -39.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.48 -24.39 50.19 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.508 -0.745 . . . . 0.0 110.139 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.97 -22.14 20.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.943 -1.098 . . . . 0.0 110.113 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' SER . 56.5 m -104.62 -30.43 9.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.987 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.2 t -98.51 -66.13 0.92 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.947 -1.095 . . . . 0.0 109.855 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -57.63 -9.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.3 m -161.72 -176.48 5.3 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.587 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 57.4 mt -106.64 137.81 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.063 -1.023 . . . . 0.0 108.849 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.44 156.86 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.472 -0.767 . . . . 0.0 109.947 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.1 m -99.78 147.94 24.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.44 -34.26 1.27 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.492 -0.755 . . . . 0.0 110.16 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.55 -34.7 78.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.723 -1.236 . . . . 0.0 108.75 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -78.82 -28.76 44.51 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.8 -49.53 15.65 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.68 -25.29 67.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -60.56 -35.83 77.01 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.173 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -83.43 0.35 46.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.626 -1.296 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.81 146.36 31.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.736 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.81 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -47.77 158.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.747 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.07 89.47 3.01 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.18 141.89 51.63 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.573 -0.705 . . . . 0.0 109.671 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.692 ' ND1' ' H ' ' B' ' 26' ' ' HIS . 3.0 m80 -66.24 110.66 3.11 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.406 -0.809 . . . . 0.0 110.555 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -90.94 149.72 21.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -156.09 -178.13 7.09 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.31 -144.23 14.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.19 -18.94 54.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -47.32 -56.87 5.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.086 -1.009 . . . . 0.0 108.62 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.14 -56.29 11.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.5 t -51.34 -60.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.276 -0.89 . . . . 0.0 109.113 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 17.7 mm-40 -41.42 -42.39 2.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.373 0.606 . . . . 0.0 109.378 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.31 -60.3 3.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.2 mt -51.17 -49.02 61.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.628 -1.295 . . . . 0.0 108.083 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -53.07 -26.18 15.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.2 -62.96 1.41 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.06 -55.71 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.438 0.637 . . . . 0.0 110.175 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -75.37 -30.83 60.29 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 110.94 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.8 -111.94 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.184 -1.484 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -83.87 -23.89 31.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.343 -1.092 . . . . 0.0 110.947 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -52.25 -28.16 17.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.91 -1.119 . . . . 0.0 110.008 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 79.39 129.75 0.69 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.407 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 27.6 p90 -123.07 177.01 5.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.571 -0.958 . . . . 0.0 108.944 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.01 122.19 33.76 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 78.0 t80 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.919 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.6 tt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.354 0.597 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 t -54.33 -39.94 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -75.29 -19.54 59.62 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.465 -0.772 . . . . 0.0 110.472 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.8 mt-30 -90.67 -40.48 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 110.711 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -92.67 -24.27 18.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.916 -1.115 . . . . 0.0 111.944 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.1 t -94.91 -66.65 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.638 -1.289 . . . . 0.0 109.485 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -57.77 -8.84 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -160.84 -159.07 0.64 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 78.1 mt -119.03 139.76 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.28 -0.888 . . . . 0.0 109.198 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 90.6 m -104.39 171.67 7.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.439 -0.788 . . . . 0.0 110.097 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 48.2 m -118.46 145.67 45.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tp -43.65 -33.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.437 -0.789 . . . . 0.0 110.214 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.85 -34.98 79.16 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.742 -1.223 . . . . 0.0 108.491 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.8 mt-30 -77.04 -34.69 57.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.5 -50.52 30.62 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.596 -0.69 . . . . 0.0 109.212 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.32 -23.56 65.81 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.413 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.1 m-20 -65.76 -33.82 76.74 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.125 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -84.42 -4.65 59.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.674 -1.266 . . . . 0.0 109.398 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -98.9 145.99 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.404 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 22.6 p-10 . . . . . 0 C--N 1.303 -1.445 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.68 154.35 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.0 110.083 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.22 96.02 10.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -137.18 144.28 42.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.188 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.42 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.8 m-70 -74.37 108.78 7.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -94.52 150.77 19.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.082 -1.011 . . . . 0.0 109.775 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 56.6 m -155.77 -177.97 6.95 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.31 -144.75 10.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -76.24 -19.89 57.93 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.259 -1.142 . . . . 0.0 109.798 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -47.19 -57.73 4.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.061 -1.024 . . . . 0.0 108.804 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -50.92 -55.85 15.19 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.0 t -50.74 -59.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' VAL . 45.8 mt-10 -41.1 -42.36 1.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.62 -60.53 3.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.15 -48.67 61.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.595 -1.316 . . . . 0.0 108.276 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -53.9 -25.68 21.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.07 -62.91 1.43 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 t -53.62 -58.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.601 0.715 . . . . 0.0 109.909 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.95 -28.38 65.51 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 110.476 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 -130.32 46.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -82.76 -10.4 58.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -1.139 . . . . 0.0 109.971 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -52.93 -45.09 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 128.24 6.3 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.432 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 21.9 p90 -122.68 177.41 5.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -1.018 . . . . 0.0 109.121 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.57 117.74 25.0 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.709 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.3 tt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.347 0.594 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 t -52.39 -38.91 26.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.26 -27.71 59.53 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.177 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.3 tt0 -91.66 -28.78 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.841 -1.162 . . . . 0.0 110.594 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' SER . 18.3 m -92.98 -28.94 16.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 0.0 111.2 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.454 ' C ' ' H ' ' A' ' 9' ' ' SER . 14.1 t -96.43 -66.32 0.91 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.891 -1.13 . . . . 0.0 109.985 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -56.41 -12.71 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -154.93 -179.28 7.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 54.3 mt -105.83 138.78 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.136 -0.978 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.48 157.03 17.44 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 36.1 m -99.02 147.94 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.71 -33.14 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.445 -0.784 . . . . 0.0 110.092 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -65.01 -34.72 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.782 -1.199 . . . . 0.0 108.75 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.526 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.0 mt-30 -78.57 -31.82 47.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -74.09 -50.17 20.73 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.75 -25.5 66.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.3 m-20 -63.1 -34.63 78.01 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.21 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -83.14 -2.22 54.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.617 -1.302 . . . . 0.0 109.221 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.28 146.57 28.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.539 -0.726 . . . . 0.0 109.789 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.395 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.02 153.68 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.815 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.63 92.69 5.22 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.46 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.1 tm0? -134.18 139.87 46.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.387 -0.821 . . . . 0.0 109.555 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.67 ' ND1' ' H ' ' B' ' 26' ' ' HIS . 3.0 m80 -65.53 110.2 2.62 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.299 -0.876 . . . . 0.0 110.172 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -91.21 148.63 22.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.684 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.5 m -155.4 -177.87 6.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.3 -144.2 20.07 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.31 -18.94 54.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 109.677 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.1 m-20 -47.54 -57.83 4.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 108.686 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 tp -49.47 -55.54 12.89 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.2 t -52.65 -59.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.234 -0.916 . . . . 0.0 108.757 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -42.0 -41.21 2.45 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.15 -60.36 3.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -51.73 -45.74 63.73 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.761 -1.212 . . . . 0.0 108.281 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -56.05 -25.64 45.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -84.96 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -53.48 -56.98 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.645 0.736 . . . . 0.0 109.568 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.8 t -70.43 -29.42 66.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.72 -0.613 . . . . 0.0 110.781 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.92 -129.26 38.63 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.371 -1.395 . . . . 0.0 109.695 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.12 -3.69 57.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -1.139 . . . . 0.0 110.526 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -62.38 -34.08 76.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.961 -1.087 . . . . 0.0 109.629 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.0 128.01 4.27 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.451 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 17.0 p90 -123.06 177.77 5.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.42 -1.047 . . . . 0.0 109.059 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.3 114.26 19.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.1 t80 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 -179.751 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.844 0.831 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -68.4 -36.42 74.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.619 0.724 . . . . 0.0 110.018 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.82 -20.14 58.39 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.19 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.9 mt-30 -91.04 -34.98 14.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.53 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -95.48 -30.35 13.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.814 -1.179 . . . . 0.0 111.385 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.2 t -92.96 -64.14 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.816 -1.177 . . . . 0.0 109.911 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -60.1 -5.79 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 7' ' ' CYS . 42.6 t -159.74 -145.84 0.13 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.591 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 91.9 mt -130.05 142.44 43.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 60.4 m -109.18 151.05 26.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.283 -0.886 . . . . 0.0 110.628 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLN . 59.3 m -101.23 146.0 28.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.54 -34.02 1.28 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.01 -34.76 78.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.718 -1.239 . . . . 0.0 108.698 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.3 mt-30 -77.58 -33.01 54.07 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.6 tp -72.95 -50.26 24.45 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.621 -0.674 . . . . 0.0 109.237 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -61.61 -20.79 63.74 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.4 m-20 -69.2 -32.74 72.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -85.83 -6.98 59.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.588 -1.32 . . . . 0.0 109.283 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 t -93.61 142.6 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.891 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.34 154.64 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.85 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.58 90.28 4.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -132.45 145.1 50.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.614 -0.679 . . . . 0.0 109.599 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.719 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.1 m80 -68.32 110.5 4.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.514 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.76 150.87 20.36 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.19 -178.11 7.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.62 -142.07 12.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.05 -18.07 54.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.355 -1.086 . . . . 0.0 109.92 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -48.3 -55.42 10.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.99 -1.069 . . . . 0.0 108.693 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -51.04 -56.2 13.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.3 t -51.65 -59.84 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 6.0 mm-40 -40.94 -41.56 1.66 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.422 0.63 . . . . 0.0 109.378 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.55 -60.3 3.88 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.7 mt -51.05 -48.87 61.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.693 -1.254 . . . . 0.0 108.127 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -53.65 -25.41 17.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.28 -62.86 1.43 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 t -54.16 -57.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.8 -30.06 67.51 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.676 -0.64 . . . . 0.0 110.453 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 -121.25 8.0 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.61 -8.76 59.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -1.162 . . . . 0.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -62.79 -17.6 61.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.875 -1.141 . . . . 0.0 109.846 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 70.69 129.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -119.7 177.67 4.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.412 -1.052 . . . . 0.0 110.192 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -121.63 115.82 23.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 87.4 t80 . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.482 0.658 . . . . 0.0 110.317 -179.146 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.994 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -60.16 -25.73 34.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.353 -1.086 . . . . 0.0 109.311 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 -40.14 79.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.457 0.646 . . . . 0.0 110.58 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.2 -54.07 16.74 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.448 -0.782 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.8 mt-30 -61.06 -33.87 73.98 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.234 -0.916 . . . . 0.0 111.72 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 m -96.17 -30.63 13.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.691 -1.256 . . . . 0.0 112.372 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 t -91.65 -58.2 2.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.625 -1.297 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -66.22 -11.17 48.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -161.22 166.31 27.96 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.217 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.4 mt -82.29 137.65 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.877 -1.139 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 5.9 m -98.93 171.64 7.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.416 -0.803 . . . . 0.0 110.041 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 m -118.6 144.9 45.81 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -44.19 -35.09 2.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 110.135 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -61.24 -36.83 81.03 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.621 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.497 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 16.3 mt-30 -74.21 -41.62 61.09 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.35 -49.59 71.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -63.06 -25.31 68.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.943 0.878 . . . . 0.0 108.745 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.12 -32.31 73.68 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.75 -0.34 56.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.686 -1.259 . . . . 0.0 109.119 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -94.33 146.3 24.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' B' ' 44' ' ' GLY . 38.7 t-20 . . . . . 0 C--N 1.299 -1.594 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.778 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.31 159.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.987 . . . . 0.0 109.797 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.1 92.78 4.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -139.55 144.64 37.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.425 -0.797 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -68.59 109.59 3.84 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.343 -0.848 . . . . 0.0 109.133 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.2 mt -92.01 149.23 21.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.928 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.0 m -156.4 -178.13 7.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.9 -143.87 18.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.49 -20.37 54.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.831 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -47.28 -59.03 3.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.087 -1.008 . . . . 0.0 108.732 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.96 -54.72 14.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 34' ' ' GLU . 31.1 t -52.63 -59.02 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.212 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -40.99 -41.79 1.73 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.78 -60.5 3.6 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.79 -46.17 64.11 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.646 -1.284 . . . . 0.0 108.359 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -55.73 -25.57 41.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.4 tp -85.25 -63.3 1.35 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.48 -56.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.603 0.716 . . . . 0.0 110.004 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.4 t -71.71 -30.36 65.56 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 110.665 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -120.58 6.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' B' ' 42' ' ' GLU . 1.3 pm0 -84.36 -12.56 54.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -1.142 . . . . 0.0 110.959 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -54.91 -33.36 62.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.85 -1.156 . . . . 0.0 109.989 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.76 126.86 4.18 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.25 172.93 10.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.058 -1.26 . . . . 0.0 108.761 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.61 119.77 28.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.631 -0.668 . . . . 0.0 109.437 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -129.64 109.29 10.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.1 t -175.74 -129.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.537 ' N ' ' OG1' ' B' ' 48' ' ' THR . 33.1 mttp 42.76 51.58 6.79 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 26.8 Cg_exo -28.62 112.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.582 2.855 . . . . 0.0 112.674 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.427 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.917 0 N-CA-C 119.874 2.709 . . . . 0.0 119.874 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt -62.53 -32.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -1.115 . . . . 0.0 109.787 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 t -58.84 -38.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.47 -0.769 . . . . 0.0 110.037 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.94 -45.18 75.0 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.679 -0.638 . . . . 0.0 110.821 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -75.97 -31.81 59.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.139 -0.976 . . . . 0.0 111.598 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 12.0 m -94.27 -28.17 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.62 -1.3 . . . . 0.0 112.104 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' C ' ' H ' ' A' ' 9' ' ' SER . 15.1 t -90.49 -62.38 1.47 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.0 109.598 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.38 -9.75 0.77 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.5 m -160.11 -147.18 0.15 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.335 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.09 141.88 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.901 . . . . 0.0 108.931 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.56 174.12 6.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 15' ' ' GLN . 54.0 m -118.31 146.69 44.14 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.8 -34.64 1.63 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.481 -0.762 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.06 -35.46 80.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 108.521 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.9 mt-30 -76.73 -35.73 57.6 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.49 -50.29 39.51 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.644 -0.66 . . . . 0.0 109.288 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -60.81 -26.85 67.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -61.89 -34.29 75.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.235 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.01 -4.4 58.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.602 -1.311 . . . . 0.0 109.334 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 t -100.69 146.47 27.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.407 -0.808 . . . . 0.0 109.691 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 3.7 p30 . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 p -57.54 157.37 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.699 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -106.32 88.94 2.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.04 151.8 48.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.524 -0.735 . . . . 0.0 109.539 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -74.59 110.42 8.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.183 -0.948 . . . . 0.0 109.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -92.03 148.69 22.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.784 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.3 m -155.81 -177.87 6.88 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.14 -142.77 16.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.84 -18.58 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -1.134 . . . . 0.0 109.792 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.82 -57.8 5.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.0 108.814 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -49.29 -55.2 13.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 23.3 t -51.61 -59.49 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.115 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 29.0 mt-10 -41.31 -39.97 1.54 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.87 -60.49 3.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.1 mt -51.64 -46.45 63.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.547 -1.345 . . . . 0.0 108.186 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -55.03 -25.72 32.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -85.24 -63.07 1.39 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.15 -56.72 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.627 0.727 . . . . 0.0 109.943 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -71.47 -29.29 64.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.624 -0.672 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.55 -130.2 41.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -82.83 -6.91 59.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.213 -1.169 . . . . 0.0 110.152 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -56.95 -39.46 74.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.479 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 98.4 127.7 5.9 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -124.03 176.85 6.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -1.048 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.1 116.89 24.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -129.25 109.11 10.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 1.3 t -177.95 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 109.081 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' OG1' ' B' ' 48' ' ' THR . 70.3 tttt 45.22 49.75 6.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 26.7 Cg_exo -28.5 147.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.629 2.886 . . . . 0.0 112.659 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.592 ' CA ' ' HG1' ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.939 0 N-CA-C 119.791 2.676 . . . . 0.0 119.791 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.27 -38.41 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -1.108 . . . . 0.0 109.202 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 t -49.72 -40.06 15.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.589 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.49 -61.33 2.05 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.377 -0.827 . . . . 0.0 111.056 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.66 -27.96 69.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 111.037 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 m -88.42 -31.55 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.698 -1.251 . . . . 0.0 110.866 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.6 t -101.89 -58.77 1.82 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -60.49 -7.04 1.86 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 7' ' ' CYS . 37.3 t -163.12 -144.28 0.09 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.626 0.727 . . . . 0.0 109.53 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.2 mt -130.02 156.46 42.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.52 147.33 50.68 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.264 -0.897 . . . . 0.0 109.486 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.6 m -90.84 148.0 22.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -43.41 -34.31 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.533 -0.73 . . . . 0.0 110.145 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.88 -34.71 78.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 108.584 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' SER . 17.0 mt-30 -77.96 -28.04 49.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tp -78.17 -49.08 14.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.99 -23.03 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.481 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -62.85 -35.18 79.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.12 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.64 -2.73 57.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.685 -1.259 . . . . 0.0 109.232 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 t -101.42 145.92 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.425 -0.797 . . . . 0.0 109.892 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.649 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -47.99 159.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.04 90.05 3.25 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -126.09 151.97 46.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -75.45 110.3 9.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 16.2 mt -91.58 151.0 20.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.002 -1.061 . . . . 0.0 109.43 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 86.1 m -156.11 -177.95 6.95 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.33 -145.22 12.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.87 -17.67 57.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.31 -1.112 . . . . 0.0 109.714 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.71 -58.02 4.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.064 -1.022 . . . . 0.0 108.859 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -48.49 -54.38 14.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.28 -46.5 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.123 -0.986 . . . . 0.0 108.91 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -41.25 29.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -61.63 -60.11 4.17 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 24.0 mt -52.17 -42.54 63.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.301 -1.5 . . . . 0.0 108.39 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -60.45 -25.01 65.67 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.5 -63.04 1.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.18 -56.31 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.529 0.68 . . . . 0.0 110.207 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.78 -30.52 61.47 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 110.925 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.86 -117.52 4.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -84.06 -15.13 48.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -1.12 . . . . 0.0 111.035 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -57.25 -23.92 51.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.912 -1.118 . . . . 0.0 109.835 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 77.36 128.62 0.39 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.424 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 25.0 p90 -121.71 177.37 5.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.464 -1.021 . . . . 0.0 109.28 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 8.0 m-85 -125.19 120.23 30.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -129.26 107.39 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.5 OUTLIER 169.59 -116.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.551 ' N ' ' OG1' ' B' ' 48' ' ' THR . 31.8 ttmt 40.78 50.13 3.73 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 110.635 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 25.4 Cg_exo -28.27 91.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.566 2.844 . . . . 0.0 112.583 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.592 ' HG1' ' CA ' ' A' ' 1' ' ' GLY . 41.7 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.051 -1.031 . . . . 0.0 109.466 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.516 ' H3 ' ' C ' ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.911 0 N-CA-C 119.543 2.577 . . . . 0.0 119.543 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.12 -36.56 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.259 -1.142 . . . . 0.0 109.655 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 6.1 t -49.77 -43.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.849 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.24 -59.23 3.93 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.341 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -49.79 -50.2 45.79 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.772 . . . . 0.0 110.838 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 m -81.36 -30.68 33.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.022 -1.049 . . . . 0.0 112.27 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 8.5 t -92.58 -60.53 1.8 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.542 -1.349 . . . . 0.0 109.521 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 m -55.38 -17.22 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.131 -0.981 . . . . 0.0 108.566 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.9 m -157.85 -147.99 0.19 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.5 mt -123.17 137.09 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.87 . . . . 0.0 109.087 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 58.4 m -98.68 170.33 8.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 110.349 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 15' ' ' GLN . 73.2 m -118.06 145.89 44.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 tp -43.4 -33.43 1.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 110.205 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.68 -36.59 84.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.727 -1.233 . . . . 0.0 108.699 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.0 mt-30 -76.11 -36.06 59.03 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -70.5 -50.3 39.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.588 -0.695 . . . . 0.0 109.383 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -61.6 -23.23 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.22 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.37 -3.8 59.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.659 -1.276 . . . . 0.0 109.269 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.3 t -99.06 145.67 26.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.426 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.59 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -77.71 153.86 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.106 -0.997 . . . . 0.0 110.037 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -99.96 93.12 5.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -138.05 146.27 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.302 -0.873 . . . . 0.0 109.839 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.432 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.8 m-70 -71.08 109.54 5.22 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 11.8 mt -92.39 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.14 -0.975 . . . . 0.0 109.698 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.4 m -156.48 -177.75 6.83 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.25 -142.42 14.27 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.56 -18.63 54.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -1.081 . . . . 0.0 109.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -48.64 -59.07 3.82 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.966 -1.084 . . . . 0.0 108.509 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.7 -56.79 7.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.9 t -50.05 -59.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 20.4 mt-10 -41.56 -42.23 2.37 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.69 -60.44 3.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.04 -48.68 61.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.729 -1.232 . . . . 0.0 108.083 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -53.14 -25.97 15.21 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.31 -63.06 1.39 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -53.59 -57.07 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.693 0.758 . . . . 0.0 109.592 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.2 t -70.24 -29.49 66.31 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.758 -0.589 . . . . 0.0 110.594 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.86 -124.67 16.93 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.603 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -83.35 -8.23 59.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.303 -1.116 . . . . 0.0 110.733 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -59.16 -33.03 70.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.884 -1.135 . . . . 0.0 109.717 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.67 125.66 2.52 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.415 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.6 p90 -119.86 177.66 4.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.395 -1.062 . . . . 0.0 109.341 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -125.13 115.27 20.2 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -130.32 106.82 8.82 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' B' ' 48' ' ' THR . 2.0 p -150.62 48.22 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.555 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 13.0 mmmt 44.81 45.4 2.14 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 34.9 Cg_exo -25.03 -48.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 123.846 3.031 . . . . 0.0 112.89 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.516 ' C ' ' H3 ' ' A' ' 1' ' ' GLY . 8.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.375 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -76.15 -39.45 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.284 -1.127 . . . . 0.0 109.579 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 t -48.54 -40.09 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -76.09 -23.82 55.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.993 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 21.9 mt-30 -91.16 -18.48 24.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.845 -1.159 . . . . 0.0 110.109 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -109.57 -30.6 7.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.819 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.33 -63.04 1.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.996 -1.065 . . . . 0.0 109.417 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 m -62.95 -11.03 15.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -163.73 159.86 21.92 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 55.8 mt -83.57 140.64 15.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 109.677 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.13 156.96 18.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.473 -0.767 . . . . 0.0 109.621 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . 50.2 m -100.49 147.48 25.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.47 -34.39 1.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.433 -0.792 . . . . 0.0 110.118 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.13 -34.88 79.07 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.763 -1.211 . . . . 0.0 108.555 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.6 mt-30 -78.07 -30.98 49.95 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.53 -49.16 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.535 -0.728 . . . . 0.0 109.122 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.53 -22.95 66.69 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.456 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -65.06 -34.42 78.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.386 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.65 -0.71 51.8 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.585 -1.322 . . . . 0.0 109.384 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -103.48 146.41 28.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.71 . . . . 0.0 109.838 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.486 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 21.9 m-20 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.614 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.19 151.27 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.088 -1.008 . . . . 0.0 109.518 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -101.3 85.56 2.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.822 . . . . 0.0 109.354 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.36 147.65 49.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.691 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.2 m80 -69.05 111.01 4.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.312 -0.867 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.1 mt -90.59 150.93 21.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.6 m -155.96 -178.15 7.09 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.78 -143.47 10.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -78.91 -18.47 53.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 0.0 109.856 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -47.95 -49.57 29.99 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.045 -1.034 . . . . 0.0 108.49 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -58.43 -56.63 19.7 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 16.4 t -51.15 -59.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 108.877 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 13.3 mm-40 -41.87 -42.94 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.43 -60.55 3.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.8 mt -51.67 -48.75 63.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.572 -1.33 . . . . 0.0 108.141 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -53.61 -25.73 18.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.8 tp -85.13 -63.01 1.4 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 41.8 t -53.09 -58.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.67 0.747 . . . . 0.0 109.579 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 2.0 t -69.57 -29.74 67.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.721 -0.612 . . . . 0.0 110.648 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.62 -125.57 26.48 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.487 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.5 pm0 -83.81 -6.28 59.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -1.12 . . . . 0.0 110.853 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.62 -28.51 69.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 85.88 128.01 2.08 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.458 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.6 p90 -124.62 177.12 6.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.441 -1.035 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 18.7 m-85 -122.91 114.6 20.67 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -129.87 109.72 11.14 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.648 ' HG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 177.3 -78.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.499 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.648 ' N ' ' HG1' ' B' ' 48' ' ' THR . 33.6 mmtm -133.77 53.14 9.47 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.0 Cg_exo -30.66 -69.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.327 2.685 . . . . 0.0 112.497 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.407 ' OG1' ' OXT' ' B' ' 51' ' ' THR . 30.4 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.44 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.965 0 N-CA-C 119.808 2.683 . . . . 0.0 119.808 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt -68.8 -34.6 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -1.119 . . . . 0.0 109.703 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.88 -39.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 109.818 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -75.66 -20.12 58.68 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.255 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.452 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 tp-100 -91.28 -35.04 14.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.942 -1.099 . . . . 0.0 110.744 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 6.1 m -96.24 -24.32 16.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.0 111.593 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.1 t -97.44 -67.97 0.82 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.857 -1.152 . . . . 0.0 109.66 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -56.69 -12.29 1.78 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -155.87 -163.41 1.49 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 62.4 mt -116.7 146.81 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.119 -0.988 . . . . 0.0 109.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 97.9 m -111.32 169.87 8.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.536 -0.728 . . . . 0.0 110.007 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.1 m -118.4 146.36 44.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.4 -34.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.339 -0.851 . . . . 0.0 110.28 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -35.84 81.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.822 -1.174 . . . . 0.0 108.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 18.7 mt-30 -76.28 -34.86 59.1 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 tp -70.89 -50.51 34.19 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.623 -0.673 . . . . 0.0 109.263 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -60.31 -27.55 67.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.5 m-20 -61.99 -34.28 75.87 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -84.13 -5.03 59.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.627 -1.295 . . . . 0.0 109.496 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -98.42 145.9 26.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.638 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.05 148.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.041 -1.037 . . . . 0.0 109.567 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -98.7 80.95 2.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.423 -0.798 . . . . 0.0 109.465 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -120.27 148.89 43.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 110.204 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.719 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.2 m80 -68.4 111.18 4.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -90.19 150.6 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 67.9 m -155.75 -178.3 7.19 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.86 -143.24 11.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.32 -18.61 54.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.303 -1.116 . . . . 0.0 109.905 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -47.68 -53.3 15.38 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.017 -1.052 . . . . 0.0 108.695 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 tp -53.55 -55.62 24.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.6 t -53.36 -58.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.26 -0.9 . . . . 0.0 109.085 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.3 mt-10 -41.11 -40.4 1.49 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.81 -60.59 3.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -51.54 -45.94 63.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.597 -1.315 . . . . 0.0 108.366 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.27 -25.4 48.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.24 -62.88 1.43 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.7 t -54.17 -57.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.583 0.706 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -70.05 -28.46 65.47 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.596 -0.69 . . . . 0.0 110.327 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.58 -131.3 46.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 -7.33 59.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -1.13 . . . . 0.0 110.136 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -55.63 -44.28 76.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.007 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 102.98 128.08 6.28 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.1 p90 -122.88 177.6 5.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.51 -0.994 . . . . 0.0 109.178 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.35 114.39 20.12 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.88 109.95 11.31 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.523 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.6 OUTLIER -168.9 -114.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' N ' ' OG1' ' B' ' 48' ' ' THR . 26.8 mmtp 44.78 50.38 7.19 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.979 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 30.9 Cg_exo -27.57 100.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.739 2.959 . . . . 0.0 112.812 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.418 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' H3 ' ' CG2' ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.909 0 N-CA-C 119.76 2.664 . . . . 0.0 119.76 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -70.32 -34.79 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -1.15 . . . . 0.0 109.722 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 t -55.2 -40.94 58.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 110.044 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 111.011 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.446 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.2 mt-30 -59.73 -33.36 71.54 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 111.499 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.6 m -93.86 -30.34 14.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.68 -1.263 . . . . 0.0 112.062 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' C ' ' H ' ' A' ' 9' ' ' SER . 12.2 t -93.45 -62.75 1.31 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.669 -1.27 . . . . 0.0 109.429 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.12 -10.37 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.8 m -161.46 -150.5 0.2 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.2 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.487 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 72.1 mt -124.07 136.79 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 57.2 m -101.5 173.96 6.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -0.786 . . . . 0.0 110.158 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.3 m -118.82 146.67 44.65 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.55 -34.03 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 110.266 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.29 -35.19 80.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.737 -1.227 . . . . 0.0 108.83 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.7 mt-30 -77.14 -32.68 56.52 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -74.06 -50.31 20.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -61.72 -22.75 65.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.428 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.07 -33.69 76.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.267 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -86.55 -1.27 57.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.622 -1.299 . . . . 0.0 109.204 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -104.22 146.56 28.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.827 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.276 179.721 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.54 151.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -101.84 91.87 4.57 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -136.61 147.62 47.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.423 -0.798 . . . . 0.0 110.014 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.487 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.9 m-70 -71.2 109.52 5.29 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.365 -0.834 . . . . 0.0 108.793 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.04 149.9 20.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.88 -178.39 7.26 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.34 -144.74 10.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.01 -19.9 58.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -1.118 . . . . 0.0 109.87 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -47.53 -58.3 4.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.077 -1.015 . . . . 0.0 108.654 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 tp -50.08 -55.2 15.82 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' B' ' 34' ' ' GLU . 20.1 t -51.54 -60.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 109.079 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 33' ' ' VAL . 42.7 mt-10 -41.23 -42.43 2.11 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.7 -60.63 3.27 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.92 -48.85 60.61 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.8 -1.188 . . . . 0.0 108.177 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -53.69 -25.68 19.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.7 tp -85.1 -62.83 1.44 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.2 -55.95 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.555 0.693 . . . . 0.0 109.921 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 0.9 OUTLIER -73.55 -30.12 62.86 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 110.594 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.37 -119.78 7.65 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.633 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.6 -15.9 47.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.124 . . . . 0.0 110.954 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -52.94 -45.59 67.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.513 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.473 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 100.68 127.71 6.14 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.401 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 29.5 p90 -122.76 177.22 5.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.511 -0.993 . . . . 0.0 108.8 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 46' ' ' PHE . 24.1 m-85 -126.35 114.15 17.84 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.552 0.692 . . . . 0.0 109.388 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -130.5 107.29 9.11 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' B' ' 49' ' ' LYS . 1.3 t 175.54 120.95 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.459 -0.775 . . . . 0.0 109.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 69.3 mttt 38.49 50.09 2.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.0 110.626 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 33.9 Cg_exo -26.85 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.749 2.966 . . . . 0.0 113.028 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.455 ' CG2' ' H3 ' ' A' ' 1' ' ' GLY . 17.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.927 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.88 -33.68 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -1.114 . . . . 0.0 109.658 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -58.8 -37.67 67.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.712 0.768 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.1 -47.48 74.04 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.692 -0.63 . . . . 0.0 111.092 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -77.23 -39.7 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.103 -0.998 . . . . 0.0 111.727 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' SER . 16.7 m -83.12 -27.3 30.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.535 -1.353 . . . . 0.0 112.23 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.9 -55.92 3.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.497 -1.377 . . . . 0.0 109.428 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -157.32 169.85 23.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.405 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 62.9 mt -85.75 140.32 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 110.072 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' SG ' ' NE2' ' A' ' 15' ' ' GLN . 12.4 m -102.61 174.87 5.7 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.492 -0.755 . . . . 0.0 109.517 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 55.5 m -118.54 144.97 45.7 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.62 -34.73 1.52 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.451 -0.781 . . . . 0.0 110.199 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -62.76 -35.25 79.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.841 -1.162 . . . . 0.0 108.703 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.419 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 15.9 mt-30 -76.05 -34.15 59.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 tp -72.4 -50.07 29.16 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.575 -0.703 . . . . 0.0 109.324 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.3 -21.4 65.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' ND2' ' CE2' ' A' ' 14' ' ' TYR . 1.8 m-20 -66.89 -33.47 75.66 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.077 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.53 -2.96 58.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.669 -1.269 . . . . 0.0 109.408 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.5 t -101.47 145.68 28.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -0.781 . . . . 0.0 109.55 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.4 p30 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.43 153.75 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 109.675 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.81 91.13 4.03 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -137.09 146.44 45.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 109.933 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.518 ' N ' ' OE1' ' B' ' 25' ' ' GLN . 15.0 m-70 -68.78 110.03 4.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.369 -0.832 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.515 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -92.66 149.3 21.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.053 -1.03 . . . . 0.0 109.804 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.51 -178.02 7.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.75 -144.1 12.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -76.68 -19.99 57.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -1.096 . . . . 0.0 109.851 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.75 -57.96 4.93 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.027 -1.046 . . . . 0.0 108.73 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 tp -50.67 -55.21 17.53 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.62 -60.02 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.213 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 25.4 mt-10 -41.12 -43.51 2.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -55.37 -60.83 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.37 -48.9 62.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.711 -1.243 . . . . 0.0 108.256 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.16 -25.87 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.3 tp -85.56 -63.14 1.37 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 39.5 t -52.72 -55.26 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.543 0.687 . . . . 0.0 110.129 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -74.03 -30.37 62.39 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.468 -0.77 . . . . 0.0 110.475 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.92 -117.62 4.28 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.702 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.85 -13.44 53.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.267 -1.137 . . . . 0.0 111.081 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 69.6 mtt180 -58.77 -29.35 66.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.847 -1.158 . . . . 0.0 109.858 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 83.34 128.02 1.33 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.7 p90 -121.98 175.83 6.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.335 -1.097 . . . . 0.0 109.406 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -123.02 116.85 24.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -129.61 109.08 10.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.576 -0.703 . . . . 0.0 109.644 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.439 ' O ' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 179.05 65.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.876 . . . . 0.0 109.417 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 14.6 ptmt 34.05 49.36 0.69 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.221 -0.3 . . . . 0.0 111.147 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 29.7 Cg_exo -26.2 -67.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.772 2.982 . . . . 0.0 113.005 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.456 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.96 0 N-CA-C 119.819 2.688 . . . . 0.0 119.819 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.7 -35.14 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 109.72 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.05 -36.94 65.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.496 -0.753 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.57 -23.21 60.94 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.54 -0.725 . . . . 0.0 110.92 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 8.0 tt0 -92.58 -53.56 4.14 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.758 -1.213 . . . . 0.0 110.89 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -72.4 -29.94 64.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 112.266 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.0 t -89.53 -66.71 0.9 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.49 -1.381 . . . . 0.0 109.887 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 m -51.49 -14.84 0.34 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.913 -1.117 . . . . 0.0 108.538 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 7' ' ' CYS . 3.2 t -154.91 -138.73 0.07 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.3 mt -130.44 150.98 35.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.3 m -116.5 169.31 9.43 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.363 -0.836 . . . . 0.0 109.661 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.7 m -117.52 145.59 44.13 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -42.98 -33.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.509 -0.745 . . . . 0.0 110.245 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.75 -35.74 82.04 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.683 -1.26 . . . . 0.0 108.857 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.7 mt-30 -76.54 -32.49 58.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 tp -74.0 -51.0 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.3 -24.59 65.09 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -62.97 -34.86 78.42 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.071 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.62 -2.52 57.57 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.646 -1.284 . . . . 0.0 109.411 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 t -101.86 145.81 28.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.59 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.0 m-20 . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.82 142.41 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.9 OUTLIER -92.33 75.6 5.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.411 -0.806 . . . . 0.0 109.568 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -115.92 158.69 22.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.42 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 6.3 m-70 -77.28 110.79 12.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 109.91 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.509 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.8 mt -92.72 150.83 20.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.808 -1.182 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 68.6 m -156.28 -177.98 6.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.05 -144.22 10.55 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -76.99 -19.65 57.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -1.104 . . . . 0.0 109.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -47.28 -56.05 7.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.064 -1.023 . . . . 0.0 108.781 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -51.19 -55.2 19.17 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.8 t -52.18 -58.8 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.137 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.7 mt-10 -41.17 -40.09 1.46 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -59.27 -60.53 3.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.8 -44.73 63.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.607 -1.308 . . . . 0.0 108.372 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -57.12 -25.5 58.93 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.06 1.39 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.34 -55.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.522 0.677 . . . . 0.0 110.215 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.74 -30.54 61.54 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.536 -0.727 . . . . 0.0 110.87 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 -115.23 2.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.327 -1.415 . . . . 0.0 109.759 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -83.68 -21.26 32.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.38 -1.071 . . . . 0.0 110.962 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -52.2 -28.69 19.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.869 -1.145 . . . . 0.0 109.901 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 80.58 129.34 0.86 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.5 p90 -123.54 177.16 5.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.463 -1.022 . . . . 0.0 109.118 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.06 120.25 29.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -129.82 109.77 11.19 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -178.93 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.472 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 18.2 pttp -131.46 53.22 11.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.5 Cg_exo -31.7 -62.95 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 123.151 2.567 . . . . 0.0 112.327 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.46 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.729 2.652 . . . . 0.0 119.729 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 tt -73.6 -35.75 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.215 -1.168 . . . . 0.0 109.596 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -54.34 -39.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.49 -0.756 . . . . 0.0 109.778 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -73.2 -20.44 60.88 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.533 -0.729 . . . . 0.0 110.339 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.582 HE22 ' HH ' ' A' ' 19' ' ' TYR . 20.9 mt-30 -91.29 -36.89 13.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 110.622 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 m -94.85 -27.36 15.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.02 . . . . 0.0 111.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 t -91.0 -59.57 2.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.753 -1.217 . . . . 0.0 109.715 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -65.61 -13.47 59.13 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.115 -0.991 . . . . 0.0 108.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -158.49 164.52 36.1 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.9 mt -81.94 137.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.162 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 9.7 m -96.83 168.25 10.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 15' ' ' GLN . 75.4 m -118.46 144.68 45.81 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tp -43.45 -33.65 1.13 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.347 -0.846 . . . . 0.0 110.272 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.77 -35.58 81.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.719 -1.238 . . . . 0.0 108.776 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.1 mt-30 -76.84 -32.55 57.63 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -74.26 -50.14 20.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.66 -0.65 . . . . 0.0 109.292 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -61.65 -23.39 66.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -63.57 -34.71 78.4 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.945 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' HH ' HE22 ' A' ' 5' ' ' GLN . 98.4 m-85 -84.83 -6.63 59.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.7 -1.25 . . . . 0.0 109.263 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -98.99 145.89 26.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.1 p30 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -78.55 152.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.049 -1.032 . . . . 0.0 110.067 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -97.78 93.92 6.64 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -141.89 144.98 34.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 109.975 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -68.92 109.86 4.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.991 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.27 150.5 20.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.019 . . . . 0.0 109.949 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.92 -178.24 7.16 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.9 -145.3 8.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -75.22 -19.52 59.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -1.162 . . . . 0.0 109.95 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.09 -57.65 5.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.039 -1.038 . . . . 0.0 108.751 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 tp -49.99 -55.77 13.33 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.24 -59.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.312 -0.868 . . . . 0.0 109.39 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 23.1 mt-10 -41.24 -42.15 2.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.69 -60.78 3.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.2 -48.37 62.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.685 -1.259 . . . . 0.0 108.228 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.95 -25.58 21.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.41 -63.0 1.4 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 40.8 t -52.58 -56.45 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.505 0.669 . . . . 0.0 110.022 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 0.7 OUTLIER -73.28 -30.37 63.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.527 -0.733 . . . . 0.0 110.585 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.76 -118.71 5.15 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.279 -1.439 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.72 -11.55 57.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.274 -1.133 . . . . 0.0 110.894 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -59.8 -34.65 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.927 -1.108 . . . . 0.0 109.806 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.497 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.75 127.16 2.85 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.3 p90 -119.62 177.2 5.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.8 114.58 19.43 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -129.47 109.52 11.12 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' B' ' 48' ' ' THR . 0.0 OUTLIER -169.3 62.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' B' ' 51' ' ' THR . 79.0 mttt -152.36 55.73 1.6 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 23.7 Cg_exo -30.26 -31.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.325 2.683 . . . . 0.0 112.935 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.536 ' N ' ' O ' ' B' ' 49' ' ' LYS . 5.3 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.03 . . . . 0.0 109.697 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.93 0 N-CA-C 119.799 2.679 . . . . 0.0 119.799 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.13 -35.47 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.34 -1.094 . . . . 0.0 109.717 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -55.8 -38.96 53.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -75.34 -20.32 59.1 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.507 -0.745 . . . . 0.0 110.294 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -91.38 -36.99 13.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.944 -1.098 . . . . 0.0 110.771 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 4.8 m -95.76 -26.07 15.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.084 . . . . 0.0 111.882 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -90.19 -58.78 2.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.614 -1.304 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 m -65.22 -12.34 50.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.3 m -159.67 172.83 17.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 75.2 mt -89.91 135.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.735 -1.228 . . . . 0.0 109.558 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.2 m -96.8 171.48 8.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 109.846 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 60.5 m -118.53 144.83 45.79 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tp -44.18 -33.64 1.59 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.43 -34.87 78.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.702 -1.248 . . . . 0.0 108.66 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -76.92 -34.27 57.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -72.54 -50.41 25.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.631 -0.668 . . . . 0.0 109.241 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.44 -22.18 64.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -66.56 -33.64 76.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.104 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -85.62 -2.57 58.31 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.694 -1.253 . . . . 0.0 109.433 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -99.35 145.76 27.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.623 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.17 155.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.65 92.94 5.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.92 144.07 41.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.44 -0.787 . . . . 0.0 109.737 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.409 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 13.7 m-70 -69.67 109.75 4.51 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.01 150.12 20.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.814 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -155.81 -178.08 7.03 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.12 -144.04 11.0 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -76.36 -19.8 57.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -1.073 . . . . 0.0 109.928 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.88 -58.92 3.76 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.035 -1.041 . . . . 0.0 108.675 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -48.8 -56.23 9.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' B' ' 34' ' ' GLU . 28.6 t -50.09 -58.94 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.2 mt-10 -41.2 -40.98 1.71 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.97 -60.77 3.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.48 -46.08 63.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.596 -1.315 . . . . 0.0 108.361 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.36 -25.28 48.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.07 1.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.7 t -53.16 -55.86 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.593 0.711 . . . . 0.0 110.099 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -73.34 -30.67 63.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.595 -0.69 . . . . 0.0 110.701 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.76 -115.27 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.634 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -84.08 -15.65 46.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.333 -1.098 . . . . 0.0 111.004 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -58.97 -18.22 31.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.851 -1.155 . . . . 0.0 109.779 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 69.18 128.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.8 p90 -121.14 177.43 5.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.454 -1.027 . . . . 0.0 109.199 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.491 ' CE1' ' OD1' ' A' ' 21' ' ' ASN . 36.2 m-85 -125.52 119.85 29.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -129.39 107.82 9.8 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 173.92 -107.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' N ' ' OG1' ' B' ' 48' ' ' THR . 44.6 tttm 43.31 49.43 4.91 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.737 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.9 Cg_exo -27.47 83.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.744 2.963 . . . . 0.0 112.723 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 49' ' ' LYS . 2.4 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.94 0 N-CA-C 119.824 2.689 . . . . 0.0 119.824 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -58.02 -33.41 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.233 -1.157 . . . . 0.0 109.438 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.66 -39.75 56.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.622 -0.674 . . . . 0.0 109.904 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.96 -20.16 60.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.483 -0.76 . . . . 0.0 110.344 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -91.11 -37.98 13.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.993 -1.067 . . . . 0.0 110.705 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.2 m -96.59 -24.15 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.99 -1.069 . . . . 0.0 111.929 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.23 -55.57 3.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.518 -1.364 . . . . 0.0 109.25 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -65.61 -18.66 65.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -154.6 173.21 16.66 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.572 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 66.5 mt -91.13 133.4 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.738 -1.226 . . . . 0.0 109.407 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 33.5 m -92.72 172.97 8.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.9 m -118.49 145.98 44.87 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tp -43.54 -34.38 1.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 110.12 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.59 80.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.0 108.928 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -76.56 -36.81 57.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.71 -50.95 38.75 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.616 -0.678 . . . . 0.0 109.257 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.37 -25.51 65.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.4 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.19 -33.99 77.05 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.962 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' O ' ' CE2' ' B' ' 46' ' ' PHE . 91.9 m-85 -84.44 2.15 42.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.725 -1.234 . . . . 0.0 109.105 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.1 t -106.34 146.04 30.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.17 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.383 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -75.93 156.77 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.617 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.23 92.87 4.92 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.17 141.69 47.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.666 ' ND1' ' H ' ' B' ' 26' ' ' HIS . 1.8 m80 -69.23 109.85 4.3 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.408 -0.807 . . . . 0.0 109.512 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.1 mt -92.64 150.18 20.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 110.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.7 m -156.65 177.37 11.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.51 -145.54 18.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -74.17 -21.21 59.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.084 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.91 -53.19 16.64 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 0.0 108.62 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 tp -56.36 -56.48 20.54 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 34' ' ' GLU . 24.1 t -47.82 -60.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.26 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 33' ' ' VAL . 38.6 mt-10 -41.1 -42.93 2.11 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -54.74 -61.02 2.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 26.6 mt -52.67 -47.58 67.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.473 -1.392 . . . . 0.0 108.146 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -53.57 -26.1 20.03 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.5 tp -85.07 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.24 -56.91 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.716 0.77 . . . . 0.0 109.721 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.8 t -70.34 -29.96 66.79 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.724 -0.61 . . . . 0.0 110.662 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.56 -125.67 22.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.6 -9.04 59.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -1.14 . . . . 0.0 110.804 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -55.46 -42.15 73.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.903 -1.123 . . . . 0.0 109.587 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 101.64 126.62 5.88 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -130.84 165.65 22.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.567 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -120.5 114.29 21.55 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.932 0.873 . . . . 0.0 109.584 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -119.38 113.1 20.28 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -158.63 -166.44 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.121 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.563 ' N ' ' OG1' ' B' ' 48' ' ' THR . 44.8 mttp 55.06 50.33 6.07 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.155 -0.966 . . . . 0.0 109.505 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.2 Cg_exo -28.17 -39.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.75 2.967 . . . . 0.0 112.901 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.444 ' N ' ' O ' ' B' ' 49' ' ' LYS . 11.4 t . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.346 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.967 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.5 tt -74.41 -35.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.682 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.4 t -56.05 -38.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 110.581 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 6.9 tp-100 -91.42 -33.13 15.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 0.0 110.543 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 m -96.78 -29.76 13.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.938 -1.101 . . . . 0.0 111.404 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.8 t -92.83 -63.33 1.24 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.758 -1.214 . . . . 0.0 109.584 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -4.84 1.09 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 7' ' ' CYS . 39.7 t -161.07 -148.92 0.16 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.51 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.5 mt -127.71 140.96 47.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 69.4 m -109.31 164.71 12.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.37 -0.832 . . . . 0.0 110.417 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 15' ' ' GLN . 61.1 m -114.68 146.33 41.01 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -43.13 -34.16 1.03 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.758 . . . . 0.0 110.315 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.54 -33.92 77.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.746 -1.221 . . . . 0.0 108.706 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.4 mt-30 -79.22 -30.56 43.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.3 -49.83 17.96 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.67 -23.26 65.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.6 m-20 -64.78 -34.56 78.63 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.0 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.51 -4.57 59.02 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.678 -1.264 . . . . 0.0 109.151 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.9 t -100.23 145.95 27.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 109.566 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.6 p30 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.3 157.95 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.789 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.6 93.18 5.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.06 144.68 45.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.782 . . . . 0.0 110.04 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.51 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.3 m-70 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.482 -0.761 . . . . 0.0 109.666 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.6 mt -92.52 150.78 20.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 109.347 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.4 m -155.7 -177.85 6.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.3 -144.11 11.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -77.23 -18.82 57.37 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.47 -58.48 4.14 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.086 -1.009 . . . . 0.0 108.715 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.67 -55.91 10.0 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.6 t -52.19 -58.96 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.012 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 33' ' ' VAL . 15.4 mt-10 -41.47 -41.87 2.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.87 -60.8 3.04 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.74 -48.87 58.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.0 108.318 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.84 -24.42 22.97 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.3 tp -85.25 -55.78 3.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 37.6 t -61.51 -59.58 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.605 0.716 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.1 t -70.11 -30.22 67.37 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.649 -0.657 . . . . 0.0 110.711 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.52 -119.32 5.54 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.347 -1.406 . . . . 0.0 109.856 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.68 -12.64 55.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -1.133 . . . . 0.0 110.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 74.8 mtt180 -58.14 -31.87 67.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 87.52 126.49 2.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -119.22 177.23 4.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -1.091 . . . . 0.0 109.341 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' B' ' 48' ' ' THR . 17.1 t80 -125.66 115.48 20.18 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -129.79 108.28 10.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.853 -0.529 . . . . 0.0 109.715 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.55 ' CG2' ' CE2' ' B' ' 46' ' ' PHE . 1.3 t 174.06 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 40.7 mtpt -145.23 52.95 1.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.5 Cg_exo -28.34 109.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.605 2.87 . . . . 0.0 112.642 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.454 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' H3 ' ' CG2' ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.531 4.976 0 N-CA-C 119.716 2.647 . . . . 0.0 119.716 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.53 -26.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.392 -1.063 . . . . 0.0 109.4 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -61.26 -38.8 80.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.591 0.71 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.93 -20.07 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 109.995 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -90.71 -27.98 18.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.987 -1.071 . . . . 0.0 110.708 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' SER . 59.1 m -103.4 -30.45 10.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.043 -1.036 . . . . 0.0 111.082 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.0 t -93.65 -63.78 1.16 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.879 -1.138 . . . . 0.0 109.777 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -62.03 -10.05 8.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -162.93 164.15 25.95 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.358 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 67.0 mt -85.59 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 0.0 109.049 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.47 160.32 17.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.46 -0.775 . . . . 0.0 110.053 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' GLN . 44.9 m -103.39 147.71 26.78 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.46 -35.1 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.494 -0.754 . . . . 0.0 110.242 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.1 -35.3 79.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.768 -1.208 . . . . 0.0 108.566 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.1 mt-30 -77.85 -26.96 49.72 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.81 -47.97 15.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.446 -0.784 . . . . 0.0 108.947 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -62.59 -21.39 65.58 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.476 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 4.0 m-20 -65.43 -34.53 78.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.145 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' O ' ' CE2' ' B' ' 46' ' ' PHE . 83.7 m-85 -84.76 1.78 45.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.562 -1.336 . . . . 0.0 109.044 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -109.67 146.1 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 2.9 p30 . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.318 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.53 157.34 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.83 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.85 92.62 4.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -137.39 144.19 42.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 109.809 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 15.2 m-70 -69.1 109.51 4.06 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.149 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.0 mt -90.89 149.51 21.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.133 -0.98 . . . . 0.0 109.708 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 47.3 m -155.91 -178.08 7.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.12 -145.55 16.4 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.15 -19.99 57.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -47.43 -60.62 2.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.074 -1.016 . . . . 0.0 108.658 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -47.29 -56.46 6.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' B' ' 34' ' ' GLU . 35.2 t -50.78 -59.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.261 -0.899 . . . . 0.0 108.903 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.9 mt-10 -41.43 -39.58 1.53 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -59.68 -59.88 4.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -45.41 66.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.5 -1.375 . . . . 0.0 108.069 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -56.27 -25.93 49.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -84.77 -58.32 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.36 -56.73 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -72.83 -31.03 64.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.652 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -112.94 1.3 Allowed Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.794 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.03 -20.35 32.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 111.226 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -52.41 -50.81 61.78 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.799 -1.188 . . . . 0.0 109.665 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.57 127.73 6.15 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -125.3 170.23 11.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.556 ' N ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.86 114.09 19.38 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.948 0.88 . . . . 0.0 109.544 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -124.69 107.63 11.17 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 173.45 -175.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' OG1' ' B' ' 48' ' ' THR . 20.2 mmmt 41.78 50.97 5.24 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.636 -0.665 . . . . 0.0 110.622 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.1 Cg_exo -30.08 152.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.425 2.75 . . . . 0.0 112.577 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.405 ' CG2' ' H3 ' ' A' ' 1' ' ' GLY . 7.8 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.468 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.984 0 N-CA-C 119.769 2.668 . . . . 0.0 119.769 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt -75.57 -37.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -1.138 . . . . 0.0 109.517 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -50.69 -40.58 19.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.735 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -75.4 -19.65 59.39 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.769 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -88.89 -41.17 12.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.144 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.5 m -91.2 -30.41 16.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 111.75 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.5 t -92.91 -66.72 0.9 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.647 -1.283 . . . . 0.0 110.508 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -57.21 -10.17 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.976 -1.077 . . . . 0.0 108.498 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -163.12 176.64 9.83 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.113 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.0 mt -97.09 135.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.997 -1.064 . . . . 0.0 108.901 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 p -103.06 158.29 16.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.487 -0.758 . . . . 0.0 110.275 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.8 m -100.25 146.54 26.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -43.45 -34.4 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.25 79.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 108.702 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.8 mt-30 -77.58 -29.47 52.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 tp -76.9 -49.09 16.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.509 -0.745 . . . . 0.0 109.068 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.44 -23.53 66.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.478 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.7 m-20 -61.62 -35.56 78.24 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.149 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.5 -3.84 58.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.716 -1.24 . . . . 0.0 109.395 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.5 t -100.55 146.37 27.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.442 -0.786 . . . . 0.0 109.671 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' B' ' 43' ' ' ARG . 2.2 p30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.42 152.19 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 93.68 7.31 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.17 144.46 42.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.434 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.3 m-70 -73.87 109.97 7.8 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.0 mt -92.26 148.77 21.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 109.773 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.8 m -155.41 -177.79 6.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.24 -143.57 15.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.73 -18.17 54.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -1.173 . . . . 0.0 109.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -48.18 -57.07 6.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.002 -1.061 . . . . 0.0 108.447 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 tp -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.5 t -51.32 -59.03 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.898 . . . . 0.0 108.972 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.1 mt-10 -42.49 -40.19 2.52 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -59.48 -60.18 4.27 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -51.65 -45.95 63.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.675 -1.265 . . . . 0.0 108.103 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.44 -24.95 48.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.08 -62.98 1.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.41 -57.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.748 0.785 . . . . 0.0 109.749 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.477 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.7 t -70.13 -29.53 66.49 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.662 -0.649 . . . . 0.0 110.564 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.75 -126.3 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.369 -1.396 . . . . 0.0 109.758 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -83.18 -5.96 59.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.244 -1.151 . . . . 0.0 110.649 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.45 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.6 mtt180 -61.63 -37.21 83.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.943 -1.098 . . . . 0.0 109.666 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.477 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 95.19 126.07 4.74 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.417 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.4 p90 -121.53 177.6 5.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.472 -1.016 . . . . 0.0 109.181 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -127.03 118.59 24.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -129.44 107.64 9.65 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 166.63 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.668 . . . . 0.0 109.279 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 31.5 ttmt -160.23 50.88 0.36 Allowed Pre-proline 0 C--N 1.3 -1.573 0 O-C-N 121.086 -1.009 . . . . 0.0 109.961 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.6 Cg_exo -29.06 109.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.567 2.844 . . . . 0.0 112.602 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.515 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.898 0 N-CA-C 119.717 2.647 . . . . 0.0 119.717 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.5 tt -74.44 -36.47 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 t -54.51 -38.89 43.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.869 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -76.31 -25.87 55.23 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.467 -0.77 . . . . 0.0 110.261 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.523 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.2 tt0 -91.35 -29.69 16.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.888 -1.132 . . . . 0.0 110.441 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.6 m -93.39 -30.96 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 111.187 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.535 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.9 t -94.57 -63.74 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.859 -1.15 . . . . 0.0 110.174 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 m -57.68 -7.42 0.67 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 108.248 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.535 ' H ' ' C ' ' A' ' 7' ' ' CYS . 35.7 t -156.65 -148.89 0.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.856 0.836 . . . . 0.0 109.44 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.588 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 80.1 mt -130.95 144.97 36.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.69 154.91 29.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.242 -0.911 . . . . 0.0 110.064 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -98.75 149.4 22.9 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tp -44.22 -33.41 1.55 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.84 -34.67 78.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.706 -1.246 . . . . 0.0 108.752 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.523 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.3 mt-30 -78.82 -30.34 45.31 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.53 -50.17 16.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.54 -26.18 66.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -61.35 -35.03 76.32 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.161 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -83.62 -4.5 58.64 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.652 -1.28 . . . . 0.0 109.322 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -100.23 146.28 27.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 0.0 109.58 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 4.0 p30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.381 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.86 155.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.97 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -99.62 91.33 4.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 26' ' ' HIS . 0.3 OUTLIER -133.83 142.6 47.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.531 -0.731 . . . . 0.0 109.863 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.689 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.7 m80 -67.8 109.75 3.5 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.509 -0.744 . . . . 0.0 110.491 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.522 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -92.96 149.06 21.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.802 . . . . 0.0 109.339 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.3 m -155.71 -178.12 7.06 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.71 -143.37 18.59 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -78.77 -18.62 53.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -1.114 . . . . 0.0 109.815 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -47.64 -58.37 4.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.06 -1.025 . . . . 0.0 108.636 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -48.84 -55.71 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' B' ' 34' ' ' GLU . 19.9 t -52.2 -59.07 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.257 -0.902 . . . . 0.0 108.839 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' B' ' 33' ' ' VAL . 18.0 mt-10 -42.36 -41.63 2.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.59 -60.39 3.74 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.69 -47.67 63.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.618 -1.301 . . . . 0.0 108.194 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -54.68 -25.46 27.3 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -84.89 -62.83 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.24 -58.43 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.703 0.763 . . . . 0.0 109.706 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.69 -28.69 66.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.682 -0.636 . . . . 0.0 110.585 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.19 -132.49 48.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.75 -4.91 58.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -57.65 -43.26 84.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 127.09 6.0 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.444 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.2 p90 -122.98 177.36 5.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.484 -1.01 . . . . 0.0 108.87 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -122.54 113.48 19.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.85 107.63 9.26 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 167.43 75.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.494 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 31.3 tttm -142.95 50.64 1.5 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.3 Cg_exo -29.21 100.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.579 2.852 . . . . 0.0 112.635 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.529 179.903 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 5.024 0 N-CA-C 119.719 2.647 . . . . 0.0 119.719 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -80.3 -38.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 109.754 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -50.39 -39.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.48 -24.39 50.19 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.508 -0.745 . . . . 0.0 110.139 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.97 -22.14 20.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.943 -1.098 . . . . 0.0 110.113 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' SER . 56.5 m -104.62 -30.43 9.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.987 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.2 t -98.51 -66.13 0.92 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.947 -1.095 . . . . 0.0 109.855 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -57.63 -9.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.3 m -161.72 -176.48 5.3 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.587 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 57.4 mt -106.64 137.81 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.063 -1.023 . . . . 0.0 108.849 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.44 156.86 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.472 -0.767 . . . . 0.0 109.947 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.1 m -99.78 147.94 24.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.44 -34.26 1.27 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.492 -0.755 . . . . 0.0 110.16 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.55 -34.7 78.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.723 -1.236 . . . . 0.0 108.75 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -78.82 -28.76 44.51 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.8 -49.53 15.65 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.68 -25.29 67.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -60.56 -35.83 77.01 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.173 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -83.43 0.35 46.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.626 -1.296 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.81 146.36 31.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.736 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.81 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.1 p -47.77 158.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.747 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.07 89.47 3.01 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.18 141.89 51.63 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.573 -0.705 . . . . 0.0 109.671 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.692 ' ND1' ' H ' ' B' ' 26' ' ' HIS . 3.0 m80 -66.24 110.66 3.11 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.406 -0.809 . . . . 0.0 110.555 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -90.94 149.72 21.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -156.09 -178.13 7.09 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.31 -144.23 14.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.19 -18.94 54.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -47.32 -56.87 5.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.086 -1.009 . . . . 0.0 108.62 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.14 -56.29 11.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.5 t -51.34 -60.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.276 -0.89 . . . . 0.0 109.113 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 17.7 mm-40 -41.42 -42.39 2.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.373 0.606 . . . . 0.0 109.378 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.31 -60.3 3.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.2 mt -51.17 -49.02 61.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.628 -1.295 . . . . 0.0 108.083 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -53.07 -26.18 15.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.2 -62.96 1.41 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.06 -55.71 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.438 0.637 . . . . 0.0 110.175 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -75.37 -30.83 60.29 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 110.94 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.8 -111.94 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.184 -1.484 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -83.87 -23.89 31.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.343 -1.092 . . . . 0.0 110.947 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -52.25 -28.16 17.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.91 -1.119 . . . . 0.0 110.008 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 79.39 129.75 0.69 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.407 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 27.6 p90 -123.07 177.01 5.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.571 -0.958 . . . . 0.0 108.944 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.01 122.19 33.76 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.82 110.52 11.79 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -175.18 56.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.435 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 0.4 OUTLIER -138.23 53.06 5.41 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.509 -0.744 . . . . 0.0 109.273 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 35.7 Cg_exo -26.28 -47.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 124.054 3.169 . . . . 0.0 113.569 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 3.0 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.946 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.6 tt -75.23 -37.06 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.887 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 t -54.33 -39.94 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -75.29 -19.54 59.62 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.465 -0.772 . . . . 0.0 110.472 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.8 mt-30 -90.67 -40.48 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 110.711 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -92.67 -24.27 18.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.916 -1.115 . . . . 0.0 111.944 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.1 t -94.91 -66.65 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.638 -1.289 . . . . 0.0 109.485 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 m -57.77 -8.84 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -160.84 -159.07 0.64 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 78.1 mt -119.03 139.76 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.28 -0.888 . . . . 0.0 109.198 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 90.6 m -104.39 171.67 7.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.439 -0.788 . . . . 0.0 110.097 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 48.2 m -118.46 145.67 45.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tp -43.65 -33.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.437 -0.789 . . . . 0.0 110.214 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.85 -34.98 79.16 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.742 -1.223 . . . . 0.0 108.491 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.8 mt-30 -77.04 -34.69 57.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.5 -50.52 30.62 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.596 -0.69 . . . . 0.0 109.212 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.32 -23.56 65.81 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.1 m-20 -65.76 -33.82 76.74 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.125 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -84.42 -4.65 59.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.674 -1.266 . . . . 0.0 109.398 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -98.9 145.99 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.404 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.6 p-10 . . . . . 0 C--N 1.303 -1.445 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.68 154.35 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.0 110.083 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.22 96.02 10.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -137.18 144.28 42.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.188 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.42 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.8 m-70 -74.37 108.78 7.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -94.52 150.77 19.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.082 -1.011 . . . . 0.0 109.775 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 56.6 m -155.77 -177.97 6.95 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.31 -144.75 10.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -76.24 -19.89 57.93 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.259 -1.142 . . . . 0.0 109.798 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -47.19 -57.73 4.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.061 -1.024 . . . . 0.0 108.804 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.1 tp -50.92 -55.85 15.19 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.0 t -50.74 -59.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' VAL . 45.8 mt-10 -41.1 -42.36 1.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -56.62 -60.53 3.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.15 -48.67 61.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.595 -1.316 . . . . 0.0 108.276 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -53.9 -25.68 21.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.07 -62.91 1.43 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 t -53.62 -58.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.601 0.715 . . . . 0.0 109.909 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.95 -28.38 65.51 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 110.476 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 -130.32 46.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -82.76 -10.4 58.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -1.139 . . . . 0.0 109.971 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -52.93 -45.09 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 128.24 6.3 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.432 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 21.9 p90 -122.68 177.41 5.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -1.018 . . . . 0.0 109.121 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.57 117.74 25.0 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -129.46 108.37 10.21 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 174.68 179.87 0.12 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.114 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' OG1' ' B' ' 48' ' ' THR . 17.5 ttpp 44.66 50.58 7.35 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.485 -0.76 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 31.1 Cg_exo -27.46 -62.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.721 2.948 . . . . 0.0 112.6 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.289 179.783 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.92 0 N-CA-C 119.86 2.704 . . . . 0.0 119.86 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.3 tt -73.91 -37.69 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 t -52.39 -38.91 26.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.26 -27.71 59.53 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.177 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.3 tt0 -91.66 -28.78 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.841 -1.162 . . . . 0.0 110.594 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' SER . 18.3 m -92.98 -28.94 16.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 0.0 111.2 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' C ' ' H ' ' A' ' 9' ' ' SER . 14.1 t -96.43 -66.32 0.91 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.891 -1.13 . . . . 0.0 109.985 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -56.41 -12.71 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -154.93 -179.28 7.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 54.3 mt -105.83 138.78 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.136 -0.978 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.48 157.03 17.44 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 36.1 m -99.02 147.94 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.71 -33.14 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.445 -0.784 . . . . 0.0 110.092 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -65.01 -34.72 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.782 -1.199 . . . . 0.0 108.75 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.526 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.0 mt-30 -78.57 -31.82 47.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 tp -74.09 -50.17 20.73 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.75 -25.5 66.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.3 m-20 -63.1 -34.63 78.01 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.21 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -83.14 -2.22 54.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.617 -1.302 . . . . 0.0 109.221 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.28 146.57 28.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.539 -0.726 . . . . 0.0 109.789 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.395 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -73.02 153.68 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.815 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.63 92.69 5.22 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.46 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.1 tm0? -134.18 139.87 46.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.387 -0.821 . . . . 0.0 109.555 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.67 ' ND1' ' H ' ' B' ' 26' ' ' HIS . 3.0 m80 -65.53 110.2 2.62 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.299 -0.876 . . . . 0.0 110.172 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -91.21 148.63 22.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.684 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.5 m -155.4 -177.87 6.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.3 -144.2 20.07 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.31 -18.94 54.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 109.677 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.1 m-20 -47.54 -57.83 4.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 108.686 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 tp -49.47 -55.54 12.89 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.2 t -52.65 -59.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.234 -0.916 . . . . 0.0 108.757 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -42.0 -41.21 2.45 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.15 -60.36 3.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -51.73 -45.74 63.73 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.761 -1.212 . . . . 0.0 108.281 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -56.05 -25.64 45.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -84.96 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -53.48 -56.98 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.645 0.736 . . . . 0.0 109.568 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.8 t -70.43 -29.42 66.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.72 -0.613 . . . . 0.0 110.781 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.92 -129.26 38.63 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.371 -1.395 . . . . 0.0 109.695 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.12 -3.69 57.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -1.139 . . . . 0.0 110.526 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -62.38 -34.08 76.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.961 -1.087 . . . . 0.0 109.629 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.0 128.01 4.27 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.451 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 17.0 p90 -123.06 177.77 5.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.42 -1.047 . . . . 0.0 109.059 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.3 114.26 19.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -130.02 110.61 11.78 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.522 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.1 t -173.32 -128.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.522 ' N ' ' OG1' ' B' ' 48' ' ' THR . 30.6 ttmt 45.99 49.71 6.98 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.4 Cg_exo -28.78 103.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.704 2.936 . . . . 0.0 112.722 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.449 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.954 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 tt -72.52 -20.58 19.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.414 -1.051 . . . . 0.0 109.035 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -68.4 -36.42 74.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.619 0.724 . . . . 0.0 110.018 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.82 -20.14 58.39 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.19 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.9 mt-30 -91.04 -34.98 14.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.53 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -95.48 -30.35 13.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.814 -1.179 . . . . 0.0 111.385 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.2 t -92.96 -64.14 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.816 -1.177 . . . . 0.0 109.911 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -60.1 -5.79 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 7' ' ' CYS . 42.6 t -159.74 -145.84 0.13 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.591 ' CD1' ' CE1' ' B' ' 26' ' ' HIS . 91.9 mt -130.05 142.44 43.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 60.4 m -109.18 151.05 26.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.283 -0.886 . . . . 0.0 110.628 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLN . 59.3 m -101.23 146.0 28.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.54 -34.02 1.28 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.01 -34.76 78.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.718 -1.239 . . . . 0.0 108.698 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.3 mt-30 -77.58 -33.01 54.07 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.6 tp -72.95 -50.26 24.45 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.621 -0.674 . . . . 0.0 109.237 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -61.61 -20.79 63.74 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.4 m-20 -69.2 -32.74 72.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -85.83 -6.98 59.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.588 -1.32 . . . . 0.0 109.283 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 t -93.61 142.6 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.891 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.34 154.64 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.85 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.58 90.28 4.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -132.45 145.1 50.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.614 -0.679 . . . . 0.0 109.599 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.719 ' HD1' ' H ' ' B' ' 26' ' ' HIS . 2.1 m80 -68.32 110.5 4.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.514 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.76 150.87 20.36 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.19 -178.11 7.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.62 -142.07 12.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.05 -18.07 54.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.355 -1.086 . . . . 0.0 109.92 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -48.3 -55.42 10.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.99 -1.069 . . . . 0.0 108.693 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -51.04 -56.2 13.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.3 t -51.65 -59.84 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 6.0 mm-40 -40.94 -41.56 1.66 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.422 0.63 . . . . 0.0 109.378 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.55 -60.3 3.88 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.7 mt -51.05 -48.87 61.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.693 -1.254 . . . . 0.0 108.127 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -53.65 -25.41 17.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.28 -62.86 1.43 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 t -54.16 -57.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.8 -30.06 67.51 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.676 -0.64 . . . . 0.0 110.453 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 -121.25 8.0 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.61 -8.76 59.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -1.162 . . . . 0.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -62.79 -17.6 61.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.875 -1.141 . . . . 0.0 109.846 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 70.69 129.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -119.7 177.67 4.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.412 -1.052 . . . . 0.0 110.192 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -121.63 115.82 23.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -129.79 118.2 21.43 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.482 0.658 . . . . 0.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 75.8 p -133.18 -170.67 2.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.572 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 18.1 ptmt -144.06 46.82 0.68 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.964 -1.085 . . . . 0.0 110.42 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 12.6 Cg_exo -35.98 -48.3 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.836 2.357 . . . . 0.0 111.266 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.377 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.854 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.1 tt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 121.868 0.842 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.42 ' H ' HG23 ' A' ' 3' ' ' VAL . 5.5 t -58.93 -40.14 79.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.457 0.646 . . . . 0.0 110.58 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.2 -54.07 16.74 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.448 -0.782 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 62.1 mt-30 -61.06 -33.87 73.98 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.234 -0.916 . . . . 0.0 111.72 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 m -96.17 -30.63 13.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.691 -1.256 . . . . 0.0 112.372 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 t -91.65 -58.2 2.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.625 -1.297 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -66.22 -11.17 48.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -161.22 166.31 27.96 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.217 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' B' ' 26' ' ' HIS . 74.4 mt -82.29 137.65 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.877 -1.139 . . . . 0.0 109.563 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 5.9 m -98.93 171.64 7.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.416 -0.803 . . . . 0.0 110.041 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 m -118.6 144.9 45.81 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.8 tp -44.19 -35.09 2.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 110.135 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -61.24 -36.83 81.03 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.621 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -74.21 -41.62 61.09 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.848 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -64.35 -49.59 71.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.621 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -63.06 -25.31 68.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.943 0.878 . . . . 0.0 108.745 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.12 -32.31 73.68 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.854 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.3 m-85 -87.75 -0.34 56.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.686 -1.259 . . . . 0.0 109.119 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -94.33 146.3 24.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' B' ' 44' ' ' GLY . 38.7 t-20 . . . . . 0 C--N 1.299 -1.594 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.778 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.424 ' HB2' HD13 ' A' ' 13' ' ' LEU . 4.7 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.465 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.31 159.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.987 . . . . 0.0 109.797 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.465 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.1 92.78 4.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -139.55 144.64 37.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.425 -0.797 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.516 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.9 m80 -68.59 109.59 3.84 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.343 -0.848 . . . . 0.0 109.133 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.2 mt -92.01 149.23 21.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.928 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.0 m -156.4 -178.13 7.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.9 -143.87 18.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.49 -20.37 54.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.831 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -47.28 -59.03 3.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.087 -1.008 . . . . 0.0 108.732 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.96 -54.72 14.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 34' ' ' GLU . 31.1 t -52.63 -59.02 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.212 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -40.99 -41.79 1.73 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.78 -60.5 3.6 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.79 -46.17 64.11 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.646 -1.284 . . . . 0.0 108.359 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -55.73 -25.57 41.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.4 tp -85.25 -63.3 1.35 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -53.48 -56.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.603 0.716 . . . . 0.0 110.004 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.4 t -71.71 -30.36 65.56 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 110.665 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -120.58 6.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.3 pm0 -84.36 -12.56 54.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -1.142 . . . . 0.0 110.959 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -54.91 -33.36 62.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.85 -1.156 . . . . 0.0 109.989 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.76 126.86 4.18 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.25 172.93 10.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.058 -1.26 . . . . 0.0 108.761 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.61 119.77 28.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.631 -0.668 . . . . 0.0 109.437 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.606 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.908 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.518 0.675 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 t -58.84 -38.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.47 -0.769 . . . . 0.0 110.037 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.94 -45.18 75.0 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.679 -0.638 . . . . 0.0 110.821 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -75.97 -31.81 59.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.139 -0.976 . . . . 0.0 111.598 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 12.0 m -94.27 -28.17 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.62 -1.3 . . . . 0.0 112.104 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' N ' ' A' ' 9' ' ' SER . 15.1 t -90.49 -62.38 1.47 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.0 109.598 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.38 -9.75 0.77 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.472 ' N ' ' C ' ' A' ' 7' ' ' CYS . 1.5 m -160.11 -147.18 0.15 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.335 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD11 ' NE2' ' B' ' 26' ' ' HIS . 61.5 mt -128.09 141.88 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.901 . . . . 0.0 108.931 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.56 174.12 6.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 54.0 m -118.31 146.69 44.14 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.8 -34.64 1.63 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.481 -0.762 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.06 -35.46 80.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 108.521 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.9 mt-30 -76.73 -35.73 57.6 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.849 HD23 HG21 ' B' ' 39' ' ' VAL . 9.9 tp -70.49 -50.29 39.51 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.644 -0.66 . . . . 0.0 109.288 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -60.81 -26.85 67.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -34.29 75.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.235 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.908 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.01 -4.4 58.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.602 -1.311 . . . . 0.0 109.334 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 t -100.69 146.47 27.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.407 -0.808 . . . . 0.0 109.691 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 3.7 p30 . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -57.54 157.37 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.699 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -106.32 88.94 2.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.04 151.8 48.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.524 -0.735 . . . . 0.0 109.539 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 10' ' ' ILE . 10.1 m-70 -74.59 110.42 8.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.183 -0.948 . . . . 0.0 109.925 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -92.03 148.69 22.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.784 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.3 m -155.81 -177.87 6.88 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.14 -142.77 16.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.84 -18.58 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -1.134 . . . . 0.0 109.792 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.82 -57.8 5.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.0 108.814 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.8 tp -49.29 -55.2 13.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 23.3 t -51.61 -59.49 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.115 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 29.0 mt-10 -41.31 -39.97 1.54 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.87 -60.49 3.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.1 mt -51.64 -46.45 63.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.547 -1.345 . . . . 0.0 108.186 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -55.03 -25.72 32.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -85.24 -63.07 1.39 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.849 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -54.15 -56.72 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.627 0.727 . . . . 0.0 109.943 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -71.47 -29.29 64.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.624 -0.672 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.55 -130.2 41.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -82.83 -6.91 59.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.213 -1.169 . . . . 0.0 110.152 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -56.95 -39.46 74.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.479 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 98.4 127.7 5.9 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -124.03 176.85 6.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -1.048 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.1 116.89 24.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 81.3 t80 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.892 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.8 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 3' ' ' VAL . 7.2 t -49.72 -40.06 15.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.589 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.49 -61.33 2.05 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.377 -0.827 . . . . 0.0 111.056 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.66 -27.96 69.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 111.037 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 m -88.42 -31.55 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.698 -1.251 . . . . 0.0 110.866 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.6 t -101.89 -58.77 1.82 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -60.49 -7.04 1.86 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 7' ' ' CYS . 37.3 t -163.12 -144.28 0.09 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.626 0.727 . . . . 0.0 109.53 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.47 HD11 ' NE2' ' B' ' 26' ' ' HIS . 77.2 mt -130.02 156.46 42.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.52 147.33 50.68 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.264 -0.897 . . . . 0.0 109.486 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.6 m -90.84 148.0 22.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 HD13 ' CB ' ' B' ' 22' ' ' PHE . 7.2 tp -43.41 -34.31 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.533 -0.73 . . . . 0.0 110.145 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -34.71 78.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 108.584 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.9 mt-30 -77.96 -28.04 49.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.88 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -78.17 -49.08 14.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.99 -23.03 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -35.18 79.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.12 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.8 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -84.64 -2.73 57.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.685 -1.259 . . . . 0.0 109.232 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 t -101.42 145.92 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.425 -0.797 . . . . 0.0 109.892 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.649 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 13' ' ' LEU . 7.5 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.9 p -47.99 159.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.45 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.04 90.05 3.25 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -126.09 151.97 46.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.47 ' NE2' HD11 ' A' ' 10' ' ' ILE . 9.6 m-70 -75.45 110.3 9.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 16.2 mt -91.58 151.0 20.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.002 -1.061 . . . . 0.0 109.43 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 86.1 m -156.11 -177.95 6.95 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.33 -145.22 12.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.87 -17.67 57.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.31 -1.112 . . . . 0.0 109.714 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.71 -58.02 4.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.064 -1.022 . . . . 0.0 108.859 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -48.49 -54.38 14.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.28 -46.5 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.123 -0.986 . . . . 0.0 108.91 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -41.25 29.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.66 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.63 -60.11 4.17 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 24.0 mt -52.17 -42.54 63.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.301 -1.5 . . . . 0.0 108.39 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -60.45 -25.01 65.67 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.5 -63.04 1.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.88 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -52.18 -56.31 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.529 0.68 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.78 -30.52 61.47 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 110.925 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.86 -117.52 4.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -84.06 -15.13 48.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -1.12 . . . . 0.0 111.035 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -57.25 -23.92 51.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.912 -1.118 . . . . 0.0 109.835 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 77.36 128.62 0.39 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.424 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 25.0 p90 -121.71 177.37 5.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.464 -1.021 . . . . 0.0 109.28 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 8.0 m-85 -125.19 120.23 30.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.435 ' OH ' HG22 ' A' ' 3' ' ' VAL . 77.4 t80 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.886 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.9 tt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.465 0.65 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.1 t -49.77 -43.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.849 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.24 -59.23 3.93 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.341 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -49.79 -50.2 45.79 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.772 . . . . 0.0 110.838 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 m -81.36 -30.68 33.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.022 -1.049 . . . . 0.0 112.27 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 8.5 t -92.58 -60.53 1.8 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.542 -1.349 . . . . 0.0 109.521 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 m -55.38 -17.22 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.131 -0.981 . . . . 0.0 108.566 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.9 m -157.85 -147.99 0.19 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.5 mt -123.17 137.09 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.87 . . . . 0.0 109.087 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 58.4 m -98.68 170.33 8.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 110.349 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 15' ' ' GLN . 73.2 m -118.06 145.89 44.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.2 tp -43.4 -33.43 1.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 110.205 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.68 -36.59 84.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.727 -1.233 . . . . 0.0 108.699 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 12' ' ' SER . 62.5 mt-30 -76.11 -36.06 59.03 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -70.5 -50.3 39.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.588 -0.695 . . . . 0.0 109.383 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -61.6 -23.23 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.22 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.886 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -86.37 -3.8 59.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.659 -1.276 . . . . 0.0 109.269 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.3 t -99.06 145.67 26.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.426 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.59 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.427 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.2 t80 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.5 p -77.71 153.86 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.106 -0.997 . . . . 0.0 110.037 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -99.96 93.12 5.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -138.05 146.27 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.302 -0.873 . . . . 0.0 109.839 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.432 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.8 m-70 -71.08 109.54 5.22 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 11.8 mt -92.39 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.14 -0.975 . . . . 0.0 109.698 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.4 m -156.48 -177.75 6.83 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.25 -142.42 14.27 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.56 -18.63 54.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -1.081 . . . . 0.0 109.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -48.64 -59.07 3.82 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.966 -1.084 . . . . 0.0 108.509 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 33.9 tp -48.7 -56.79 7.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.9 t -50.05 -59.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 20.4 mt-10 -41.56 -42.23 2.37 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.44 3.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.04 -48.68 61.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.729 -1.232 . . . . 0.0 108.083 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -53.14 -25.97 15.21 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.31 -63.06 1.39 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 37.1 t -53.59 -57.07 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.693 0.758 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.2 t -70.24 -29.49 66.31 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.758 -0.589 . . . . 0.0 110.594 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.86 -124.67 16.93 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.603 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -83.35 -8.23 59.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.303 -1.116 . . . . 0.0 110.733 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -59.16 -33.03 70.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.884 -1.135 . . . . 0.0 109.717 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.67 125.66 2.52 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.415 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.6 p90 -119.86 177.66 4.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.395 -1.062 . . . . 0.0 109.341 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -125.13 115.27 20.2 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 t80 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.66 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.846 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.9 tt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.41 0.624 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.485 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.6 t -48.54 -40.09 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -76.09 -23.82 55.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.993 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.3 mt-30 -91.16 -18.48 24.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.845 -1.159 . . . . 0.0 110.109 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -109.57 -30.6 7.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.819 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.33 -63.04 1.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.996 -1.065 . . . . 0.0 109.417 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 m -62.95 -11.03 15.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -163.73 159.86 21.92 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 55.8 mt -83.57 140.64 15.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 109.677 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.13 156.96 18.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.473 -0.767 . . . . 0.0 109.621 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . 50.2 m -100.49 147.48 25.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.47 -34.39 1.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.433 -0.792 . . . . 0.0 110.118 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.13 -34.88 79.07 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.763 -1.211 . . . . 0.0 108.555 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' SER . 60.5 mt-30 -78.07 -30.98 49.95 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -74.53 -49.16 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.535 -0.728 . . . . 0.0 109.122 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.53 -22.95 66.69 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -34.42 78.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.386 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.846 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.3 m-85 -83.65 -0.71 51.8 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.585 -1.322 . . . . 0.0 109.384 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -103.48 146.41 28.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.71 . . . . 0.0 109.838 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.486 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 21.9 m-20 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.614 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.19 151.27 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.088 -1.008 . . . . 0.0 109.518 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -101.3 85.56 2.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.822 . . . . 0.0 109.354 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.36 147.65 49.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -69.05 111.01 4.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.312 -0.867 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.1 mt -90.59 150.93 21.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.6 m -155.96 -178.15 7.09 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.78 -143.47 10.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -78.91 -18.47 53.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 0.0 109.856 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -47.95 -49.57 29.99 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.045 -1.034 . . . . 0.0 108.49 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.7 tp -58.43 -56.63 19.7 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 16.4 t -51.15 -59.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 108.877 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 13.3 mm-40 -41.87 -42.94 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.43 -60.55 3.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.8 mt -51.67 -48.75 63.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.572 -1.33 . . . . 0.0 108.141 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -53.61 -25.73 18.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.8 tp -85.13 -63.01 1.4 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 16' ' ' LEU . 41.8 t -53.09 -58.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.67 0.747 . . . . 0.0 109.579 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 2.0 t -69.57 -29.74 67.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.721 -0.612 . . . . 0.0 110.648 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.62 -125.57 26.48 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.487 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.5 pm0 -83.81 -6.28 59.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -1.12 . . . . 0.0 110.853 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.62 -28.51 69.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 85.88 128.01 2.08 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.458 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.6 p90 -124.62 177.12 6.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.441 -1.035 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 18.7 m-85 -122.91 114.6 20.67 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 t80 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.686 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.913 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.439 0.638 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -56.88 -39.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 109.818 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -75.66 -20.12 58.68 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.255 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.452 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 17.6 tp60 -91.28 -35.04 14.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.942 -1.099 . . . . 0.0 110.744 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.529 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 6.1 m -96.24 -24.32 16.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.0 111.593 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.464 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.1 t -97.44 -67.97 0.82 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.857 -1.152 . . . . 0.0 109.66 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -56.69 -12.29 1.78 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -155.87 -163.41 1.49 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' B' ' 26' ' ' HIS . 62.4 mt -116.7 146.81 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.119 -0.988 . . . . 0.0 109.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 97.9 m -111.32 169.87 8.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.536 -0.728 . . . . 0.0 110.007 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.1 m -118.4 146.36 44.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.4 -34.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.339 -0.851 . . . . 0.0 110.28 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -35.84 81.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.822 -1.174 . . . . 0.0 108.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 69.6 mt-30 -76.28 -34.86 59.1 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.8 tp -70.89 -50.51 34.19 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.623 -0.673 . . . . 0.0 109.263 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -60.31 -27.55 67.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -34.28 75.87 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.913 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.2 m-85 -84.13 -5.03 59.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.627 -1.295 . . . . 0.0 109.496 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -98.42 145.9 26.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.638 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.05 148.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.041 -1.037 . . . . 0.0 109.567 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -98.7 80.95 2.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.423 -0.798 . . . . 0.0 109.465 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' B' ' 25' ' ' GLN . 3.8 pt20 -120.27 148.89 43.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 110.204 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.951 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -68.4 111.18 4.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -90.19 150.6 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 67.9 m -155.75 -178.3 7.19 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.86 -143.24 11.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.32 -18.61 54.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.303 -1.116 . . . . 0.0 109.905 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -47.68 -53.3 15.38 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.017 -1.052 . . . . 0.0 108.695 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 26.4 tp -53.55 -55.62 24.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.6 t -53.36 -58.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.26 -0.9 . . . . 0.0 109.085 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.3 mt-10 -41.11 -40.4 1.49 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.661 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.81 -60.59 3.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -51.54 -45.94 63.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.597 -1.315 . . . . 0.0 108.366 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.27 -25.4 48.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.24 -62.88 1.43 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 31.7 t -54.17 -57.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.583 0.706 . . . . 0.0 109.843 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -70.05 -28.46 65.47 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.596 -0.69 . . . . 0.0 110.327 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.58 -131.3 46.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 -7.33 59.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -1.13 . . . . 0.0 110.136 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -55.63 -44.28 76.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.007 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 102.98 128.08 6.28 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.1 p90 -122.88 177.6 5.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.51 -0.994 . . . . 0.0 109.178 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.35 114.39 20.12 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 80.0 t80 . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 -179.656 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.821 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.7 tt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.411 0.624 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -55.2 -40.94 58.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 111.011 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.446 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 58.6 mt-30 -59.73 -33.36 71.54 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 111.499 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.6 m -93.86 -30.34 14.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.68 -1.263 . . . . 0.0 112.062 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 9' ' ' SER . 12.2 t -93.45 -62.75 1.31 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.669 -1.27 . . . . 0.0 109.429 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.12 -10.37 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.8 m -161.46 -150.5 0.2 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.2 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.487 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 72.1 mt -124.07 136.79 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 57.2 m -101.5 173.96 6.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -0.786 . . . . 0.0 110.158 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.3 m -118.82 146.67 44.65 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.4 tp -43.55 -34.03 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 110.266 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.29 -35.19 80.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.737 -1.227 . . . . 0.0 108.83 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.1 mt-30 -77.14 -32.68 56.52 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.06 -50.31 20.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -61.72 -22.75 65.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -33.69 76.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.267 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.0 m-85 -86.55 -1.27 57.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.622 -1.299 . . . . 0.0 109.204 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -104.22 146.56 28.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.827 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.276 179.721 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 13' ' ' LEU . 1.5 t80 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.54 151.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -101.84 91.87 4.57 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -136.61 147.62 47.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.423 -0.798 . . . . 0.0 110.014 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.487 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.9 m-70 -71.2 109.52 5.29 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.365 -0.834 . . . . 0.0 108.793 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.04 149.9 20.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.88 -178.39 7.26 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.34 -144.74 10.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.01 -19.9 58.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -1.118 . . . . 0.0 109.87 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -47.53 -58.3 4.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.077 -1.015 . . . . 0.0 108.654 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -50.08 -55.2 15.82 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' B' ' 34' ' ' GLU . 20.1 t -51.54 -60.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 109.079 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 33' ' ' VAL . 42.7 mt-10 -41.23 -42.43 2.11 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.7 -60.63 3.27 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.92 -48.85 60.61 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.8 -1.188 . . . . 0.0 108.177 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -53.69 -25.68 19.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.7 tp -85.1 -62.83 1.44 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 43.8 t -52.2 -55.95 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.555 0.693 . . . . 0.0 109.921 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 0.9 OUTLIER -73.55 -30.12 62.86 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 110.594 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.37 -119.78 7.65 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.633 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.6 -15.9 47.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.124 . . . . 0.0 110.954 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -52.94 -45.59 67.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.513 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.473 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 100.68 127.71 6.14 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.401 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 29.5 p90 -122.76 177.22 5.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.511 -0.993 . . . . 0.0 108.8 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 46' ' ' PHE . 24.1 m-85 -126.35 114.15 17.84 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.552 0.692 . . . . 0.0 109.388 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 71.7 t80 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.405 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.5 tt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.529 0.68 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -58.8 -37.67 67.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.712 0.768 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.1 -47.48 74.04 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.692 -0.63 . . . . 0.0 111.092 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -77.23 -39.7 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.103 -0.998 . . . . 0.0 111.727 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' SER . 16.7 m -83.12 -27.3 30.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.535 -1.353 . . . . 0.0 112.23 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.9 -55.92 3.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.497 -1.377 . . . . 0.0 109.428 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -157.32 169.85 23.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.514 HG13 ' CE1' ' B' ' 26' ' ' HIS . 62.9 mt -85.75 140.32 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 110.072 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.4 m -102.61 174.87 5.7 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.492 -0.755 . . . . 0.0 109.517 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 55.5 m -118.54 144.97 45.7 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.62 -34.73 1.52 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.451 -0.781 . . . . 0.0 110.199 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -62.76 -35.25 79.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.841 -1.162 . . . . 0.0 108.703 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' SER . 63.6 mt-30 -76.05 -34.15 59.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.5 tp -72.4 -50.07 29.16 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.575 -0.703 . . . . 0.0 109.324 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.3 -21.4 65.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -33.47 75.66 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.077 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.9 m-85 -84.53 -2.96 58.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.669 -1.269 . . . . 0.0 109.408 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.5 t -101.47 145.68 28.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -0.781 . . . . 0.0 109.55 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.4 p30 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.3 p -77.43 153.75 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -102.81 91.13 4.03 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -137.09 146.44 45.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 109.933 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.518 ' N ' ' OE1' ' B' ' 25' ' ' GLN . 17.3 m80 -68.78 110.03 4.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.369 -0.832 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.515 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -92.66 149.3 21.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.053 -1.03 . . . . 0.0 109.804 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.51 -178.02 7.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.75 -144.1 12.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -76.68 -19.99 57.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -1.096 . . . . 0.0 109.851 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.75 -57.96 4.93 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.027 -1.046 . . . . 0.0 108.73 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.2 tp -50.67 -55.21 17.53 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.62 -60.02 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.213 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 25.4 mt-10 -41.12 -43.51 2.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -55.37 -60.83 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.37 -48.9 62.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.711 -1.243 . . . . 0.0 108.256 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.16 -25.87 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.3 tp -85.56 -63.14 1.37 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 39.5 t -52.72 -55.26 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.543 0.687 . . . . 0.0 110.129 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -74.03 -30.37 62.39 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.468 -0.77 . . . . 0.0 110.475 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.92 -117.62 4.28 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.702 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.85 -13.44 53.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.267 -1.137 . . . . 0.0 111.081 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 69.6 mtt180 -58.77 -29.35 66.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.847 -1.158 . . . . 0.0 109.858 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 83.34 128.02 1.33 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.7 p90 -121.98 175.83 6.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.335 -1.097 . . . . 0.0 109.406 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -123.02 116.85 24.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.6 t80 . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.576 -0.703 . . . . 0.0 109.644 -179.716 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.895 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.385 0.612 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.05 -36.94 65.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.496 -0.753 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.57 -23.21 60.94 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.54 -0.725 . . . . 0.0 110.92 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.58 -53.56 4.14 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.758 -1.213 . . . . 0.0 110.89 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -72.4 -29.94 64.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 112.266 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' C ' ' N ' ' A' ' 9' ' ' SER . 10.0 t -89.53 -66.71 0.9 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.49 -1.381 . . . . 0.0 109.887 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 m -51.49 -14.84 0.34 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.913 -1.117 . . . . 0.0 108.538 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 7' ' ' CYS . 3.2 t -154.91 -138.73 0.07 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' NE2' ' B' ' 26' ' ' HIS . 93.3 mt -130.44 150.98 35.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.3 m -116.5 169.31 9.43 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.363 -0.836 . . . . 0.0 109.661 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.7 m -117.52 145.59 44.13 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -42.98 -33.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.509 -0.745 . . . . 0.0 110.245 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.75 -35.74 82.04 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.683 -1.26 . . . . 0.0 108.857 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 12' ' ' SER . 61.6 mt-30 -76.54 -32.49 58.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.853 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -74.0 -51.0 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.3 -24.59 65.09 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -34.86 78.42 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.071 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.895 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.5 m-85 -84.62 -2.52 57.57 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.646 -1.284 . . . . 0.0 109.411 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 t -101.86 145.81 28.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.59 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.0 m-20 . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.82 142.41 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.9 OUTLIER -92.33 75.6 5.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.411 -0.806 . . . . 0.0 109.568 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -115.92 158.69 22.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.496 ' NE2' HD11 ' A' ' 10' ' ' ILE . 6.3 m-70 -77.28 110.79 12.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 109.91 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.509 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.8 mt -92.72 150.83 20.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.808 -1.182 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 68.6 m -156.28 -177.98 6.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.05 -144.22 10.55 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -76.99 -19.65 57.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -1.104 . . . . 0.0 109.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -47.28 -56.05 7.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.064 -1.023 . . . . 0.0 108.781 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.1 tp -51.19 -55.2 19.17 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.8 t -52.18 -58.8 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.137 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.7 mt-10 -41.17 -40.09 1.46 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.27 -60.53 3.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.8 -44.73 63.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.607 -1.308 . . . . 0.0 108.372 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -57.12 -25.5 58.93 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.06 1.39 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.853 HG21 HD23 ' A' ' 16' ' ' LEU . 38.9 t -53.34 -55.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.522 0.677 . . . . 0.0 110.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.74 -30.54 61.54 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.536 -0.727 . . . . 0.0 110.87 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 -115.23 2.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.327 -1.415 . . . . 0.0 109.759 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -83.68 -21.26 32.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.38 -1.071 . . . . 0.0 110.962 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -52.2 -28.69 19.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.869 -1.145 . . . . 0.0 109.901 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 80.58 129.34 0.86 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.5 p90 -123.54 177.16 5.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.463 -1.022 . . . . 0.0 109.118 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.06 120.25 29.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.655 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.911 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.48 0.657 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -54.34 -39.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.49 -0.756 . . . . 0.0 109.778 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -73.2 -20.44 60.88 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.533 -0.729 . . . . 0.0 110.339 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' SER . 78.1 mt-30 -91.29 -36.89 13.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 110.622 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 m -94.85 -27.36 15.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.02 . . . . 0.0 111.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 t -91.0 -59.57 2.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.753 -1.217 . . . . 0.0 109.715 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -65.61 -13.47 59.13 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.115 -0.991 . . . . 0.0 108.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -158.49 164.52 36.1 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG13 ' CE1' ' B' ' 26' ' ' HIS . 77.9 mt -81.94 137.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.162 . . . . 0.0 109.759 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 9.7 m -96.83 168.25 10.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 15' ' ' GLN . 75.4 m -118.46 144.68 45.81 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.3 tp -43.45 -33.65 1.13 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.347 -0.846 . . . . 0.0 110.272 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.77 -35.58 81.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.719 -1.238 . . . . 0.0 108.776 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' SER . 63.1 mt-30 -76.84 -32.55 57.63 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.851 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.26 -50.14 20.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.66 -0.65 . . . . 0.0 109.292 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -61.65 -23.39 66.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -34.71 78.4 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.945 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.911 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.4 m-85 -84.83 -6.63 59.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.7 -1.25 . . . . 0.0 109.263 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -98.99 145.89 26.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.1 p30 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.7 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -78.55 152.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.049 -1.032 . . . . 0.0 110.067 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -97.78 93.92 6.64 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -141.89 144.98 34.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 109.975 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.503 ' CE1' HG13 ' A' ' 10' ' ' ILE . 16.2 m80 -68.92 109.86 4.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.27 150.5 20.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.019 . . . . 0.0 109.949 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.92 -178.24 7.16 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.9 -145.3 8.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -75.22 -19.52 59.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -1.162 . . . . 0.0 109.95 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.09 -57.65 5.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.039 -1.038 . . . . 0.0 108.751 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 31.2 tp -49.99 -55.77 13.33 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.24 -59.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.312 -0.868 . . . . 0.0 109.39 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 23.1 mt-10 -41.24 -42.15 2.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.78 3.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.2 -48.37 62.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.685 -1.259 . . . . 0.0 108.228 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.95 -25.58 21.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.41 -63.0 1.4 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.851 HG21 HD23 ' A' ' 16' ' ' LEU . 40.8 t -52.58 -56.45 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.505 0.669 . . . . 0.0 110.022 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 0.7 OUTLIER -73.28 -30.37 63.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.527 -0.733 . . . . 0.0 110.585 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.76 -118.71 5.15 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.279 -1.439 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.72 -11.55 57.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.274 -1.133 . . . . 0.0 110.894 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -59.8 -34.65 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.927 -1.108 . . . . 0.0 109.806 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.497 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.75 127.16 2.85 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.3 p90 -119.62 177.2 5.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.8 114.58 19.43 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.9 tt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.394 0.616 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -55.8 -38.96 53.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -75.34 -20.32 59.1 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.507 -0.745 . . . . 0.0 110.294 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -91.38 -36.99 13.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.944 -1.098 . . . . 0.0 110.771 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 4.8 m -95.76 -26.07 15.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.084 . . . . 0.0 111.882 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -90.19 -58.78 2.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.614 -1.304 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.407 ' C ' ' HG ' ' A' ' 9' ' ' SER . 7.1 m -65.22 -12.34 50.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.3 m -159.67 172.83 17.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.506 HG13 ' CE1' ' B' ' 26' ' ' HIS . 75.2 mt -89.91 135.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.735 -1.228 . . . . 0.0 109.558 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.2 m -96.8 171.48 8.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 109.846 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 60.5 m -118.53 144.83 45.79 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.18 -33.64 1.59 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.43 -34.87 78.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.702 -1.248 . . . . 0.0 108.66 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 60.9 mt-30 -76.92 -34.27 57.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.841 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -72.54 -50.41 25.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.631 -0.668 . . . . 0.0 109.241 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.44 -22.18 64.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -33.64 76.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.104 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.8 m-85 -85.62 -2.57 58.31 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.694 -1.253 . . . . 0.0 109.433 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -99.35 145.76 27.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.623 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.0 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.17 155.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -98.65 92.94 5.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.92 144.07 41.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.44 -0.787 . . . . 0.0 109.737 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.506 ' CE1' HG13 ' A' ' 10' ' ' ILE . 15.6 m80 -69.67 109.75 4.51 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.01 150.12 20.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.814 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -155.81 -178.08 7.03 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.12 -144.04 11.0 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -76.36 -19.8 57.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -1.073 . . . . 0.0 109.928 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.88 -58.92 3.76 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.035 -1.041 . . . . 0.0 108.675 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 27.5 tp -48.8 -56.23 9.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' B' ' 34' ' ' GLU . 28.6 t -50.09 -58.94 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.2 mt-10 -41.2 -40.98 1.71 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.97 -60.77 3.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.48 -46.08 63.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.596 -1.315 . . . . 0.0 108.361 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.36 -25.28 48.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.07 1.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 16' ' ' LEU . 30.7 t -53.16 -55.86 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.593 0.711 . . . . 0.0 110.099 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -73.34 -30.67 63.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.595 -0.69 . . . . 0.0 110.701 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.76 -115.27 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.634 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -84.08 -15.65 46.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.333 -1.098 . . . . 0.0 111.004 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -58.97 -18.22 31.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.851 -1.155 . . . . 0.0 109.779 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 69.18 128.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.8 p90 -121.14 177.43 5.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.454 -1.027 . . . . 0.0 109.199 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.491 ' CE1' ' OD1' ' A' ' 21' ' ' ASN . 36.2 m-85 -125.52 119.85 29.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.2 t80 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.782 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.875 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.7 tt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.527 0.679 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.6 t -55.66 -39.75 56.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.622 -0.674 . . . . 0.0 109.904 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.96 -20.16 60.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.483 -0.76 . . . . 0.0 110.344 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -91.11 -37.98 13.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.993 -1.067 . . . . 0.0 110.705 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.2 m -96.59 -24.15 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.99 -1.069 . . . . 0.0 111.929 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.23 -55.57 3.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.518 -1.364 . . . . 0.0 109.25 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -65.61 -18.66 65.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -154.6 173.21 16.66 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.968 HD11 ' CE1' ' B' ' 26' ' ' HIS . 66.5 mt -91.13 133.4 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.738 -1.226 . . . . 0.0 109.407 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 33.5 m -92.72 172.97 8.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.9 m -118.49 145.98 44.87 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.3 tp -43.54 -34.38 1.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 110.12 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.59 80.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.0 108.928 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -76.56 -36.81 57.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.838 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -69.71 -50.95 38.75 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.616 -0.678 . . . . 0.0 109.257 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.37 -25.51 65.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -33.99 77.05 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.962 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.875 ' CD2' HD12 ' A' ' 2' ' ' ILE . 91.9 m-85 -84.44 2.15 42.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.725 -1.234 . . . . 0.0 109.105 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.1 t -106.34 146.04 30.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.17 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.383 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.43 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.4 p -75.93 156.77 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.43 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -102.23 92.87 4.92 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.17 141.69 47.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.968 ' CE1' HD11 ' A' ' 10' ' ' ILE . 1.8 m80 -69.23 109.85 4.3 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.408 -0.807 . . . . 0.0 109.512 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.1 mt -92.64 150.18 20.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 110.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.7 m -156.65 177.37 11.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.51 -145.54 18.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -74.17 -21.21 59.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.084 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.91 -53.19 16.64 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 0.0 108.62 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 21.8 tp -56.36 -56.48 20.54 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 34' ' ' GLU . 24.1 t -47.82 -60.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.26 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 33' ' ' VAL . 38.6 mt-10 -41.1 -42.93 2.11 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.707 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -54.74 -61.02 2.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 26.6 mt -52.67 -47.58 67.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.473 -1.392 . . . . 0.0 108.146 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -53.57 -26.1 20.03 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.5 tp -85.07 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.838 HG21 HD23 ' A' ' 16' ' ' LEU . 42.3 t -54.24 -56.91 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.716 0.77 . . . . 0.0 109.721 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.8 t -70.34 -29.96 66.79 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.724 -0.61 . . . . 0.0 110.662 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.56 -125.67 22.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.6 -9.04 59.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -1.14 . . . . 0.0 110.804 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -55.46 -42.15 73.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.903 -1.123 . . . . 0.0 109.587 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 101.64 126.62 5.88 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -130.84 165.65 22.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.567 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -120.5 114.29 21.55 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.932 0.873 . . . . 0.0 109.584 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 85.4 t80 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.445 0.64 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 8.4 t -56.05 -38.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 110.581 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 49.1 tp60 -91.42 -33.13 15.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 0.0 110.543 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 m -96.78 -29.76 13.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.938 -1.101 . . . . 0.0 111.404 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.8 t -92.83 -63.33 1.24 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.758 -1.214 . . . . 0.0 109.584 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -4.84 1.09 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 39.7 t -161.07 -148.92 0.16 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.51 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.5 mt -127.71 140.96 47.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 69.4 m -109.31 164.71 12.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.37 -0.832 . . . . 0.0 110.417 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 61.1 m -114.68 146.33 41.01 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.8 tp -43.13 -34.16 1.03 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.758 . . . . 0.0 110.315 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.54 -33.92 77.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.746 -1.221 . . . . 0.0 108.706 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' SER . 59.7 mt-30 -79.22 -30.56 43.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.82 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -75.3 -49.83 17.96 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.67 -23.26 65.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.78 -34.56 78.63 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.0 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.51 -4.57 59.02 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.678 -1.264 . . . . 0.0 109.151 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.9 t -100.23 145.95 27.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 109.566 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.6 p30 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -65.3 157.95 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.789 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -101.6 93.18 5.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.06 144.68 45.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.782 . . . . 0.0 110.04 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.51 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.3 m-70 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.482 -0.761 . . . . 0.0 109.666 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.6 mt -92.52 150.78 20.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 109.347 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.4 m -155.7 -177.85 6.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.3 -144.11 11.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -77.23 -18.82 57.37 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.47 -58.48 4.14 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.086 -1.009 . . . . 0.0 108.715 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 29.4 tp -48.67 -55.91 10.0 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.6 t -52.19 -58.96 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.012 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 33' ' ' VAL . 15.4 mt-10 -41.47 -41.87 2.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.87 -60.8 3.04 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.74 -48.87 58.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.0 108.318 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.84 -24.42 22.97 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.3 tp -85.25 -55.78 3.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -61.51 -59.58 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.605 0.716 . . . . 0.0 110.061 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.1 t -70.11 -30.22 67.37 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.649 -0.657 . . . . 0.0 110.711 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.52 -119.32 5.54 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.347 -1.406 . . . . 0.0 109.856 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.68 -12.64 55.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -1.133 . . . . 0.0 110.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 74.8 mtt180 -58.14 -31.87 67.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 87.52 126.49 2.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -119.22 177.23 4.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -1.091 . . . . 0.0 109.341 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -125.66 115.48 20.18 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.853 -0.529 . . . . 0.0 109.715 -179.63 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.2 tt . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.594 0.711 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.6 t -61.26 -38.8 80.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.591 0.71 . . . . 0.0 109.869 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.93 -20.07 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 109.995 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.71 -27.98 18.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.987 -1.071 . . . . 0.0 110.708 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' SER . 59.1 m -103.4 -30.45 10.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.043 -1.036 . . . . 0.0 111.082 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.0 t -93.65 -63.78 1.16 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.879 -1.138 . . . . 0.0 109.777 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -62.03 -10.05 8.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -162.93 164.15 25.95 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.358 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.523 HG13 ' CE1' ' B' ' 26' ' ' HIS . 67.0 mt -85.59 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 0.0 109.049 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.47 160.32 17.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.46 -0.775 . . . . 0.0 110.053 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' GLN . 44.9 m -103.39 147.71 26.78 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 13' ' ' LEU . 7.7 tp -43.46 -35.1 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.494 -0.754 . . . . 0.0 110.242 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.1 -35.3 79.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.768 -1.208 . . . . 0.0 108.566 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' SER . 59.0 mt-30 -77.85 -26.96 49.72 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 HG21 ' B' ' 39' ' ' VAL . 7.2 tp -78.81 -47.97 15.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.446 -0.784 . . . . 0.0 108.947 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -62.59 -21.39 65.58 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -34.53 78.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.145 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 83.7 m-85 -84.76 1.78 45.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.562 -1.336 . . . . 0.0 109.044 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -109.67 146.1 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 2.9 p30 . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.318 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.6 p -63.53 157.34 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.83 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -103.85 92.62 4.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.39 144.19 42.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 109.809 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.523 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.4 m80 -69.1 109.51 4.06 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.149 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.0 mt -90.89 149.51 21.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.133 -0.98 . . . . 0.0 109.708 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 47.3 m -155.91 -178.08 7.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.12 -145.55 16.4 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.15 -19.99 57.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -47.43 -60.62 2.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.074 -1.016 . . . . 0.0 108.658 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 22.7 tp -47.29 -56.46 6.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' B' ' 34' ' ' GLU . 35.2 t -50.78 -59.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.261 -0.899 . . . . 0.0 108.903 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.9 mt-10 -41.43 -39.58 1.53 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.687 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.68 -59.88 4.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -45.41 66.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.5 -1.375 . . . . 0.0 108.069 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -56.27 -25.93 49.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -84.77 -58.32 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.868 HG21 HD23 ' A' ' 16' ' ' LEU . 46.9 t -57.36 -56.73 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -72.83 -31.03 64.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.652 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -112.94 1.3 Allowed Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.794 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.03 -20.35 32.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 111.226 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -52.41 -50.81 61.78 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.799 -1.188 . . . . 0.0 109.665 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.57 127.73 6.15 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -125.3 170.23 11.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.86 114.09 19.38 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.948 0.88 . . . . 0.0 109.544 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 73.3 t80 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.773 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.407 0.622 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.69 -40.58 19.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.735 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -75.4 -19.65 59.39 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.769 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.89 -41.17 12.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.144 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.5 m -91.2 -30.41 16.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 111.75 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.5 t -92.91 -66.72 0.9 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.647 -1.283 . . . . 0.0 110.508 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -57.21 -10.17 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.976 -1.077 . . . . 0.0 108.498 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -163.12 176.64 9.83 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.113 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.595 HD11 ' CE1' ' B' ' 26' ' ' HIS . 71.0 mt -97.09 135.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.997 -1.064 . . . . 0.0 108.901 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 p -103.06 158.29 16.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.487 -0.758 . . . . 0.0 110.275 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.8 m -100.25 146.54 26.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.8 tp -43.45 -34.4 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.25 79.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 108.702 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.2 mt-30 -77.58 -29.47 52.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.878 HD23 HG21 ' B' ' 39' ' ' VAL . 8.3 tp -76.9 -49.09 16.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.509 -0.745 . . . . 0.0 109.068 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.44 -23.53 66.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -35.56 78.24 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.149 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.773 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.1 m-85 -84.5 -3.84 58.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.716 -1.24 . . . . 0.0 109.395 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.5 t -100.55 146.37 27.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.442 -0.786 . . . . 0.0 109.671 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' B' ' 43' ' ' ARG . 2.2 p30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 13' ' ' LEU . 4.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.42 152.19 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 93.68 7.31 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.17 144.46 42.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' HD11 ' A' ' 10' ' ' ILE . 8.3 m80 -73.87 109.97 7.8 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.0 mt -92.26 148.77 21.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 109.773 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.8 m -155.41 -177.79 6.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.24 -143.57 15.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.73 -18.17 54.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -1.173 . . . . 0.0 109.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -48.18 -57.07 6.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.002 -1.061 . . . . 0.0 108.447 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.5 t -51.32 -59.03 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.898 . . . . 0.0 108.972 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.1 mt-10 -42.49 -40.19 2.52 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.48 -60.18 4.27 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -51.65 -45.95 63.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.675 -1.265 . . . . 0.0 108.103 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.44 -24.95 48.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.08 -62.98 1.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 16' ' ' LEU . 58.7 t -52.41 -57.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.748 0.785 . . . . 0.0 109.749 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.477 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.7 t -70.13 -29.53 66.49 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.662 -0.649 . . . . 0.0 110.564 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.75 -126.3 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.369 -1.396 . . . . 0.0 109.758 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -83.18 -5.96 59.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.244 -1.151 . . . . 0.0 110.649 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.45 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.6 mtt180 -61.63 -37.21 83.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.943 -1.098 . . . . 0.0 109.666 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.477 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 95.19 126.07 4.74 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.417 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.4 p90 -121.53 177.6 5.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.472 -1.016 . . . . 0.0 109.181 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -127.03 118.59 24.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 t80 . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.366 0.603 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.3 t -54.51 -38.89 43.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.869 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -76.31 -25.87 55.23 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.467 -0.77 . . . . 0.0 110.261 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.35 -29.69 16.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.888 -1.132 . . . . 0.0 110.441 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.6 m -93.39 -30.96 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 111.187 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.9 t -94.57 -63.74 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.859 -1.15 . . . . 0.0 110.174 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 m -57.68 -7.42 0.67 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 108.248 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 7' ' ' CYS . 35.7 t -156.65 -148.89 0.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.856 0.836 . . . . 0.0 109.44 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' B' ' 26' ' ' HIS . 80.1 mt -130.95 144.97 36.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.69 154.91 29.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.242 -0.911 . . . . 0.0 110.064 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -98.75 149.4 22.9 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.22 -33.41 1.55 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.84 -34.67 78.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.706 -1.246 . . . . 0.0 108.752 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -78.82 -30.34 45.31 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -75.53 -50.17 16.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.54 -26.18 66.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.35 -35.03 76.32 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.161 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 92.2 m-85 -83.62 -4.5 58.64 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.652 -1.28 . . . . 0.0 109.322 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -100.23 146.28 27.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 0.0 109.58 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 4.0 p30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.381 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.41 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.4 p -81.86 155.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.97 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.41 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -99.62 91.33 4.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.034 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 26' ' ' HIS . 0.3 OUTLIER -133.83 142.6 47.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.531 -0.731 . . . . 0.0 109.863 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.976 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.7 m80 -67.8 109.75 3.5 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.509 -0.744 . . . . 0.0 110.491 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.522 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -92.96 149.06 21.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.802 . . . . 0.0 109.339 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.3 m -155.71 -178.12 7.06 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.71 -143.37 18.59 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -78.77 -18.62 53.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -1.114 . . . . 0.0 109.815 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -47.64 -58.37 4.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.06 -1.025 . . . . 0.0 108.636 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 18.6 tp -48.84 -55.71 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' B' ' 34' ' ' GLU . 19.9 t -52.2 -59.07 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.257 -0.902 . . . . 0.0 108.839 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' B' ' 33' ' ' VAL . 18.0 mt-10 -42.36 -41.63 2.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.59 -60.39 3.74 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.69 -47.67 63.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.618 -1.301 . . . . 0.0 108.194 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -54.68 -25.46 27.3 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -84.89 -62.83 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.865 HG21 HD23 ' A' ' 16' ' ' LEU . 40.7 t -53.24 -58.43 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.703 0.763 . . . . 0.0 109.706 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.69 -28.69 66.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.682 -0.636 . . . . 0.0 110.585 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.19 -132.49 48.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.75 -4.91 58.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -57.65 -43.26 84.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 127.09 6.0 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.444 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.2 p90 -122.98 177.36 5.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.484 -1.01 . . . . 0.0 108.87 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -122.54 113.48 19.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 72.5 t80 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.27 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.852 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.351 0.596 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.455 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.39 -39.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.48 -24.39 50.19 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.508 -0.745 . . . . 0.0 110.139 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.97 -22.14 20.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.943 -1.098 . . . . 0.0 110.113 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' SER . 56.5 m -104.62 -30.43 9.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.987 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.2 t -98.51 -66.13 0.92 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.947 -1.095 . . . . 0.0 109.855 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -57.63 -9.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.3 m -161.72 -176.48 5.3 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.965 HD11 ' CE1' ' B' ' 26' ' ' HIS . 57.4 mt -106.64 137.81 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.063 -1.023 . . . . 0.0 108.849 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.44 156.86 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.472 -0.767 . . . . 0.0 109.947 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.1 m -99.78 147.94 24.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 tp -43.44 -34.26 1.27 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.492 -0.755 . . . . 0.0 110.16 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.55 -34.7 78.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.723 -1.236 . . . . 0.0 108.75 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.9 mt-30 -78.82 -28.76 44.51 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 8.9 tp -76.8 -49.53 15.65 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.68 -25.29 67.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -35.83 77.01 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.173 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.1 m-85 -83.43 0.35 46.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.626 -1.296 . . . . 0.0 109.094 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.81 146.36 31.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.736 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.81 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.401 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.6 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.463 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.1 p -47.77 158.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.747 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -107.07 89.47 3.01 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.18 141.89 51.63 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.573 -0.705 . . . . 0.0 109.671 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.965 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -66.24 110.66 3.11 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.406 -0.809 . . . . 0.0 110.555 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -90.94 149.72 21.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -156.09 -178.13 7.09 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.31 -144.23 14.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.19 -18.94 54.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -47.32 -56.87 5.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.086 -1.009 . . . . 0.0 108.62 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.3 tp -50.14 -56.29 11.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.5 t -51.34 -60.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.276 -0.89 . . . . 0.0 109.113 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 17.7 mm-40 -41.42 -42.39 2.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.373 0.606 . . . . 0.0 109.378 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.31 -60.3 3.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.2 mt -51.17 -49.02 61.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.628 -1.295 . . . . 0.0 108.083 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -53.07 -26.18 15.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.2 -62.96 1.41 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 56.4 t -51.06 -55.71 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.438 0.637 . . . . 0.0 110.175 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -75.37 -30.83 60.29 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 110.94 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.8 -111.94 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.184 -1.484 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -83.87 -23.89 31.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.343 -1.092 . . . . 0.0 110.947 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -52.25 -28.16 17.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.91 -1.119 . . . . 0.0 110.008 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 79.39 129.75 0.69 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.407 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 27.6 p90 -123.07 177.01 5.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.571 -0.958 . . . . 0.0 108.944 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.01 122.19 33.76 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 78.0 t80 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.919 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.891 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.354 0.597 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.453 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.9 t -54.33 -39.94 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -75.29 -19.54 59.62 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.465 -0.772 . . . . 0.0 110.472 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 84.1 mt-30 -90.67 -40.48 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 110.711 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -92.67 -24.27 18.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.916 -1.115 . . . . 0.0 111.944 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.1 t -94.91 -66.65 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.638 -1.289 . . . . 0.0 109.485 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.492 ' C ' ' HG ' ' A' ' 9' ' ' SER . 9.1 m -57.77 -8.84 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' A' ' 8' ' ' THR . 1.4 m -160.84 -159.07 0.64 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.69 HD11 ' CE1' ' B' ' 26' ' ' HIS . 78.1 mt -119.03 139.76 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.28 -0.888 . . . . 0.0 109.198 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 90.6 m -104.39 171.67 7.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.439 -0.788 . . . . 0.0 110.097 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 48.2 m -118.46 145.67 45.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.7 tp -43.65 -33.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.437 -0.789 . . . . 0.0 110.214 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.85 -34.98 79.16 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.742 -1.223 . . . . 0.0 108.491 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.9 mt-30 -77.04 -34.69 57.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.833 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -71.5 -50.52 30.62 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.596 -0.69 . . . . 0.0 109.212 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.32 -23.56 65.81 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -33.82 76.74 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.125 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.891 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.0 m-85 -84.42 -4.65 59.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.674 -1.266 . . . . 0.0 109.398 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -98.9 145.99 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.404 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.6 p-10 . . . . . 0 C--N 1.303 -1.445 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.453 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.3 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.68 154.35 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.0 110.083 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.22 96.02 10.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -137.18 144.28 42.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.188 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.69 ' CE1' HD11 ' A' ' 10' ' ' ILE . 9.1 m80 -74.37 108.78 7.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -94.52 150.77 19.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.082 -1.011 . . . . 0.0 109.775 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 56.6 m -155.77 -177.97 6.95 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.31 -144.75 10.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -76.24 -19.89 57.93 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.259 -1.142 . . . . 0.0 109.798 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -47.19 -57.73 4.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.061 -1.024 . . . . 0.0 108.804 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 28.1 tp -50.92 -55.85 15.19 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.0 t -50.74 -59.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' VAL . 45.8 mt-10 -41.1 -42.36 1.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.62 -60.53 3.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.15 -48.67 61.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.595 -1.316 . . . . 0.0 108.276 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -53.9 -25.68 21.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.07 -62.91 1.43 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.833 HG21 HD23 ' A' ' 16' ' ' LEU . 30.2 t -53.62 -58.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.601 0.715 . . . . 0.0 109.909 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.95 -28.38 65.51 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 110.476 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 -130.32 46.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -82.76 -10.4 58.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -1.139 . . . . 0.0 109.971 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -52.93 -45.09 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 128.24 6.3 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.432 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 21.9 p90 -122.68 177.41 5.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -1.018 . . . . 0.0 109.121 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.57 117.74 25.0 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.709 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.924 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.3 tt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.347 0.594 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 9.4 t -52.39 -38.91 26.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.26 -27.71 59.53 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.177 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.66 -28.78 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.841 -1.162 . . . . 0.0 110.594 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' SER . 18.3 m -92.98 -28.94 16.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 0.0 111.2 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' C ' ' N ' ' A' ' 9' ' ' SER . 14.1 t -96.43 -66.32 0.91 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.891 -1.13 . . . . 0.0 109.985 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -56.41 -12.71 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.4 m -154.93 -179.28 7.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 54.3 mt -105.83 138.78 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.136 -0.978 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.48 157.03 17.44 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 36.1 m -99.02 147.94 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.6 tp -43.71 -33.14 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.445 -0.784 . . . . 0.0 110.092 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -65.01 -34.72 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.782 -1.199 . . . . 0.0 108.75 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.4 mt-30 -78.57 -31.82 47.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.09 -50.17 20.73 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.75 -25.5 66.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -34.63 78.01 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.21 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.924 ' CD2' HD12 ' A' ' 2' ' ' ILE . 93.2 m-85 -83.14 -2.22 54.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.617 -1.302 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.28 146.57 28.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.539 -0.726 . . . . 0.0 109.789 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.395 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.405 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.2 p -73.02 153.68 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.815 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.405 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -100.63 92.69 5.22 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.46 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.1 tm0? -134.18 139.87 46.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.387 -0.821 . . . . 0.0 109.555 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -65.53 110.2 2.62 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.299 -0.876 . . . . 0.0 110.172 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -91.21 148.63 22.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.684 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.5 m -155.4 -177.87 6.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.3 -144.2 20.07 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.31 -18.94 54.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 109.677 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.1 m-20 -47.54 -57.83 4.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 108.686 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.9 tp -49.47 -55.54 12.89 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.2 t -52.65 -59.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.234 -0.916 . . . . 0.0 108.757 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -42.0 -41.21 2.45 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.15 -60.36 3.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -51.73 -45.74 63.73 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.761 -1.212 . . . . 0.0 108.281 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -56.05 -25.64 45.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -84.96 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 41.7 t -53.48 -56.98 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.645 0.736 . . . . 0.0 109.568 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.8 t -70.43 -29.42 66.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.72 -0.613 . . . . 0.0 110.781 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.92 -129.26 38.63 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.371 -1.395 . . . . 0.0 109.695 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.12 -3.69 57.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -1.139 . . . . 0.0 110.526 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -62.38 -34.08 76.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.961 -1.087 . . . . 0.0 109.629 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.0 128.01 4.27 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.451 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 17.0 p90 -123.06 177.77 5.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.42 -1.047 . . . . 0.0 109.059 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.3 114.26 19.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.1 t80 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 -179.751 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.904 HD12 ' CD2' ' A' ' 19' ' ' TYR . 14.5 tt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.844 0.831 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.8 t -68.4 -36.42 74.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.619 0.724 . . . . 0.0 110.018 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.82 -20.14 58.39 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.19 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 77.1 mt-30 -91.04 -34.98 14.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.53 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -95.48 -30.35 13.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.814 -1.179 . . . . 0.0 111.385 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.2 t -92.96 -64.14 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.816 -1.177 . . . . 0.0 109.911 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -60.1 -5.79 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 7' ' ' CYS . 42.6 t -159.74 -145.84 0.13 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.963 HD11 ' CE1' ' B' ' 26' ' ' HIS . 91.9 mt -130.05 142.44 43.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 60.4 m -109.18 151.05 26.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.283 -0.886 . . . . 0.0 110.628 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLN . 59.3 m -101.23 146.0 28.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.6 tp -43.54 -34.02 1.28 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.01 -34.76 78.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.718 -1.239 . . . . 0.0 108.698 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' SER . 62.7 mt-30 -77.58 -33.01 54.07 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.847 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -72.95 -50.26 24.45 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.621 -0.674 . . . . 0.0 109.237 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -61.61 -20.79 63.74 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -32.74 72.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.904 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.6 m-85 -85.83 -6.98 59.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.588 -1.32 . . . . 0.0 109.283 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 t -93.61 142.6 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.891 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.477 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.1 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.411 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -82.34 154.64 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.85 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.58 90.28 4.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -132.45 145.1 50.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.614 -0.679 . . . . 0.0 109.599 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.963 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.1 m80 -68.32 110.5 4.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.514 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.76 150.87 20.36 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.19 -178.11 7.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.62 -142.07 12.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.05 -18.07 54.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.355 -1.086 . . . . 0.0 109.92 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -48.3 -55.42 10.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.99 -1.069 . . . . 0.0 108.693 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 35.1 tp -51.04 -56.2 13.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.3 t -51.65 -59.84 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 6.0 mm-40 -40.94 -41.56 1.66 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.422 0.63 . . . . 0.0 109.378 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.647 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.55 -60.3 3.88 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.7 mt -51.05 -48.87 61.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.693 -1.254 . . . . 0.0 108.127 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -53.65 -25.41 17.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.28 -62.86 1.43 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 16' ' ' LEU . 33.7 t -54.16 -57.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.8 -30.06 67.51 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.676 -0.64 . . . . 0.0 110.453 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 -121.25 8.0 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.61 -8.76 59.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -1.162 . . . . 0.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -62.79 -17.6 61.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.875 -1.141 . . . . 0.0 109.846 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 70.69 129.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -119.7 177.67 4.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.412 -1.052 . . . . 0.0 110.192 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -121.63 115.82 23.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 87.4 t80 . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.482 0.658 . . . . 0.0 110.317 -179.146 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.994 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.854 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.1 tt -60.16 -25.73 34.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.353 -1.086 . . . . 0.0 109.311 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.42 ' H ' HG23 ' A' ' 3' ' ' VAL . 5.5 t -58.93 -40.14 79.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.457 0.646 . . . . 0.0 110.58 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.2 -54.07 16.74 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.448 -0.782 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 62.1 mt-30 -61.06 -33.87 73.98 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.234 -0.916 . . . . 0.0 111.72 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 m -96.17 -30.63 13.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.691 -1.256 . . . . 0.0 112.372 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 t -91.65 -58.2 2.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.625 -1.297 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -66.22 -11.17 48.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -161.22 166.31 27.96 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.217 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.516 HG13 ' CE1' ' B' ' 26' ' ' HIS . 74.4 mt -82.29 137.65 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.877 -1.139 . . . . 0.0 109.563 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 5.9 m -98.93 171.64 7.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.416 -0.803 . . . . 0.0 110.041 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 m -118.6 144.9 45.81 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.8 tp -44.19 -35.09 2.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 110.135 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -61.24 -36.83 81.03 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.621 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -74.21 -41.62 61.09 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.848 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -64.35 -49.59 71.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.621 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -63.06 -25.31 68.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.943 0.878 . . . . 0.0 108.745 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.12 -32.31 73.68 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.854 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.3 m-85 -87.75 -0.34 56.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.686 -1.259 . . . . 0.0 109.119 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -94.33 146.3 24.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' B' ' 44' ' ' GLY . 38.7 t-20 . . . . . 0 C--N 1.299 -1.594 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.778 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.424 ' HB2' HD13 ' A' ' 13' ' ' LEU . 4.7 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.465 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.31 159.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.987 . . . . 0.0 109.797 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.465 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.1 92.78 4.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -139.55 144.64 37.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.425 -0.797 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.516 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.9 m80 -68.59 109.59 3.84 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.343 -0.848 . . . . 0.0 109.133 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.2 mt -92.01 149.23 21.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.928 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.0 m -156.4 -178.13 7.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.9 -143.87 18.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.49 -20.37 54.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.831 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -47.28 -59.03 3.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.087 -1.008 . . . . 0.0 108.732 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.96 -54.72 14.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 34' ' ' GLU . 31.1 t -52.63 -59.02 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.212 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -40.99 -41.79 1.73 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.78 -60.5 3.6 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.79 -46.17 64.11 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.646 -1.284 . . . . 0.0 108.359 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -55.73 -25.57 41.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.4 tp -85.25 -63.3 1.35 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -53.48 -56.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.603 0.716 . . . . 0.0 110.004 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.4 t -71.71 -30.36 65.56 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 110.665 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -120.58 6.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.3 pm0 -84.36 -12.56 54.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -1.142 . . . . 0.0 110.959 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -54.91 -33.36 62.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.85 -1.156 . . . . 0.0 109.989 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.76 126.86 4.18 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.25 172.93 10.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.058 -1.26 . . . . 0.0 108.761 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.61 119.77 28.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.631 -0.668 . . . . 0.0 109.437 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -129.64 109.29 10.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.1 t -175.74 -129.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.537 ' N ' ' OG1' ' B' ' 48' ' ' THR . 33.1 mttp 42.76 51.58 6.79 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 26.8 Cg_exo -28.62 112.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.582 2.855 . . . . 0.0 112.674 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.427 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.917 0 N-CA-C 119.874 2.709 . . . . 0.0 119.874 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.908 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt -62.53 -32.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -1.115 . . . . 0.0 109.787 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 t -58.84 -38.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.47 -0.769 . . . . 0.0 110.037 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.94 -45.18 75.0 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.679 -0.638 . . . . 0.0 110.821 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 -75.97 -31.81 59.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.139 -0.976 . . . . 0.0 111.598 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 12.0 m -94.27 -28.17 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.62 -1.3 . . . . 0.0 112.104 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' N ' ' A' ' 9' ' ' SER . 15.1 t -90.49 -62.38 1.47 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.0 109.598 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.38 -9.75 0.77 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.472 ' N ' ' C ' ' A' ' 7' ' ' CYS . 1.5 m -160.11 -147.18 0.15 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.335 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.418 HD11 ' NE2' ' B' ' 26' ' ' HIS . 61.5 mt -128.09 141.88 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.901 . . . . 0.0 108.931 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.56 174.12 6.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 54.0 m -118.31 146.69 44.14 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.8 -34.64 1.63 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.481 -0.762 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.06 -35.46 80.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 108.521 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.9 mt-30 -76.73 -35.73 57.6 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.849 HD23 HG21 ' B' ' 39' ' ' VAL . 9.9 tp -70.49 -50.29 39.51 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.644 -0.66 . . . . 0.0 109.288 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -60.81 -26.85 67.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -34.29 75.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.235 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.908 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.01 -4.4 58.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.602 -1.311 . . . . 0.0 109.334 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 t -100.69 146.47 27.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.407 -0.808 . . . . 0.0 109.691 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 3.7 p30 . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -57.54 157.37 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.699 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -106.32 88.94 2.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.04 151.8 48.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.524 -0.735 . . . . 0.0 109.539 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 10' ' ' ILE . 10.1 m-70 -74.59 110.42 8.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.183 -0.948 . . . . 0.0 109.925 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -92.03 148.69 22.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.784 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.3 m -155.81 -177.87 6.88 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.14 -142.77 16.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.84 -18.58 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -1.134 . . . . 0.0 109.792 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.82 -57.8 5.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.0 108.814 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.8 tp -49.29 -55.2 13.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 23.3 t -51.61 -59.49 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.115 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 29.0 mt-10 -41.31 -39.97 1.54 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.87 -60.49 3.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.1 mt -51.64 -46.45 63.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.547 -1.345 . . . . 0.0 108.186 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -55.03 -25.72 32.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -85.24 -63.07 1.39 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.849 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -54.15 -56.72 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.627 0.727 . . . . 0.0 109.943 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -71.47 -29.29 64.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.624 -0.672 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.55 -130.2 41.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -82.83 -6.91 59.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.213 -1.169 . . . . 0.0 110.152 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -56.95 -39.46 74.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.479 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 98.4 127.7 5.9 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -124.03 176.85 6.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -1.048 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.1 116.89 24.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -129.25 109.11 10.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 1.3 t -177.95 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 109.081 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' OG1' ' B' ' 48' ' ' THR . 70.3 tttt 45.22 49.75 6.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 26.7 Cg_exo -28.5 147.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.629 2.886 . . . . 0.0 112.659 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.939 0 N-CA-C 119.791 2.676 . . . . 0.0 119.791 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.8 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt -70.27 -38.41 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -1.108 . . . . 0.0 109.202 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 3' ' ' VAL . 7.2 t -49.72 -40.06 15.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.589 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.49 -61.33 2.05 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.377 -0.827 . . . . 0.0 111.056 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.66 -27.96 69.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 111.037 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 m -88.42 -31.55 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.698 -1.251 . . . . 0.0 110.866 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.6 t -101.89 -58.77 1.82 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -60.49 -7.04 1.86 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 7' ' ' CYS . 37.3 t -163.12 -144.28 0.09 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.626 0.727 . . . . 0.0 109.53 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.47 HD11 ' NE2' ' B' ' 26' ' ' HIS . 77.2 mt -130.02 156.46 42.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.52 147.33 50.68 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.264 -0.897 . . . . 0.0 109.486 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.6 m -90.84 148.0 22.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 HD13 ' CB ' ' B' ' 22' ' ' PHE . 7.2 tp -43.41 -34.31 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.533 -0.73 . . . . 0.0 110.145 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -34.71 78.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 108.584 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.9 mt-30 -77.96 -28.04 49.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.88 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -78.17 -49.08 14.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.99 -23.03 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -35.18 79.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.12 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.8 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -84.64 -2.73 57.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.685 -1.259 . . . . 0.0 109.232 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 t -101.42 145.92 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.425 -0.797 . . . . 0.0 109.892 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.649 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 13' ' ' LEU . 7.5 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.9 p -47.99 159.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.45 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.04 90.05 3.25 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -126.09 151.97 46.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.47 ' NE2' HD11 ' A' ' 10' ' ' ILE . 9.6 m-70 -75.45 110.3 9.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 16.2 mt -91.58 151.0 20.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.002 -1.061 . . . . 0.0 109.43 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 86.1 m -156.11 -177.95 6.95 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.33 -145.22 12.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.87 -17.67 57.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.31 -1.112 . . . . 0.0 109.714 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.71 -58.02 4.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.064 -1.022 . . . . 0.0 108.859 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -48.49 -54.38 14.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.28 -46.5 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.123 -0.986 . . . . 0.0 108.91 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -41.25 29.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.66 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.63 -60.11 4.17 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 24.0 mt -52.17 -42.54 63.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.301 -1.5 . . . . 0.0 108.39 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -60.45 -25.01 65.67 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.5 -63.04 1.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.88 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -52.18 -56.31 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.529 0.68 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.78 -30.52 61.47 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 110.925 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.86 -117.52 4.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -84.06 -15.13 48.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -1.12 . . . . 0.0 111.035 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -57.25 -23.92 51.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.912 -1.118 . . . . 0.0 109.835 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 77.36 128.62 0.39 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.424 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 25.0 p90 -121.71 177.37 5.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.464 -1.021 . . . . 0.0 109.28 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 8.0 m-85 -125.19 120.23 30.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.435 ' OH ' HG22 ' A' ' 3' ' ' VAL . 77.4 t80 -129.26 107.39 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.5 OUTLIER 169.59 -116.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.551 ' N ' ' OG1' ' B' ' 48' ' ' THR . 31.8 ttmt 40.78 50.13 3.73 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 110.635 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 25.4 Cg_exo -28.27 91.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.566 2.844 . . . . 0.0 112.583 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 1' ' ' GLY . 41.7 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.051 -1.031 . . . . 0.0 109.466 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' H1 ' HG23 ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.911 0 N-CA-C 119.543 2.577 . . . . 0.0 119.543 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.886 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.9 tt -53.12 -36.56 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.259 -1.142 . . . . 0.0 109.655 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.1 t -49.77 -43.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.849 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.24 -59.23 3.93 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.341 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -49.79 -50.2 45.79 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.772 . . . . 0.0 110.838 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 m -81.36 -30.68 33.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.022 -1.049 . . . . 0.0 112.27 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 8.5 t -92.58 -60.53 1.8 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.542 -1.349 . . . . 0.0 109.521 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 m -55.38 -17.22 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.131 -0.981 . . . . 0.0 108.566 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.9 m -157.85 -147.99 0.19 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.5 mt -123.17 137.09 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.87 . . . . 0.0 109.087 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 58.4 m -98.68 170.33 8.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 110.349 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 15' ' ' GLN . 73.2 m -118.06 145.89 44.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.2 tp -43.4 -33.43 1.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 110.205 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.68 -36.59 84.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.727 -1.233 . . . . 0.0 108.699 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 12' ' ' SER . 62.5 mt-30 -76.11 -36.06 59.03 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -70.5 -50.3 39.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.588 -0.695 . . . . 0.0 109.383 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -61.6 -23.23 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.22 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.886 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -86.37 -3.8 59.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.659 -1.276 . . . . 0.0 109.269 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.3 t -99.06 145.67 26.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.426 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.59 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.427 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.2 t80 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.5 p -77.71 153.86 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.106 -0.997 . . . . 0.0 110.037 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -99.96 93.12 5.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -138.05 146.27 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.302 -0.873 . . . . 0.0 109.839 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.432 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.8 m-70 -71.08 109.54 5.22 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 11.8 mt -92.39 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.14 -0.975 . . . . 0.0 109.698 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.4 m -156.48 -177.75 6.83 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.25 -142.42 14.27 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.56 -18.63 54.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -1.081 . . . . 0.0 109.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -48.64 -59.07 3.82 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.966 -1.084 . . . . 0.0 108.509 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 33.9 tp -48.7 -56.79 7.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.9 t -50.05 -59.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 20.4 mt-10 -41.56 -42.23 2.37 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.44 3.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.04 -48.68 61.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.729 -1.232 . . . . 0.0 108.083 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -53.14 -25.97 15.21 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.31 -63.06 1.39 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 37.1 t -53.59 -57.07 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.693 0.758 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.2 t -70.24 -29.49 66.31 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.758 -0.589 . . . . 0.0 110.594 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.86 -124.67 16.93 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.603 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -83.35 -8.23 59.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.303 -1.116 . . . . 0.0 110.733 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -59.16 -33.03 70.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.884 -1.135 . . . . 0.0 109.717 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.67 125.66 2.52 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.415 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.6 p90 -119.86 177.66 4.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.395 -1.062 . . . . 0.0 109.341 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -125.13 115.27 20.2 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -130.32 106.82 8.82 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.523 ' H ' ' HD3' ' B' ' 50' ' ' PRO . 2.0 p -150.62 48.22 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.555 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 13.0 mmmt 44.81 45.4 2.14 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 34.9 Cg_exo -25.03 -48.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 123.846 3.031 . . . . 0.0 112.89 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.491 HG23 ' H1 ' ' A' ' 1' ' ' GLY . 8.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.375 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.846 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.9 tt -76.15 -39.45 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.284 -1.127 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.485 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.6 t -48.54 -40.09 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -76.09 -23.82 55.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.993 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.3 mt-30 -91.16 -18.48 24.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.845 -1.159 . . . . 0.0 110.109 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -109.57 -30.6 7.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.819 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.33 -63.04 1.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.996 -1.065 . . . . 0.0 109.417 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 m -62.95 -11.03 15.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -163.73 159.86 21.92 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 55.8 mt -83.57 140.64 15.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 109.677 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.13 156.96 18.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.473 -0.767 . . . . 0.0 109.621 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . 50.2 m -100.49 147.48 25.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.47 -34.39 1.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.433 -0.792 . . . . 0.0 110.118 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.13 -34.88 79.07 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.763 -1.211 . . . . 0.0 108.555 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' SER . 60.5 mt-30 -78.07 -30.98 49.95 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -74.53 -49.16 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.535 -0.728 . . . . 0.0 109.122 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.53 -22.95 66.69 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -34.42 78.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.386 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.846 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.3 m-85 -83.65 -0.71 51.8 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.585 -1.322 . . . . 0.0 109.384 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -103.48 146.41 28.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.71 . . . . 0.0 109.838 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.486 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 21.9 m-20 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.614 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.19 151.27 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.088 -1.008 . . . . 0.0 109.518 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -101.3 85.56 2.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.822 . . . . 0.0 109.354 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.36 147.65 49.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -69.05 111.01 4.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.312 -0.867 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.1 mt -90.59 150.93 21.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.6 m -155.96 -178.15 7.09 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.78 -143.47 10.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -78.91 -18.47 53.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 0.0 109.856 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -47.95 -49.57 29.99 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.045 -1.034 . . . . 0.0 108.49 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.7 tp -58.43 -56.63 19.7 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 16.4 t -51.15 -59.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 108.877 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 13.3 mm-40 -41.87 -42.94 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.43 -60.55 3.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.8 mt -51.67 -48.75 63.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.572 -1.33 . . . . 0.0 108.141 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -53.61 -25.73 18.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.8 tp -85.13 -63.01 1.4 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 16' ' ' LEU . 41.8 t -53.09 -58.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.67 0.747 . . . . 0.0 109.579 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 2.0 t -69.57 -29.74 67.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.721 -0.612 . . . . 0.0 110.648 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.62 -125.57 26.48 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.487 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.5 pm0 -83.81 -6.28 59.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -1.12 . . . . 0.0 110.853 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.62 -28.51 69.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 85.88 128.01 2.08 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.458 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.6 p90 -124.62 177.12 6.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.441 -1.035 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 18.7 m-85 -122.91 114.6 20.67 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.54 ' C ' HG22 ' B' ' 48' ' ' THR . 82.5 t80 -129.87 109.72 11.14 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.621 HG23 ' H ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 177.3 -78.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.499 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.621 ' H ' HG23 ' B' ' 48' ' ' THR . 33.6 mmtm -133.77 53.14 9.47 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.0 Cg_exo -30.66 -69.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.327 2.685 . . . . 0.0 112.497 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.44 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.965 0 N-CA-C 119.808 2.683 . . . . 0.0 119.808 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.913 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt -68.8 -34.6 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -1.119 . . . . 0.0 109.703 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -56.88 -39.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 109.818 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -75.66 -20.12 58.68 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.255 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.452 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 17.6 tp60 -91.28 -35.04 14.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.942 -1.099 . . . . 0.0 110.744 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 6.1 m -96.24 -24.32 16.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.0 111.593 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.1 t -97.44 -67.97 0.82 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.857 -1.152 . . . . 0.0 109.66 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -56.69 -12.29 1.78 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -155.87 -163.41 1.49 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' B' ' 26' ' ' HIS . 62.4 mt -116.7 146.81 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.119 -0.988 . . . . 0.0 109.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 97.9 m -111.32 169.87 8.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.536 -0.728 . . . . 0.0 110.007 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.1 m -118.4 146.36 44.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.4 -34.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.339 -0.851 . . . . 0.0 110.28 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -35.84 81.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.822 -1.174 . . . . 0.0 108.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 69.6 mt-30 -76.28 -34.86 59.1 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.8 tp -70.89 -50.51 34.19 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.623 -0.673 . . . . 0.0 109.263 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -60.31 -27.55 67.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -34.28 75.87 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.913 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.2 m-85 -84.13 -5.03 59.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.627 -1.295 . . . . 0.0 109.496 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -98.42 145.9 26.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.638 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.05 148.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.041 -1.037 . . . . 0.0 109.567 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -98.7 80.95 2.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.423 -0.798 . . . . 0.0 109.465 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' B' ' 25' ' ' GLN . 3.8 pt20 -120.27 148.89 43.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 110.204 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.951 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -68.4 111.18 4.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -90.19 150.6 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 67.9 m -155.75 -178.3 7.19 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.86 -143.24 11.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.32 -18.61 54.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.303 -1.116 . . . . 0.0 109.905 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -47.68 -53.3 15.38 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.017 -1.052 . . . . 0.0 108.695 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 26.4 tp -53.55 -55.62 24.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.6 t -53.36 -58.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.26 -0.9 . . . . 0.0 109.085 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.3 mt-10 -41.11 -40.4 1.49 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.661 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.81 -60.59 3.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -51.54 -45.94 63.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.597 -1.315 . . . . 0.0 108.366 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.27 -25.4 48.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.24 -62.88 1.43 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 31.7 t -54.17 -57.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.583 0.706 . . . . 0.0 109.843 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -70.05 -28.46 65.47 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.596 -0.69 . . . . 0.0 110.327 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.58 -131.3 46.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 -7.33 59.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -1.13 . . . . 0.0 110.136 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -55.63 -44.28 76.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.007 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 102.98 128.08 6.28 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.1 p90 -122.88 177.6 5.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.51 -0.994 . . . . 0.0 109.178 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.35 114.39 20.12 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.88 109.95 11.31 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.523 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.6 OUTLIER -168.9 -114.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' N ' ' OG1' ' B' ' 48' ' ' THR . 26.8 mmtp 44.78 50.38 7.19 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.979 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 30.9 Cg_exo -27.57 100.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.739 2.959 . . . . 0.0 112.812 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.418 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.909 0 N-CA-C 119.76 2.664 . . . . 0.0 119.76 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.821 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.7 tt -70.32 -34.79 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -1.15 . . . . 0.0 109.722 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -55.2 -40.94 58.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 111.011 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.446 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 58.6 mt-30 -59.73 -33.36 71.54 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 111.499 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.6 m -93.86 -30.34 14.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.68 -1.263 . . . . 0.0 112.062 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 9' ' ' SER . 12.2 t -93.45 -62.75 1.31 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.669 -1.27 . . . . 0.0 109.429 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.12 -10.37 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.8 m -161.46 -150.5 0.2 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.2 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.487 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 72.1 mt -124.07 136.79 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 57.2 m -101.5 173.96 6.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -0.786 . . . . 0.0 110.158 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.3 m -118.82 146.67 44.65 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.4 tp -43.55 -34.03 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 110.266 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.29 -35.19 80.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.737 -1.227 . . . . 0.0 108.83 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.1 mt-30 -77.14 -32.68 56.52 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.06 -50.31 20.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -61.72 -22.75 65.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -33.69 76.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.267 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.0 m-85 -86.55 -1.27 57.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.622 -1.299 . . . . 0.0 109.204 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -104.22 146.56 28.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.827 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.276 179.721 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 13' ' ' LEU . 1.5 t80 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.54 151.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -101.84 91.87 4.57 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -136.61 147.62 47.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.423 -0.798 . . . . 0.0 110.014 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.487 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.9 m-70 -71.2 109.52 5.29 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.365 -0.834 . . . . 0.0 108.793 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.04 149.9 20.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.88 -178.39 7.26 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.34 -144.74 10.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.01 -19.9 58.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -1.118 . . . . 0.0 109.87 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -47.53 -58.3 4.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.077 -1.015 . . . . 0.0 108.654 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -50.08 -55.2 15.82 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' B' ' 34' ' ' GLU . 20.1 t -51.54 -60.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 109.079 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 33' ' ' VAL . 42.7 mt-10 -41.23 -42.43 2.11 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.7 -60.63 3.27 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.92 -48.85 60.61 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.8 -1.188 . . . . 0.0 108.177 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -53.69 -25.68 19.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.7 tp -85.1 -62.83 1.44 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 43.8 t -52.2 -55.95 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.555 0.693 . . . . 0.0 109.921 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 0.9 OUTLIER -73.55 -30.12 62.86 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 110.594 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.37 -119.78 7.65 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.633 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.6 -15.9 47.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.124 . . . . 0.0 110.954 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -52.94 -45.59 67.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.513 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.473 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 100.68 127.71 6.14 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.401 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 29.5 p90 -122.76 177.22 5.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.511 -0.993 . . . . 0.0 108.8 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 46' ' ' PHE . 24.1 m-85 -126.35 114.15 17.84 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.552 0.692 . . . . 0.0 109.388 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -130.5 107.29 9.11 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' B' ' 49' ' ' LYS . 1.3 t 175.54 120.95 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.459 -0.775 . . . . 0.0 109.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 69.3 mttt 38.49 50.09 2.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.0 110.626 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 33.9 Cg_exo -26.85 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.749 2.966 . . . . 0.0 113.028 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.541 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.927 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.5 tt -70.88 -33.68 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -1.114 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -58.8 -37.67 67.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.712 0.768 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.1 -47.48 74.04 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.692 -0.63 . . . . 0.0 111.092 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -77.23 -39.7 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.103 -0.998 . . . . 0.0 111.727 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' SER . 16.7 m -83.12 -27.3 30.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.535 -1.353 . . . . 0.0 112.23 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.9 -55.92 3.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.497 -1.377 . . . . 0.0 109.428 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -157.32 169.85 23.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.514 HG13 ' CE1' ' B' ' 26' ' ' HIS . 62.9 mt -85.75 140.32 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 110.072 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.4 m -102.61 174.87 5.7 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.492 -0.755 . . . . 0.0 109.517 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 55.5 m -118.54 144.97 45.7 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.62 -34.73 1.52 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.451 -0.781 . . . . 0.0 110.199 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -62.76 -35.25 79.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.841 -1.162 . . . . 0.0 108.703 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' SER . 63.6 mt-30 -76.05 -34.15 59.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.5 tp -72.4 -50.07 29.16 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.575 -0.703 . . . . 0.0 109.324 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.3 -21.4 65.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -33.47 75.66 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.077 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.9 m-85 -84.53 -2.96 58.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.669 -1.269 . . . . 0.0 109.408 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.5 t -101.47 145.68 28.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -0.781 . . . . 0.0 109.55 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.4 p30 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.3 p -77.43 153.75 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -102.81 91.13 4.03 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -137.09 146.44 45.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 109.933 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.518 ' N ' ' OE1' ' B' ' 25' ' ' GLN . 17.3 m80 -68.78 110.03 4.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.369 -0.832 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.515 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -92.66 149.3 21.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.053 -1.03 . . . . 0.0 109.804 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.51 -178.02 7.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.75 -144.1 12.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -76.68 -19.99 57.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -1.096 . . . . 0.0 109.851 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.75 -57.96 4.93 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.027 -1.046 . . . . 0.0 108.73 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.2 tp -50.67 -55.21 17.53 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.62 -60.02 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.213 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 25.4 mt-10 -41.12 -43.51 2.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -55.37 -60.83 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.37 -48.9 62.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.711 -1.243 . . . . 0.0 108.256 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.16 -25.87 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.3 tp -85.56 -63.14 1.37 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 39.5 t -52.72 -55.26 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.543 0.687 . . . . 0.0 110.129 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -74.03 -30.37 62.39 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.468 -0.77 . . . . 0.0 110.475 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.92 -117.62 4.28 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.702 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.85 -13.44 53.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.267 -1.137 . . . . 0.0 111.081 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 69.6 mtt180 -58.77 -29.35 66.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.847 -1.158 . . . . 0.0 109.858 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 83.34 128.02 1.33 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.7 p90 -121.98 175.83 6.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.335 -1.097 . . . . 0.0 109.406 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -123.02 116.85 24.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -129.61 109.08 10.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.576 -0.703 . . . . 0.0 109.644 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.439 ' O ' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 179.05 65.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.876 . . . . 0.0 109.417 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 14.6 ptmt 34.05 49.36 0.69 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.221 -0.3 . . . . 0.0 111.147 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 29.7 Cg_exo -26.2 -67.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.772 2.982 . . . . 0.0 113.005 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.423 HG22 ' H ' ' B' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.96 0 N-CA-C 119.819 2.688 . . . . 0.0 119.819 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.895 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt -71.7 -35.14 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 109.72 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.05 -36.94 65.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.496 -0.753 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.57 -23.21 60.94 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.54 -0.725 . . . . 0.0 110.92 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -92.58 -53.56 4.14 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.758 -1.213 . . . . 0.0 110.89 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -72.4 -29.94 64.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 112.266 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' C ' ' N ' ' A' ' 9' ' ' SER . 10.0 t -89.53 -66.71 0.9 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.49 -1.381 . . . . 0.0 109.887 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 m -51.49 -14.84 0.34 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.913 -1.117 . . . . 0.0 108.538 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 7' ' ' CYS . 3.2 t -154.91 -138.73 0.07 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' NE2' ' B' ' 26' ' ' HIS . 93.3 mt -130.44 150.98 35.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.3 m -116.5 169.31 9.43 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.363 -0.836 . . . . 0.0 109.661 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.7 m -117.52 145.59 44.13 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -42.98 -33.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.509 -0.745 . . . . 0.0 110.245 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.75 -35.74 82.04 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.683 -1.26 . . . . 0.0 108.857 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 12' ' ' SER . 61.6 mt-30 -76.54 -32.49 58.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.853 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -74.0 -51.0 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.3 -24.59 65.09 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -34.86 78.42 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.071 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.895 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.5 m-85 -84.62 -2.52 57.57 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.646 -1.284 . . . . 0.0 109.411 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 t -101.86 145.81 28.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.59 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.0 m-20 . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.82 142.41 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.9 OUTLIER -92.33 75.6 5.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.411 -0.806 . . . . 0.0 109.568 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -115.92 158.69 22.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.496 ' NE2' HD11 ' A' ' 10' ' ' ILE . 6.3 m-70 -77.28 110.79 12.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 109.91 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.509 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.8 mt -92.72 150.83 20.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.808 -1.182 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 68.6 m -156.28 -177.98 6.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.05 -144.22 10.55 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -76.99 -19.65 57.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -1.104 . . . . 0.0 109.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -47.28 -56.05 7.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.064 -1.023 . . . . 0.0 108.781 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.1 tp -51.19 -55.2 19.17 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.8 t -52.18 -58.8 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.137 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.7 mt-10 -41.17 -40.09 1.46 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.27 -60.53 3.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.8 -44.73 63.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.607 -1.308 . . . . 0.0 108.372 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -57.12 -25.5 58.93 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.06 1.39 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.853 HG21 HD23 ' A' ' 16' ' ' LEU . 38.9 t -53.34 -55.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.522 0.677 . . . . 0.0 110.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.74 -30.54 61.54 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.536 -0.727 . . . . 0.0 110.87 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 -115.23 2.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.327 -1.415 . . . . 0.0 109.759 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -83.68 -21.26 32.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.38 -1.071 . . . . 0.0 110.962 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -52.2 -28.69 19.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.869 -1.145 . . . . 0.0 109.901 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 80.58 129.34 0.86 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.5 p90 -123.54 177.16 5.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.463 -1.022 . . . . 0.0 109.118 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.06 120.25 29.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.463 ' C ' HG22 ' B' ' 48' ' ' THR . 82.8 t80 -129.82 109.77 11.19 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.587 HG23 ' H ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -178.93 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.587 ' H ' HG23 ' B' ' 48' ' ' THR . 18.2 pttp -131.46 53.22 11.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.5 Cg_exo -31.7 -62.95 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 123.151 2.567 . . . . 0.0 112.327 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.46 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.729 2.652 . . . . 0.0 119.729 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.911 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt -73.6 -35.75 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.215 -1.168 . . . . 0.0 109.596 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -54.34 -39.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.49 -0.756 . . . . 0.0 109.778 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -73.2 -20.44 60.88 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.533 -0.729 . . . . 0.0 110.339 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' SER . 78.1 mt-30 -91.29 -36.89 13.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 110.622 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 m -94.85 -27.36 15.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.02 . . . . 0.0 111.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 t -91.0 -59.57 2.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.753 -1.217 . . . . 0.0 109.715 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -65.61 -13.47 59.13 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.115 -0.991 . . . . 0.0 108.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -158.49 164.52 36.1 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG13 ' CE1' ' B' ' 26' ' ' HIS . 77.9 mt -81.94 137.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.162 . . . . 0.0 109.759 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 9.7 m -96.83 168.25 10.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 15' ' ' GLN . 75.4 m -118.46 144.68 45.81 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.3 tp -43.45 -33.65 1.13 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.347 -0.846 . . . . 0.0 110.272 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.77 -35.58 81.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.719 -1.238 . . . . 0.0 108.776 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' SER . 63.1 mt-30 -76.84 -32.55 57.63 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.851 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.26 -50.14 20.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.66 -0.65 . . . . 0.0 109.292 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -61.65 -23.39 66.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -34.71 78.4 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.945 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.911 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.4 m-85 -84.83 -6.63 59.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.7 -1.25 . . . . 0.0 109.263 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -98.99 145.89 26.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.1 p30 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.7 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -78.55 152.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.049 -1.032 . . . . 0.0 110.067 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -97.78 93.92 6.64 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -141.89 144.98 34.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 109.975 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.503 ' CE1' HG13 ' A' ' 10' ' ' ILE . 16.2 m80 -68.92 109.86 4.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.27 150.5 20.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.019 . . . . 0.0 109.949 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.92 -178.24 7.16 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.9 -145.3 8.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -75.22 -19.52 59.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -1.162 . . . . 0.0 109.95 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.09 -57.65 5.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.039 -1.038 . . . . 0.0 108.751 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 31.2 tp -49.99 -55.77 13.33 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.24 -59.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.312 -0.868 . . . . 0.0 109.39 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 23.1 mt-10 -41.24 -42.15 2.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.78 3.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.2 -48.37 62.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.685 -1.259 . . . . 0.0 108.228 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.95 -25.58 21.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.41 -63.0 1.4 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.851 HG21 HD23 ' A' ' 16' ' ' LEU . 40.8 t -52.58 -56.45 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.505 0.669 . . . . 0.0 110.022 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 0.7 OUTLIER -73.28 -30.37 63.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.527 -0.733 . . . . 0.0 110.585 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.76 -118.71 5.15 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.279 -1.439 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.72 -11.55 57.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.274 -1.133 . . . . 0.0 110.894 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -59.8 -34.65 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.927 -1.108 . . . . 0.0 109.806 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.497 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.75 127.16 2.85 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.3 p90 -119.62 177.2 5.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.8 114.58 19.43 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -129.47 109.52 11.12 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.3 62.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' B' ' 51' ' ' THR . 79.0 mttt -152.36 55.73 1.6 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 23.7 Cg_exo -30.26 -31.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.325 2.683 . . . . 0.0 112.935 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.536 ' N ' ' O ' ' B' ' 49' ' ' LYS . 5.3 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.03 . . . . 0.0 109.697 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.93 0 N-CA-C 119.799 2.679 . . . . 0.0 119.799 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.9 tt -65.13 -35.47 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.34 -1.094 . . . . 0.0 109.717 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -55.8 -38.96 53.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -75.34 -20.32 59.1 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.507 -0.745 . . . . 0.0 110.294 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -91.38 -36.99 13.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.944 -1.098 . . . . 0.0 110.771 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 4.8 m -95.76 -26.07 15.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.084 . . . . 0.0 111.882 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -90.19 -58.78 2.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.614 -1.304 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.407 ' C ' ' HG ' ' A' ' 9' ' ' SER . 7.1 m -65.22 -12.34 50.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.3 m -159.67 172.83 17.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.506 HG13 ' CE1' ' B' ' 26' ' ' HIS . 75.2 mt -89.91 135.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.735 -1.228 . . . . 0.0 109.558 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.2 m -96.8 171.48 8.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 109.846 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 60.5 m -118.53 144.83 45.79 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.18 -33.64 1.59 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.43 -34.87 78.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.702 -1.248 . . . . 0.0 108.66 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 60.9 mt-30 -76.92 -34.27 57.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.841 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -72.54 -50.41 25.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.631 -0.668 . . . . 0.0 109.241 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.44 -22.18 64.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.56 -33.64 76.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.104 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.8 m-85 -85.62 -2.57 58.31 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.694 -1.253 . . . . 0.0 109.433 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -99.35 145.76 27.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.623 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.0 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.17 155.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -98.65 92.94 5.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.92 144.07 41.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.44 -0.787 . . . . 0.0 109.737 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.506 ' CE1' HG13 ' A' ' 10' ' ' ILE . 15.6 m80 -69.67 109.75 4.51 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.01 150.12 20.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.814 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -155.81 -178.08 7.03 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.12 -144.04 11.0 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -76.36 -19.8 57.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -1.073 . . . . 0.0 109.928 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.88 -58.92 3.76 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.035 -1.041 . . . . 0.0 108.675 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 27.5 tp -48.8 -56.23 9.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' B' ' 34' ' ' GLU . 28.6 t -50.09 -58.94 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.2 mt-10 -41.2 -40.98 1.71 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.97 -60.77 3.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.48 -46.08 63.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.596 -1.315 . . . . 0.0 108.361 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.36 -25.28 48.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.07 1.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 16' ' ' LEU . 30.7 t -53.16 -55.86 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.593 0.711 . . . . 0.0 110.099 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -73.34 -30.67 63.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.595 -0.69 . . . . 0.0 110.701 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.76 -115.27 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.634 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -84.08 -15.65 46.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.333 -1.098 . . . . 0.0 111.004 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -58.97 -18.22 31.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.851 -1.155 . . . . 0.0 109.779 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 69.18 128.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.8 p90 -121.14 177.43 5.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.454 -1.027 . . . . 0.0 109.199 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.491 ' CE1' ' OD1' ' A' ' 21' ' ' ASN . 36.2 m-85 -125.52 119.85 29.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -129.39 107.82 9.8 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 173.92 -107.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' N ' ' OG1' ' B' ' 48' ' ' THR . 44.6 tttm 43.31 49.43 4.91 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.737 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.9 Cg_exo -27.47 83.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.744 2.963 . . . . 0.0 112.723 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 49' ' ' LYS . 2.4 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.94 0 N-CA-C 119.824 2.689 . . . . 0.0 119.824 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.875 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.7 tt -58.02 -33.41 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.233 -1.157 . . . . 0.0 109.438 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.6 t -55.66 -39.75 56.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.622 -0.674 . . . . 0.0 109.904 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.96 -20.16 60.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.483 -0.76 . . . . 0.0 110.344 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -91.11 -37.98 13.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.993 -1.067 . . . . 0.0 110.705 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.2 m -96.59 -24.15 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.99 -1.069 . . . . 0.0 111.929 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.23 -55.57 3.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.518 -1.364 . . . . 0.0 109.25 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -65.61 -18.66 65.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -154.6 173.21 16.66 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.968 HD11 ' CE1' ' B' ' 26' ' ' HIS . 66.5 mt -91.13 133.4 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.738 -1.226 . . . . 0.0 109.407 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 33.5 m -92.72 172.97 8.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.9 m -118.49 145.98 44.87 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.3 tp -43.54 -34.38 1.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 110.12 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.59 80.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.0 108.928 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -76.56 -36.81 57.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.838 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -69.71 -50.95 38.75 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.616 -0.678 . . . . 0.0 109.257 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.37 -25.51 65.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -33.99 77.05 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.962 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.875 ' CD2' HD12 ' A' ' 2' ' ' ILE . 91.9 m-85 -84.44 2.15 42.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.725 -1.234 . . . . 0.0 109.105 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.1 t -106.34 146.04 30.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.17 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.383 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.43 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.4 p -75.93 156.77 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.43 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -102.23 92.87 4.92 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.17 141.69 47.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.968 ' CE1' HD11 ' A' ' 10' ' ' ILE . 1.8 m80 -69.23 109.85 4.3 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.408 -0.807 . . . . 0.0 109.512 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.1 mt -92.64 150.18 20.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 110.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.7 m -156.65 177.37 11.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.51 -145.54 18.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -74.17 -21.21 59.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.084 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.91 -53.19 16.64 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 0.0 108.62 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 21.8 tp -56.36 -56.48 20.54 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 34' ' ' GLU . 24.1 t -47.82 -60.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.26 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 33' ' ' VAL . 38.6 mt-10 -41.1 -42.93 2.11 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.707 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -54.74 -61.02 2.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 26.6 mt -52.67 -47.58 67.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.473 -1.392 . . . . 0.0 108.146 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -53.57 -26.1 20.03 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.5 tp -85.07 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.838 HG21 HD23 ' A' ' 16' ' ' LEU . 42.3 t -54.24 -56.91 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.716 0.77 . . . . 0.0 109.721 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.8 t -70.34 -29.96 66.79 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.724 -0.61 . . . . 0.0 110.662 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.56 -125.67 22.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.6 -9.04 59.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -1.14 . . . . 0.0 110.804 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -55.46 -42.15 73.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.903 -1.123 . . . . 0.0 109.587 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 101.64 126.62 5.88 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -130.84 165.65 22.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.567 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -120.5 114.29 21.55 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.932 0.873 . . . . 0.0 109.584 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -119.38 113.1 20.28 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -158.63 -166.44 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.121 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.563 ' N ' ' OG1' ' B' ' 48' ' ' THR . 44.8 mttp 55.06 50.33 6.07 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.155 -0.966 . . . . 0.0 109.505 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.2 Cg_exo -28.17 -39.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.75 2.967 . . . . 0.0 112.901 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.444 ' N ' ' O ' ' B' ' 49' ' ' LYS . 11.4 t . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.346 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.967 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt -74.41 -35.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.682 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 8.4 t -56.05 -38.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 110.581 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 49.1 tp60 -91.42 -33.13 15.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 0.0 110.543 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 m -96.78 -29.76 13.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.938 -1.101 . . . . 0.0 111.404 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.8 t -92.83 -63.33 1.24 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.758 -1.214 . . . . 0.0 109.584 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -4.84 1.09 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 39.7 t -161.07 -148.92 0.16 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.51 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.5 mt -127.71 140.96 47.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 69.4 m -109.31 164.71 12.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.37 -0.832 . . . . 0.0 110.417 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 61.1 m -114.68 146.33 41.01 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.8 tp -43.13 -34.16 1.03 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.758 . . . . 0.0 110.315 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.54 -33.92 77.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.746 -1.221 . . . . 0.0 108.706 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' SER . 59.7 mt-30 -79.22 -30.56 43.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.82 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -75.3 -49.83 17.96 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.67 -23.26 65.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.78 -34.56 78.63 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.0 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.51 -4.57 59.02 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.678 -1.264 . . . . 0.0 109.151 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.9 t -100.23 145.95 27.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 109.566 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.6 p30 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -65.3 157.95 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.789 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -101.6 93.18 5.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.06 144.68 45.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.782 . . . . 0.0 110.04 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.51 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.3 m-70 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.482 -0.761 . . . . 0.0 109.666 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.6 mt -92.52 150.78 20.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 109.347 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.4 m -155.7 -177.85 6.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.3 -144.11 11.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -77.23 -18.82 57.37 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.47 -58.48 4.14 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.086 -1.009 . . . . 0.0 108.715 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 29.4 tp -48.67 -55.91 10.0 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.6 t -52.19 -58.96 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.012 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 33' ' ' VAL . 15.4 mt-10 -41.47 -41.87 2.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.87 -60.8 3.04 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.74 -48.87 58.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.0 108.318 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.84 -24.42 22.97 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.3 tp -85.25 -55.78 3.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -61.51 -59.58 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.605 0.716 . . . . 0.0 110.061 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.1 t -70.11 -30.22 67.37 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.649 -0.657 . . . . 0.0 110.711 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.52 -119.32 5.54 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.347 -1.406 . . . . 0.0 109.856 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.68 -12.64 55.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -1.133 . . . . 0.0 110.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 74.8 mtt180 -58.14 -31.87 67.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 87.52 126.49 2.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -119.22 177.23 4.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -1.091 . . . . 0.0 109.341 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' B' ' 48' ' ' THR . 17.1 t80 -125.66 115.48 20.18 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -129.79 108.28 10.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.853 -0.529 . . . . 0.0 109.715 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.55 ' CG2' ' CE2' ' B' ' 46' ' ' PHE . 1.3 t 174.06 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 40.7 mtpt -145.23 52.95 1.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.5 Cg_exo -28.34 109.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.605 2.87 . . . . 0.0 112.642 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.454 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.976 0 N-CA-C 119.716 2.647 . . . . 0.0 119.716 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.2 tt -57.53 -26.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.392 -1.063 . . . . 0.0 109.4 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.6 t -61.26 -38.8 80.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.591 0.71 . . . . 0.0 109.869 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.93 -20.07 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 109.995 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.71 -27.98 18.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.987 -1.071 . . . . 0.0 110.708 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' SER . 59.1 m -103.4 -30.45 10.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.043 -1.036 . . . . 0.0 111.082 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.0 t -93.65 -63.78 1.16 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.879 -1.138 . . . . 0.0 109.777 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -62.03 -10.05 8.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -162.93 164.15 25.95 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.358 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 HG13 ' CE1' ' B' ' 26' ' ' HIS . 67.0 mt -85.59 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 0.0 109.049 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.47 160.32 17.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.46 -0.775 . . . . 0.0 110.053 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' GLN . 44.9 m -103.39 147.71 26.78 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 13' ' ' LEU . 7.7 tp -43.46 -35.1 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.494 -0.754 . . . . 0.0 110.242 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.1 -35.3 79.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.768 -1.208 . . . . 0.0 108.566 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' SER . 59.0 mt-30 -77.85 -26.96 49.72 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 HG21 ' B' ' 39' ' ' VAL . 7.2 tp -78.81 -47.97 15.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.446 -0.784 . . . . 0.0 108.947 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -62.59 -21.39 65.58 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -34.53 78.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.145 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 83.7 m-85 -84.76 1.78 45.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.562 -1.336 . . . . 0.0 109.044 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -109.67 146.1 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 2.9 p30 . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.318 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.6 p -63.53 157.34 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.83 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -103.85 92.62 4.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.39 144.19 42.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 109.809 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.523 ' CE1' HG13 ' A' ' 10' ' ' ILE . 17.4 m80 -69.1 109.51 4.06 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.149 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.0 mt -90.89 149.51 21.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.133 -0.98 . . . . 0.0 109.708 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 47.3 m -155.91 -178.08 7.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.12 -145.55 16.4 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.15 -19.99 57.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -47.43 -60.62 2.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.074 -1.016 . . . . 0.0 108.658 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 22.7 tp -47.29 -56.46 6.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' B' ' 34' ' ' GLU . 35.2 t -50.78 -59.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.261 -0.899 . . . . 0.0 108.903 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.9 mt-10 -41.43 -39.58 1.53 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.687 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.68 -59.88 4.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -45.41 66.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.5 -1.375 . . . . 0.0 108.069 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -56.27 -25.93 49.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -84.77 -58.32 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.868 HG21 HD23 ' A' ' 16' ' ' LEU . 46.9 t -57.36 -56.73 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -72.83 -31.03 64.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.652 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -112.94 1.3 Allowed Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.794 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.03 -20.35 32.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 111.226 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -52.41 -50.81 61.78 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.799 -1.188 . . . . 0.0 109.665 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.57 127.73 6.15 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -125.3 170.23 11.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.86 114.09 19.38 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.948 0.88 . . . . 0.0 109.544 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.406 ' C ' HG22 ' B' ' 48' ' ' THR . 73.3 t80 -124.69 107.63 11.17 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 173.45 -175.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' OG1' ' B' ' 48' ' ' THR . 20.2 mmmt 41.78 50.97 5.24 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.636 -0.665 . . . . 0.0 110.622 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.1 Cg_exo -30.08 152.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.425 2.75 . . . . 0.0 112.577 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.468 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.984 0 N-CA-C 119.769 2.668 . . . . 0.0 119.769 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.773 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt -75.57 -37.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -1.138 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.69 -40.58 19.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.735 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -75.4 -19.65 59.39 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.769 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.89 -41.17 12.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.144 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.5 m -91.2 -30.41 16.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 111.75 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.5 t -92.91 -66.72 0.9 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.647 -1.283 . . . . 0.0 110.508 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -57.21 -10.17 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.976 -1.077 . . . . 0.0 108.498 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -163.12 176.64 9.83 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.113 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.595 HD11 ' CE1' ' B' ' 26' ' ' HIS . 71.0 mt -97.09 135.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.997 -1.064 . . . . 0.0 108.901 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 p -103.06 158.29 16.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.487 -0.758 . . . . 0.0 110.275 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.8 m -100.25 146.54 26.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.8 tp -43.45 -34.4 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.25 79.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 108.702 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.2 mt-30 -77.58 -29.47 52.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.878 HD23 HG21 ' B' ' 39' ' ' VAL . 8.3 tp -76.9 -49.09 16.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.509 -0.745 . . . . 0.0 109.068 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.44 -23.53 66.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -35.56 78.24 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.149 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.773 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.1 m-85 -84.5 -3.84 58.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.716 -1.24 . . . . 0.0 109.395 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.5 t -100.55 146.37 27.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.442 -0.786 . . . . 0.0 109.671 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' B' ' 43' ' ' ARG . 2.2 p30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 13' ' ' LEU . 4.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.42 152.19 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 93.68 7.31 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.17 144.46 42.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' HD11 ' A' ' 10' ' ' ILE . 8.3 m80 -73.87 109.97 7.8 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.0 mt -92.26 148.77 21.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 109.773 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.8 m -155.41 -177.79 6.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.24 -143.57 15.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.73 -18.17 54.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -1.173 . . . . 0.0 109.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -48.18 -57.07 6.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.002 -1.061 . . . . 0.0 108.447 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.5 t -51.32 -59.03 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.898 . . . . 0.0 108.972 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.1 mt-10 -42.49 -40.19 2.52 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.48 -60.18 4.27 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -51.65 -45.95 63.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.675 -1.265 . . . . 0.0 108.103 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.44 -24.95 48.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.08 -62.98 1.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 16' ' ' LEU . 58.7 t -52.41 -57.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.748 0.785 . . . . 0.0 109.749 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.477 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.7 t -70.13 -29.53 66.49 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.662 -0.649 . . . . 0.0 110.564 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.75 -126.3 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.369 -1.396 . . . . 0.0 109.758 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -83.18 -5.96 59.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.244 -1.151 . . . . 0.0 110.649 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.45 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.6 mtt180 -61.63 -37.21 83.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.943 -1.098 . . . . 0.0 109.666 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.477 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 95.19 126.07 4.74 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.417 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.4 p90 -121.53 177.6 5.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.472 -1.016 . . . . 0.0 109.181 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -127.03 118.59 24.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.533 ' C ' HG22 ' B' ' 48' ' ' THR . 76.9 t80 -129.44 107.64 9.65 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.533 HG22 ' C ' ' B' ' 47' ' ' TYR . 0.0 OUTLIER 166.63 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.668 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 31.5 ttmt -160.23 50.88 0.36 Allowed Pre-proline 0 C--N 1.3 -1.573 0 O-C-N 121.086 -1.009 . . . . 0.0 109.961 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.6 Cg_exo -29.06 109.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.567 2.844 . . . . 0.0 112.602 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.515 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.898 0 N-CA-C 119.717 2.647 . . . . 0.0 119.717 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt -74.44 -36.47 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.3 t -54.51 -38.89 43.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.869 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -76.31 -25.87 55.23 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.467 -0.77 . . . . 0.0 110.261 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -91.35 -29.69 16.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.888 -1.132 . . . . 0.0 110.441 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.6 m -93.39 -30.96 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 111.187 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.9 t -94.57 -63.74 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.859 -1.15 . . . . 0.0 110.174 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 m -57.68 -7.42 0.67 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 108.248 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 7' ' ' CYS . 35.7 t -156.65 -148.89 0.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.856 0.836 . . . . 0.0 109.44 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' B' ' 26' ' ' HIS . 80.1 mt -130.95 144.97 36.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.69 154.91 29.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.242 -0.911 . . . . 0.0 110.064 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -98.75 149.4 22.9 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.22 -33.41 1.55 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.84 -34.67 78.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.706 -1.246 . . . . 0.0 108.752 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -78.82 -30.34 45.31 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -75.53 -50.17 16.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.54 -26.18 66.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.35 -35.03 76.32 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.161 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 92.2 m-85 -83.62 -4.5 58.64 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.652 -1.28 . . . . 0.0 109.322 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -100.23 146.28 27.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 0.0 109.58 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 4.0 p30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.381 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.41 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.4 p -81.86 155.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.97 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.41 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -99.62 91.33 4.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.034 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 26' ' ' HIS . 0.3 OUTLIER -133.83 142.6 47.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.531 -0.731 . . . . 0.0 109.863 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.976 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.7 m80 -67.8 109.75 3.5 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.509 -0.744 . . . . 0.0 110.491 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.522 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -92.96 149.06 21.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.802 . . . . 0.0 109.339 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.3 m -155.71 -178.12 7.06 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.71 -143.37 18.59 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -78.77 -18.62 53.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -1.114 . . . . 0.0 109.815 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -47.64 -58.37 4.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.06 -1.025 . . . . 0.0 108.636 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 18.6 tp -48.84 -55.71 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' B' ' 34' ' ' GLU . 19.9 t -52.2 -59.07 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.257 -0.902 . . . . 0.0 108.839 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' B' ' 33' ' ' VAL . 18.0 mt-10 -42.36 -41.63 2.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.59 -60.39 3.74 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.69 -47.67 63.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.618 -1.301 . . . . 0.0 108.194 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -54.68 -25.46 27.3 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -84.89 -62.83 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.865 HG21 HD23 ' A' ' 16' ' ' LEU . 40.7 t -53.24 -58.43 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.703 0.763 . . . . 0.0 109.706 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.69 -28.69 66.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.682 -0.636 . . . . 0.0 110.585 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.19 -132.49 48.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.75 -4.91 58.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -57.65 -43.26 84.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 127.09 6.0 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.444 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.2 p90 -122.98 177.36 5.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.484 -1.01 . . . . 0.0 108.87 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -122.54 113.48 19.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.579 ' C ' HG22 ' B' ' 48' ' ' THR . 72.5 t80 -130.85 107.63 9.26 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.579 HG22 ' C ' ' B' ' 47' ' ' TYR . 0.0 OUTLIER 167.43 75.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.0 109.423 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.494 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 31.3 tttm -142.95 50.64 1.5 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.3 Cg_exo -29.21 100.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.579 2.852 . . . . 0.0 112.635 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.407 HG22 ' O ' ' B' ' 49' ' ' LYS . 15.2 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.529 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 5.024 0 N-CA-C 119.719 2.647 . . . . 0.0 119.719 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.852 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt -80.3 -38.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 109.754 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.455 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.39 -39.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.48 -24.39 50.19 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.508 -0.745 . . . . 0.0 110.139 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.97 -22.14 20.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.943 -1.098 . . . . 0.0 110.113 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' SER . 56.5 m -104.62 -30.43 9.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.987 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.2 t -98.51 -66.13 0.92 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.947 -1.095 . . . . 0.0 109.855 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -57.63 -9.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.3 m -161.72 -176.48 5.3 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.965 HD11 ' CE1' ' B' ' 26' ' ' HIS . 57.4 mt -106.64 137.81 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.063 -1.023 . . . . 0.0 108.849 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.44 156.86 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.472 -0.767 . . . . 0.0 109.947 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.1 m -99.78 147.94 24.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 tp -43.44 -34.26 1.27 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.492 -0.755 . . . . 0.0 110.16 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.55 -34.7 78.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.723 -1.236 . . . . 0.0 108.75 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.9 mt-30 -78.82 -28.76 44.51 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 8.9 tp -76.8 -49.53 15.65 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.68 -25.29 67.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -35.83 77.01 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.173 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.1 m-85 -83.43 0.35 46.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.626 -1.296 . . . . 0.0 109.094 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.81 146.36 31.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.736 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.81 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.401 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.6 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.463 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.1 p -47.77 158.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.747 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -107.07 89.47 3.01 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.18 141.89 51.63 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.573 -0.705 . . . . 0.0 109.671 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.965 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -66.24 110.66 3.11 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.406 -0.809 . . . . 0.0 110.555 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -90.94 149.72 21.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -156.09 -178.13 7.09 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.31 -144.23 14.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.19 -18.94 54.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -47.32 -56.87 5.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.086 -1.009 . . . . 0.0 108.62 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.3 tp -50.14 -56.29 11.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.5 t -51.34 -60.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.276 -0.89 . . . . 0.0 109.113 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 17.7 mm-40 -41.42 -42.39 2.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.373 0.606 . . . . 0.0 109.378 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.31 -60.3 3.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.2 mt -51.17 -49.02 61.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.628 -1.295 . . . . 0.0 108.083 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -53.07 -26.18 15.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.2 -62.96 1.41 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 56.4 t -51.06 -55.71 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.438 0.637 . . . . 0.0 110.175 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -75.37 -30.83 60.29 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 110.94 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.8 -111.94 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.184 -1.484 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -83.87 -23.89 31.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.343 -1.092 . . . . 0.0 110.947 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -52.25 -28.16 17.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.91 -1.119 . . . . 0.0 110.008 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 79.39 129.75 0.69 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.407 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 27.6 p90 -123.07 177.01 5.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.571 -0.958 . . . . 0.0 108.944 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.01 122.19 33.76 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.82 110.52 11.79 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -175.18 56.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.435 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 0.4 OUTLIER -138.23 53.06 5.41 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.509 -0.744 . . . . 0.0 109.273 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 35.7 Cg_exo -26.28 -47.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 124.054 3.169 . . . . 0.0 113.569 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 3.0 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.946 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.891 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt -75.23 -37.06 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.887 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.9 t -54.33 -39.94 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -75.29 -19.54 59.62 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.465 -0.772 . . . . 0.0 110.472 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 84.1 mt-30 -90.67 -40.48 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 110.711 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -92.67 -24.27 18.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.916 -1.115 . . . . 0.0 111.944 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.1 t -94.91 -66.65 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.638 -1.289 . . . . 0.0 109.485 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.492 ' C ' ' HG ' ' A' ' 9' ' ' SER . 9.1 m -57.77 -8.84 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' A' ' 8' ' ' THR . 1.4 m -160.84 -159.07 0.64 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.69 HD11 ' CE1' ' B' ' 26' ' ' HIS . 78.1 mt -119.03 139.76 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.28 -0.888 . . . . 0.0 109.198 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 90.6 m -104.39 171.67 7.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.439 -0.788 . . . . 0.0 110.097 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 48.2 m -118.46 145.67 45.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.7 tp -43.65 -33.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.437 -0.789 . . . . 0.0 110.214 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.85 -34.98 79.16 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.742 -1.223 . . . . 0.0 108.491 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.9 mt-30 -77.04 -34.69 57.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.833 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -71.5 -50.52 30.62 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.596 -0.69 . . . . 0.0 109.212 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.32 -23.56 65.81 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -33.82 76.74 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.125 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.891 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.0 m-85 -84.42 -4.65 59.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.674 -1.266 . . . . 0.0 109.398 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -98.9 145.99 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.404 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.6 p-10 . . . . . 0 C--N 1.303 -1.445 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.453 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.3 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.68 154.35 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.0 110.083 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.22 96.02 10.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -137.18 144.28 42.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.188 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.69 ' CE1' HD11 ' A' ' 10' ' ' ILE . 9.1 m80 -74.37 108.78 7.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -94.52 150.77 19.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.082 -1.011 . . . . 0.0 109.775 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 56.6 m -155.77 -177.97 6.95 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.31 -144.75 10.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -76.24 -19.89 57.93 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.259 -1.142 . . . . 0.0 109.798 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -47.19 -57.73 4.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.061 -1.024 . . . . 0.0 108.804 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 28.1 tp -50.92 -55.85 15.19 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.0 t -50.74 -59.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' VAL . 45.8 mt-10 -41.1 -42.36 1.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.62 -60.53 3.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.15 -48.67 61.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.595 -1.316 . . . . 0.0 108.276 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -53.9 -25.68 21.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.07 -62.91 1.43 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.833 HG21 HD23 ' A' ' 16' ' ' LEU . 30.2 t -53.62 -58.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.601 0.715 . . . . 0.0 109.909 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.95 -28.38 65.51 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 110.476 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 -130.32 46.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -82.76 -10.4 58.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -1.139 . . . . 0.0 109.971 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -52.93 -45.09 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 128.24 6.3 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.432 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 21.9 p90 -122.68 177.41 5.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -1.018 . . . . 0.0 109.121 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.57 117.74 25.0 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.422 ' C ' HG22 ' B' ' 48' ' ' THR . 79.5 t80 -129.46 108.37 10.21 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 174.68 179.87 0.12 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.114 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' OG1' ' B' ' 48' ' ' THR . 17.5 ttpp 44.66 50.58 7.35 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.485 -0.76 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 31.1 Cg_exo -27.46 -62.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.721 2.948 . . . . 0.0 112.6 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 50' ' ' PRO . 27.1 p . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.289 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.92 0 N-CA-C 119.86 2.704 . . . . 0.0 119.86 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.924 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.3 tt -73.91 -37.69 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 9.4 t -52.39 -38.91 26.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.26 -27.71 59.53 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.177 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.66 -28.78 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.841 -1.162 . . . . 0.0 110.594 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' SER . 18.3 m -92.98 -28.94 16.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 0.0 111.2 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' C ' ' N ' ' A' ' 9' ' ' SER . 14.1 t -96.43 -66.32 0.91 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.891 -1.13 . . . . 0.0 109.985 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -56.41 -12.71 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.4 m -154.93 -179.28 7.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 54.3 mt -105.83 138.78 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.136 -0.978 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.48 157.03 17.44 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 36.1 m -99.02 147.94 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.6 tp -43.71 -33.14 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.445 -0.784 . . . . 0.0 110.092 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -65.01 -34.72 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.782 -1.199 . . . . 0.0 108.75 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 58.4 mt-30 -78.57 -31.82 47.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.09 -50.17 20.73 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.75 -25.5 66.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -34.63 78.01 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.21 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.924 ' CD2' HD12 ' A' ' 2' ' ' ILE . 93.2 m-85 -83.14 -2.22 54.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.617 -1.302 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.28 146.57 28.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.539 -0.726 . . . . 0.0 109.789 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.395 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.405 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.2 p -73.02 153.68 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.815 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.405 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -100.63 92.69 5.22 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.46 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.1 tm0? -134.18 139.87 46.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.387 -0.821 . . . . 0.0 109.555 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -65.53 110.2 2.62 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.299 -0.876 . . . . 0.0 110.172 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -91.21 148.63 22.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.684 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.5 m -155.4 -177.87 6.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.3 -144.2 20.07 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.31 -18.94 54.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 109.677 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.1 m-20 -47.54 -57.83 4.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 108.686 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.9 tp -49.47 -55.54 12.89 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.2 t -52.65 -59.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.234 -0.916 . . . . 0.0 108.757 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -42.0 -41.21 2.45 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.15 -60.36 3.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -51.73 -45.74 63.73 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.761 -1.212 . . . . 0.0 108.281 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -56.05 -25.64 45.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -84.96 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 41.7 t -53.48 -56.98 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.645 0.736 . . . . 0.0 109.568 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.8 t -70.43 -29.42 66.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.72 -0.613 . . . . 0.0 110.781 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.92 -129.26 38.63 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.371 -1.395 . . . . 0.0 109.695 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.12 -3.69 57.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -1.139 . . . . 0.0 110.526 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -62.38 -34.08 76.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.961 -1.087 . . . . 0.0 109.629 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.0 128.01 4.27 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.451 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 17.0 p90 -123.06 177.77 5.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.42 -1.047 . . . . 0.0 109.059 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.3 114.26 19.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -130.02 110.61 11.78 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.522 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.1 t -173.32 -128.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.522 ' N ' ' OG1' ' B' ' 48' ' ' THR . 30.6 ttmt 45.99 49.71 6.98 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.4 Cg_exo -28.78 103.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.704 2.936 . . . . 0.0 112.722 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.449 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.954 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.904 HD12 ' CD2' ' A' ' 19' ' ' TYR . 14.5 tt -72.52 -20.58 19.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.414 -1.051 . . . . 0.0 109.035 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.8 t -68.4 -36.42 74.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.619 0.724 . . . . 0.0 110.018 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.82 -20.14 58.39 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.19 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 77.1 mt-30 -91.04 -34.98 14.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.53 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -95.48 -30.35 13.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.814 -1.179 . . . . 0.0 111.385 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.2 t -92.96 -64.14 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.816 -1.177 . . . . 0.0 109.911 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -60.1 -5.79 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 7' ' ' CYS . 42.6 t -159.74 -145.84 0.13 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.963 HD11 ' CE1' ' B' ' 26' ' ' HIS . 91.9 mt -130.05 142.44 43.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 60.4 m -109.18 151.05 26.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.283 -0.886 . . . . 0.0 110.628 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLN . 59.3 m -101.23 146.0 28.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.6 tp -43.54 -34.02 1.28 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.01 -34.76 78.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.718 -1.239 . . . . 0.0 108.698 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' SER . 62.7 mt-30 -77.58 -33.01 54.07 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.847 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -72.95 -50.26 24.45 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.621 -0.674 . . . . 0.0 109.237 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -61.61 -20.79 63.74 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -32.74 72.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.904 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.6 m-85 -85.83 -6.98 59.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.588 -1.32 . . . . 0.0 109.283 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 t -93.61 142.6 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.891 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.477 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.1 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.411 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -82.34 154.64 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.85 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.58 90.28 4.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -132.45 145.1 50.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.614 -0.679 . . . . 0.0 109.599 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.963 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.1 m80 -68.32 110.5 4.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.514 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.76 150.87 20.36 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.19 -178.11 7.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.62 -142.07 12.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.05 -18.07 54.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.355 -1.086 . . . . 0.0 109.92 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -48.3 -55.42 10.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.99 -1.069 . . . . 0.0 108.693 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 35.1 tp -51.04 -56.2 13.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.3 t -51.65 -59.84 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 6.0 mm-40 -40.94 -41.56 1.66 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.422 0.63 . . . . 0.0 109.378 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.647 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.55 -60.3 3.88 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.7 mt -51.05 -48.87 61.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.693 -1.254 . . . . 0.0 108.127 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -53.65 -25.41 17.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.28 -62.86 1.43 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 16' ' ' LEU . 33.7 t -54.16 -57.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.8 -30.06 67.51 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.676 -0.64 . . . . 0.0 110.453 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 -121.25 8.0 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.61 -8.76 59.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -1.162 . . . . 0.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -62.79 -17.6 61.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.875 -1.141 . . . . 0.0 109.846 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 70.69 129.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -119.7 177.67 4.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.412 -1.052 . . . . 0.0 110.192 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -121.63 115.82 23.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -129.79 118.2 21.43 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.482 0.658 . . . . 0.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 75.8 p -133.18 -170.67 2.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.572 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 18.1 ptmt -144.06 46.82 0.68 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.964 -1.085 . . . . 0.0 110.42 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 12.6 Cg_exo -35.98 -48.3 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.836 2.357 . . . . 0.0 111.266 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.444 HG22 ' H ' ' B' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.377 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.854 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.1 tt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 121.868 0.842 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.42 ' H ' HG23 ' A' ' 3' ' ' VAL . 5.5 t -58.93 -40.14 79.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.457 0.646 . . . . 0.0 110.58 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.2 -54.07 16.74 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.448 -0.782 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.8 mt-30 -61.06 -33.87 73.98 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.234 -0.916 . . . . 0.0 111.72 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 m -96.17 -30.63 13.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.691 -1.256 . . . . 0.0 112.372 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 t -91.65 -58.2 2.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.625 -1.297 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -66.22 -11.17 48.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -161.22 166.31 27.96 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.217 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.4 mt -82.29 137.65 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.877 -1.139 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 5.9 m -98.93 171.64 7.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.416 -0.803 . . . . 0.0 110.041 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 m -118.6 144.9 45.81 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.8 tp -44.19 -35.09 2.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 110.135 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -61.24 -36.83 81.03 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.621 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.497 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 16.3 mt-30 -74.21 -41.62 61.09 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.848 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -64.35 -49.59 71.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.621 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -63.06 -25.31 68.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.943 0.878 . . . . 0.0 108.745 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.12 -32.31 73.68 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.854 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.3 m-85 -87.75 -0.34 56.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.686 -1.259 . . . . 0.0 109.119 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -94.33 146.3 24.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' B' ' 44' ' ' GLY . 38.7 t-20 . . . . . 0 C--N 1.299 -1.594 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.778 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.424 ' HB2' HD13 ' A' ' 13' ' ' LEU . 4.7 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.465 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.31 159.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.987 . . . . 0.0 109.797 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.465 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.1 92.78 4.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -139.55 144.64 37.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.425 -0.797 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.42 ' H ' ' CD2' ' B' ' 26' ' ' HIS . 15.6 m-70 -68.59 109.59 3.84 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.343 -0.848 . . . . 0.0 109.133 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.2 mt -92.01 149.23 21.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.928 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.0 m -156.4 -178.13 7.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.9 -143.87 18.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.49 -20.37 54.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.831 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -47.28 -59.03 3.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.087 -1.008 . . . . 0.0 108.732 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.96 -54.72 14.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 34' ' ' GLU . 31.1 t -52.63 -59.02 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.212 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -40.99 -41.79 1.73 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.78 -60.5 3.6 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.79 -46.17 64.11 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.646 -1.284 . . . . 0.0 108.359 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -55.73 -25.57 41.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.4 tp -85.25 -63.3 1.35 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -53.48 -56.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.603 0.716 . . . . 0.0 110.004 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.4 t -71.71 -30.36 65.56 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 110.665 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -120.58 6.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.3 pm0 -84.36 -12.56 54.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -1.142 . . . . 0.0 110.959 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -54.91 -33.36 62.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.85 -1.156 . . . . 0.0 109.989 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.76 126.86 4.18 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.25 172.93 10.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.058 -1.26 . . . . 0.0 108.761 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.61 119.77 28.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.631 -0.668 . . . . 0.0 109.437 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.606 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.908 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.518 0.675 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 t -58.84 -38.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.47 -0.769 . . . . 0.0 110.037 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.94 -45.18 75.0 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.679 -0.638 . . . . 0.0 110.821 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -75.97 -31.81 59.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.139 -0.976 . . . . 0.0 111.598 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 12.0 m -94.27 -28.17 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.62 -1.3 . . . . 0.0 112.104 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' N ' ' A' ' 9' ' ' SER . 15.1 t -90.49 -62.38 1.47 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.0 109.598 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.38 -9.75 0.77 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.472 ' N ' ' C ' ' A' ' 7' ' ' CYS . 1.5 m -160.11 -147.18 0.15 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.335 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD11 ' NE2' ' B' ' 26' ' ' HIS . 61.5 mt -128.09 141.88 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.901 . . . . 0.0 108.931 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.56 174.12 6.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 54.0 m -118.31 146.69 44.14 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.8 -34.64 1.63 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.481 -0.762 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.06 -35.46 80.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 108.521 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.9 mt-30 -76.73 -35.73 57.6 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.849 HD23 HG21 ' B' ' 39' ' ' VAL . 9.9 tp -70.49 -50.29 39.51 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.644 -0.66 . . . . 0.0 109.288 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -60.81 -26.85 67.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -61.89 -34.29 75.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.235 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.908 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.01 -4.4 58.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.602 -1.311 . . . . 0.0 109.334 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 t -100.69 146.47 27.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.407 -0.808 . . . . 0.0 109.691 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 3.7 p30 . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -57.54 157.37 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.699 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -106.32 88.94 2.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.04 151.8 48.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.524 -0.735 . . . . 0.0 109.539 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 10' ' ' ILE . 10.1 m-70 -74.59 110.42 8.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.183 -0.948 . . . . 0.0 109.925 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -92.03 148.69 22.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.784 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.3 m -155.81 -177.87 6.88 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.14 -142.77 16.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.84 -18.58 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -1.134 . . . . 0.0 109.792 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.82 -57.8 5.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.0 108.814 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.8 tp -49.29 -55.2 13.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 23.3 t -51.61 -59.49 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.115 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 29.0 mt-10 -41.31 -39.97 1.54 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.87 -60.49 3.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.1 mt -51.64 -46.45 63.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.547 -1.345 . . . . 0.0 108.186 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -55.03 -25.72 32.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -85.24 -63.07 1.39 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.849 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -54.15 -56.72 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.627 0.727 . . . . 0.0 109.943 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -71.47 -29.29 64.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.624 -0.672 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.55 -130.2 41.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -82.83 -6.91 59.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.213 -1.169 . . . . 0.0 110.152 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -56.95 -39.46 74.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.479 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 98.4 127.7 5.9 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -124.03 176.85 6.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -1.048 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.1 116.89 24.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 81.3 t80 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.892 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.8 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.596 0.712 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 3' ' ' VAL . 7.2 t -49.72 -40.06 15.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.589 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.49 -61.33 2.05 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.377 -0.827 . . . . 0.0 111.056 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.66 -27.96 69.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 111.037 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 m -88.42 -31.55 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.698 -1.251 . . . . 0.0 110.866 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.6 t -101.89 -58.77 1.82 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -60.49 -7.04 1.86 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 7' ' ' CYS . 37.3 t -163.12 -144.28 0.09 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.626 0.727 . . . . 0.0 109.53 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.47 HD11 ' NE2' ' B' ' 26' ' ' HIS . 77.2 mt -130.02 156.46 42.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.52 147.33 50.68 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.264 -0.897 . . . . 0.0 109.486 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.6 m -90.84 148.0 22.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 HD13 ' CB ' ' B' ' 22' ' ' PHE . 7.2 tp -43.41 -34.31 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.533 -0.73 . . . . 0.0 110.145 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.88 -34.71 78.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 108.584 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' SER . 17.0 mt-30 -77.96 -28.04 49.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.88 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -78.17 -49.08 14.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.99 -23.03 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.481 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -62.85 -35.18 79.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.12 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.8 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -84.64 -2.73 57.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.685 -1.259 . . . . 0.0 109.232 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 t -101.42 145.92 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.425 -0.797 . . . . 0.0 109.892 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.649 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 13' ' ' LEU . 7.5 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.9 p -47.99 159.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.45 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.04 90.05 3.25 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -126.09 151.97 46.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.47 ' NE2' HD11 ' A' ' 10' ' ' ILE . 9.6 m-70 -75.45 110.3 9.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 16.2 mt -91.58 151.0 20.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.002 -1.061 . . . . 0.0 109.43 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 86.1 m -156.11 -177.95 6.95 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.33 -145.22 12.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.87 -17.67 57.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.31 -1.112 . . . . 0.0 109.714 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.71 -58.02 4.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.064 -1.022 . . . . 0.0 108.859 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -48.49 -54.38 14.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.28 -46.5 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.123 -0.986 . . . . 0.0 108.91 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -41.25 29.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.66 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.63 -60.11 4.17 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 24.0 mt -52.17 -42.54 63.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.301 -1.5 . . . . 0.0 108.39 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -60.45 -25.01 65.67 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.5 -63.04 1.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.88 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -52.18 -56.31 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.529 0.68 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.78 -30.52 61.47 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 110.925 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.86 -117.52 4.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -84.06 -15.13 48.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -1.12 . . . . 0.0 111.035 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -57.25 -23.92 51.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.912 -1.118 . . . . 0.0 109.835 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 77.36 128.62 0.39 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.424 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 25.0 p90 -121.71 177.37 5.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.464 -1.021 . . . . 0.0 109.28 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 8.0 m-85 -125.19 120.23 30.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.435 ' OH ' HG22 ' A' ' 3' ' ' VAL . 77.4 t80 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.886 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.9 tt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.465 0.65 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.1 t -49.77 -43.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.849 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.24 -59.23 3.93 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.341 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -49.79 -50.2 45.79 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.772 . . . . 0.0 110.838 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 m -81.36 -30.68 33.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.022 -1.049 . . . . 0.0 112.27 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 8.5 t -92.58 -60.53 1.8 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.542 -1.349 . . . . 0.0 109.521 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 m -55.38 -17.22 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.131 -0.981 . . . . 0.0 108.566 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.9 m -157.85 -147.99 0.19 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.5 mt -123.17 137.09 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.87 . . . . 0.0 109.087 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 58.4 m -98.68 170.33 8.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 110.349 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 15' ' ' GLN . 73.2 m -118.06 145.89 44.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.2 tp -43.4 -33.43 1.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 110.205 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.68 -36.59 84.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.727 -1.233 . . . . 0.0 108.699 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.0 mt-30 -76.11 -36.06 59.03 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -70.5 -50.3 39.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.588 -0.695 . . . . 0.0 109.383 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -61.6 -23.23 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.22 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.886 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -86.37 -3.8 59.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.659 -1.276 . . . . 0.0 109.269 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.3 t -99.06 145.67 26.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.426 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.59 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.427 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.2 t80 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.5 p -77.71 153.86 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.106 -0.997 . . . . 0.0 110.037 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -99.96 93.12 5.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -138.05 146.27 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.302 -0.873 . . . . 0.0 109.839 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.432 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.8 m-70 -71.08 109.54 5.22 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 11.8 mt -92.39 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.14 -0.975 . . . . 0.0 109.698 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.4 m -156.48 -177.75 6.83 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.25 -142.42 14.27 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.56 -18.63 54.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -1.081 . . . . 0.0 109.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -48.64 -59.07 3.82 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.966 -1.084 . . . . 0.0 108.509 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 33.9 tp -48.7 -56.79 7.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.9 t -50.05 -59.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 20.4 mt-10 -41.56 -42.23 2.37 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.44 3.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.04 -48.68 61.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.729 -1.232 . . . . 0.0 108.083 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -53.14 -25.97 15.21 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.31 -63.06 1.39 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 37.1 t -53.59 -57.07 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.693 0.758 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.2 t -70.24 -29.49 66.31 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.758 -0.589 . . . . 0.0 110.594 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.86 -124.67 16.93 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.603 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -83.35 -8.23 59.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.303 -1.116 . . . . 0.0 110.733 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -59.16 -33.03 70.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.884 -1.135 . . . . 0.0 109.717 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.67 125.66 2.52 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.415 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.6 p90 -119.86 177.66 4.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.395 -1.062 . . . . 0.0 109.341 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -125.13 115.27 20.2 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 t80 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.66 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.846 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.9 tt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.41 0.624 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.485 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.6 t -48.54 -40.09 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -76.09 -23.82 55.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.993 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 21.9 mt-30 -91.16 -18.48 24.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.845 -1.159 . . . . 0.0 110.109 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -109.57 -30.6 7.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.819 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.33 -63.04 1.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.996 -1.065 . . . . 0.0 109.417 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 m -62.95 -11.03 15.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -163.73 159.86 21.92 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 55.8 mt -83.57 140.64 15.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 109.677 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.13 156.96 18.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.473 -0.767 . . . . 0.0 109.621 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . 50.2 m -100.49 147.48 25.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.47 -34.39 1.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.433 -0.792 . . . . 0.0 110.118 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.13 -34.88 79.07 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.763 -1.211 . . . . 0.0 108.555 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.6 mt-30 -78.07 -30.98 49.95 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -74.53 -49.16 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.535 -0.728 . . . . 0.0 109.122 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.53 -22.95 66.69 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.456 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -65.06 -34.42 78.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.386 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.846 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.3 m-85 -83.65 -0.71 51.8 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.585 -1.322 . . . . 0.0 109.384 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -103.48 146.41 28.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.71 . . . . 0.0 109.838 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.486 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 21.9 m-20 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.614 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.19 151.27 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.088 -1.008 . . . . 0.0 109.518 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -101.3 85.56 2.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.822 . . . . 0.0 109.354 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.36 147.65 49.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -69.05 111.01 4.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.312 -0.867 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.1 mt -90.59 150.93 21.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.6 m -155.96 -178.15 7.09 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.78 -143.47 10.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -78.91 -18.47 53.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 0.0 109.856 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -47.95 -49.57 29.99 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.045 -1.034 . . . . 0.0 108.49 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.7 tp -58.43 -56.63 19.7 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 16.4 t -51.15 -59.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 108.877 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 13.3 mm-40 -41.87 -42.94 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.43 -60.55 3.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.8 mt -51.67 -48.75 63.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.572 -1.33 . . . . 0.0 108.141 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -53.61 -25.73 18.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.8 tp -85.13 -63.01 1.4 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 16' ' ' LEU . 41.8 t -53.09 -58.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.67 0.747 . . . . 0.0 109.579 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 2.0 t -69.57 -29.74 67.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.721 -0.612 . . . . 0.0 110.648 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.62 -125.57 26.48 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.487 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.5 pm0 -83.81 -6.28 59.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -1.12 . . . . 0.0 110.853 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.62 -28.51 69.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 85.88 128.01 2.08 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.458 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.6 p90 -124.62 177.12 6.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.441 -1.035 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 18.7 m-85 -122.91 114.6 20.67 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.5 t80 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.913 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.439 0.638 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -56.88 -39.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 109.818 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -75.66 -20.12 58.68 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.255 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.452 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 tp-100 -91.28 -35.04 14.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.942 -1.099 . . . . 0.0 110.744 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.529 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 6.1 m -96.24 -24.32 16.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.0 111.593 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.464 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.1 t -97.44 -67.97 0.82 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.857 -1.152 . . . . 0.0 109.66 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -56.69 -12.29 1.78 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -155.87 -163.41 1.49 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' B' ' 26' ' ' HIS . 62.4 mt -116.7 146.81 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.119 -0.988 . . . . 0.0 109.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 97.9 m -111.32 169.87 8.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.536 -0.728 . . . . 0.0 110.007 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.1 m -118.4 146.36 44.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.4 -34.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.339 -0.851 . . . . 0.0 110.28 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -35.84 81.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.822 -1.174 . . . . 0.0 108.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 18.7 mt-30 -76.28 -34.86 59.1 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.8 tp -70.89 -50.51 34.19 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.623 -0.673 . . . . 0.0 109.263 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -60.31 -27.55 67.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.427 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.5 m-20 -61.99 -34.28 75.87 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.913 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.2 m-85 -84.13 -5.03 59.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.627 -1.295 . . . . 0.0 109.496 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -98.42 145.9 26.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.638 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.05 148.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.041 -1.037 . . . . 0.0 109.567 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -98.7 80.95 2.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.423 -0.798 . . . . 0.0 109.465 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' B' ' 25' ' ' GLN . 3.8 pt20 -120.27 148.89 43.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 110.204 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.951 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -68.4 111.18 4.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -90.19 150.6 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 67.9 m -155.75 -178.3 7.19 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.86 -143.24 11.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.32 -18.61 54.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.303 -1.116 . . . . 0.0 109.905 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -47.68 -53.3 15.38 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.017 -1.052 . . . . 0.0 108.695 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 26.4 tp -53.55 -55.62 24.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.6 t -53.36 -58.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.26 -0.9 . . . . 0.0 109.085 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.3 mt-10 -41.11 -40.4 1.49 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.661 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.81 -60.59 3.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -51.54 -45.94 63.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.597 -1.315 . . . . 0.0 108.366 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.27 -25.4 48.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.24 -62.88 1.43 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 31.7 t -54.17 -57.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.583 0.706 . . . . 0.0 109.843 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -70.05 -28.46 65.47 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.596 -0.69 . . . . 0.0 110.327 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.58 -131.3 46.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 -7.33 59.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -1.13 . . . . 0.0 110.136 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -55.63 -44.28 76.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.007 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 102.98 128.08 6.28 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.1 p90 -122.88 177.6 5.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.51 -0.994 . . . . 0.0 109.178 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.35 114.39 20.12 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 80.0 t80 . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 -179.656 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.821 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.7 tt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.411 0.624 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -55.2 -40.94 58.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 111.011 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.446 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.2 mt-30 -59.73 -33.36 71.54 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 111.499 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.6 m -93.86 -30.34 14.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.68 -1.263 . . . . 0.0 112.062 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 9' ' ' SER . 12.2 t -93.45 -62.75 1.31 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.669 -1.27 . . . . 0.0 109.429 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.12 -10.37 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.8 m -161.46 -150.5 0.2 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.2 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.487 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 72.1 mt -124.07 136.79 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 57.2 m -101.5 173.96 6.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -0.786 . . . . 0.0 110.158 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.3 m -118.82 146.67 44.65 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.4 tp -43.55 -34.03 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 110.266 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.29 -35.19 80.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.737 -1.227 . . . . 0.0 108.83 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.7 mt-30 -77.14 -32.68 56.52 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.06 -50.31 20.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -61.72 -22.75 65.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.428 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.07 -33.69 76.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.267 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.0 m-85 -86.55 -1.27 57.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.622 -1.299 . . . . 0.0 109.204 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -104.22 146.56 28.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.827 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.276 179.721 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 13' ' ' LEU . 1.5 t80 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.54 151.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -101.84 91.87 4.57 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -136.61 147.62 47.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.423 -0.798 . . . . 0.0 110.014 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.487 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.9 m-70 -71.2 109.52 5.29 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.365 -0.834 . . . . 0.0 108.793 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.04 149.9 20.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.88 -178.39 7.26 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.34 -144.74 10.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.01 -19.9 58.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -1.118 . . . . 0.0 109.87 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -47.53 -58.3 4.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.077 -1.015 . . . . 0.0 108.654 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -50.08 -55.2 15.82 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' B' ' 34' ' ' GLU . 20.1 t -51.54 -60.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 109.079 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 33' ' ' VAL . 42.7 mt-10 -41.23 -42.43 2.11 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.7 -60.63 3.27 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.92 -48.85 60.61 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.8 -1.188 . . . . 0.0 108.177 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -53.69 -25.68 19.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.7 tp -85.1 -62.83 1.44 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 43.8 t -52.2 -55.95 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.555 0.693 . . . . 0.0 109.921 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 0.9 OUTLIER -73.55 -30.12 62.86 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 110.594 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.37 -119.78 7.65 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.633 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.6 -15.9 47.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.124 . . . . 0.0 110.954 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -52.94 -45.59 67.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.513 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.473 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 100.68 127.71 6.14 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.401 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 29.5 p90 -122.76 177.22 5.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.511 -0.993 . . . . 0.0 108.8 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 46' ' ' PHE . 24.1 m-85 -126.35 114.15 17.84 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.552 0.692 . . . . 0.0 109.388 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 71.7 t80 . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.405 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.5 tt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.529 0.68 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -58.8 -37.67 67.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.712 0.768 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.1 -47.48 74.04 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.692 -0.63 . . . . 0.0 111.092 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -77.23 -39.7 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.103 -0.998 . . . . 0.0 111.727 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' SER . 16.7 m -83.12 -27.3 30.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.535 -1.353 . . . . 0.0 112.23 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.9 -55.92 3.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.497 -1.377 . . . . 0.0 109.428 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -157.32 169.85 23.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.405 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 62.9 mt -85.75 140.32 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 110.072 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' SG ' ' NE2' ' A' ' 15' ' ' GLN . 12.4 m -102.61 174.87 5.7 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.492 -0.755 . . . . 0.0 109.517 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 55.5 m -118.54 144.97 45.7 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.62 -34.73 1.52 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.451 -0.781 . . . . 0.0 110.199 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -62.76 -35.25 79.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.841 -1.162 . . . . 0.0 108.703 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.419 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 15.9 mt-30 -76.05 -34.15 59.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.5 tp -72.4 -50.07 29.16 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.575 -0.703 . . . . 0.0 109.324 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.3 -21.4 65.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' ND2' ' CE2' ' A' ' 14' ' ' TYR . 1.8 m-20 -66.89 -33.47 75.66 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.077 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.9 m-85 -84.53 -2.96 58.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.669 -1.269 . . . . 0.0 109.408 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.5 t -101.47 145.68 28.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -0.781 . . . . 0.0 109.55 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.4 p30 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.3 p -77.43 153.75 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -102.81 91.13 4.03 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -137.09 146.44 45.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 109.933 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.518 ' N ' ' OE1' ' B' ' 25' ' ' GLN . 15.0 m-70 -68.78 110.03 4.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.369 -0.832 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.515 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -92.66 149.3 21.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.053 -1.03 . . . . 0.0 109.804 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.51 -178.02 7.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.75 -144.1 12.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -76.68 -19.99 57.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -1.096 . . . . 0.0 109.851 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.75 -57.96 4.93 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.027 -1.046 . . . . 0.0 108.73 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.2 tp -50.67 -55.21 17.53 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.62 -60.02 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.213 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 25.4 mt-10 -41.12 -43.51 2.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -55.37 -60.83 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.37 -48.9 62.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.711 -1.243 . . . . 0.0 108.256 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.16 -25.87 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.3 tp -85.56 -63.14 1.37 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 39.5 t -52.72 -55.26 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.543 0.687 . . . . 0.0 110.129 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -74.03 -30.37 62.39 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.468 -0.77 . . . . 0.0 110.475 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.92 -117.62 4.28 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.702 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.85 -13.44 53.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.267 -1.137 . . . . 0.0 111.081 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 69.6 mtt180 -58.77 -29.35 66.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.847 -1.158 . . . . 0.0 109.858 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 83.34 128.02 1.33 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.7 p90 -121.98 175.83 6.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.335 -1.097 . . . . 0.0 109.406 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -123.02 116.85 24.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.6 t80 . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.576 -0.703 . . . . 0.0 109.644 -179.716 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.895 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.385 0.612 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.05 -36.94 65.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.496 -0.753 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.57 -23.21 60.94 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.54 -0.725 . . . . 0.0 110.92 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 8.0 tt0 -92.58 -53.56 4.14 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.758 -1.213 . . . . 0.0 110.89 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -72.4 -29.94 64.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 112.266 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' C ' ' N ' ' A' ' 9' ' ' SER . 10.0 t -89.53 -66.71 0.9 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.49 -1.381 . . . . 0.0 109.887 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 m -51.49 -14.84 0.34 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.913 -1.117 . . . . 0.0 108.538 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 7' ' ' CYS . 3.2 t -154.91 -138.73 0.07 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' NE2' ' B' ' 26' ' ' HIS . 93.3 mt -130.44 150.98 35.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.3 m -116.5 169.31 9.43 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.363 -0.836 . . . . 0.0 109.661 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.7 m -117.52 145.59 44.13 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -42.98 -33.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.509 -0.745 . . . . 0.0 110.245 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.75 -35.74 82.04 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.683 -1.26 . . . . 0.0 108.857 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.7 mt-30 -76.54 -32.49 58.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.853 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -74.0 -51.0 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.3 -24.59 65.09 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -62.97 -34.86 78.42 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.071 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.895 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.5 m-85 -84.62 -2.52 57.57 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.646 -1.284 . . . . 0.0 109.411 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 t -101.86 145.81 28.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.59 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.0 m-20 . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.82 142.41 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.9 OUTLIER -92.33 75.6 5.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.411 -0.806 . . . . 0.0 109.568 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -115.92 158.69 22.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.496 ' NE2' HD11 ' A' ' 10' ' ' ILE . 6.3 m-70 -77.28 110.79 12.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 109.91 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.509 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.8 mt -92.72 150.83 20.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.808 -1.182 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 68.6 m -156.28 -177.98 6.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.05 -144.22 10.55 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -76.99 -19.65 57.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -1.104 . . . . 0.0 109.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -47.28 -56.05 7.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.064 -1.023 . . . . 0.0 108.781 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.1 tp -51.19 -55.2 19.17 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.8 t -52.18 -58.8 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.137 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.7 mt-10 -41.17 -40.09 1.46 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.27 -60.53 3.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.8 -44.73 63.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.607 -1.308 . . . . 0.0 108.372 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -57.12 -25.5 58.93 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.06 1.39 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.853 HG21 HD23 ' A' ' 16' ' ' LEU . 38.9 t -53.34 -55.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.522 0.677 . . . . 0.0 110.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.74 -30.54 61.54 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.536 -0.727 . . . . 0.0 110.87 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 -115.23 2.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.327 -1.415 . . . . 0.0 109.759 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -83.68 -21.26 32.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.38 -1.071 . . . . 0.0 110.962 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -52.2 -28.69 19.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.869 -1.145 . . . . 0.0 109.901 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 80.58 129.34 0.86 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.5 p90 -123.54 177.16 5.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.463 -1.022 . . . . 0.0 109.118 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.06 120.25 29.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.655 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.911 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.48 0.657 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -54.34 -39.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.49 -0.756 . . . . 0.0 109.778 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -73.2 -20.44 60.88 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.533 -0.729 . . . . 0.0 110.339 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' SER . 20.9 mt-30 -91.29 -36.89 13.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 110.622 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 m -94.85 -27.36 15.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.02 . . . . 0.0 111.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 t -91.0 -59.57 2.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.753 -1.217 . . . . 0.0 109.715 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -65.61 -13.47 59.13 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.115 -0.991 . . . . 0.0 108.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -158.49 164.52 36.1 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.9 mt -81.94 137.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.162 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 9.7 m -96.83 168.25 10.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 15' ' ' GLN . 75.4 m -118.46 144.68 45.81 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.3 tp -43.45 -33.65 1.13 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.347 -0.846 . . . . 0.0 110.272 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.77 -35.58 81.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.719 -1.238 . . . . 0.0 108.776 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.1 mt-30 -76.84 -32.55 57.63 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.851 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.26 -50.14 20.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.66 -0.65 . . . . 0.0 109.292 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -61.65 -23.39 66.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -63.57 -34.71 78.4 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.945 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.911 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.4 m-85 -84.83 -6.63 59.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.7 -1.25 . . . . 0.0 109.263 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -98.99 145.89 26.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.1 p30 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.7 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -78.55 152.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.049 -1.032 . . . . 0.0 110.067 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -97.78 93.92 6.64 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -141.89 144.98 34.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 109.975 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' B' ' 26' ' ' HIS . 13.9 m-70 -68.92 109.86 4.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.27 150.5 20.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.019 . . . . 0.0 109.949 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.92 -178.24 7.16 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.9 -145.3 8.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -75.22 -19.52 59.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -1.162 . . . . 0.0 109.95 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.09 -57.65 5.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.039 -1.038 . . . . 0.0 108.751 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 31.2 tp -49.99 -55.77 13.33 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.24 -59.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.312 -0.868 . . . . 0.0 109.39 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 23.1 mt-10 -41.24 -42.15 2.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.78 3.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.2 -48.37 62.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.685 -1.259 . . . . 0.0 108.228 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.95 -25.58 21.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.41 -63.0 1.4 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.851 HG21 HD23 ' A' ' 16' ' ' LEU . 40.8 t -52.58 -56.45 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.505 0.669 . . . . 0.0 110.022 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 0.7 OUTLIER -73.28 -30.37 63.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.527 -0.733 . . . . 0.0 110.585 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.76 -118.71 5.15 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.279 -1.439 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.72 -11.55 57.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.274 -1.133 . . . . 0.0 110.894 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -59.8 -34.65 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.927 -1.108 . . . . 0.0 109.806 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.497 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.75 127.16 2.85 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.3 p90 -119.62 177.2 5.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.8 114.58 19.43 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.9 tt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.394 0.616 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -55.8 -38.96 53.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -75.34 -20.32 59.1 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.507 -0.745 . . . . 0.0 110.294 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -91.38 -36.99 13.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.944 -1.098 . . . . 0.0 110.771 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 4.8 m -95.76 -26.07 15.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.084 . . . . 0.0 111.882 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -90.19 -58.78 2.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.614 -1.304 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.407 ' C ' ' HG ' ' A' ' 9' ' ' SER . 7.1 m -65.22 -12.34 50.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.3 m -159.67 172.83 17.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 75.2 mt -89.91 135.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.735 -1.228 . . . . 0.0 109.558 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.2 m -96.8 171.48 8.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 109.846 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 60.5 m -118.53 144.83 45.79 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.18 -33.64 1.59 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.43 -34.87 78.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.702 -1.248 . . . . 0.0 108.66 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -76.92 -34.27 57.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.841 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -72.54 -50.41 25.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.631 -0.668 . . . . 0.0 109.241 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.44 -22.18 64.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -66.56 -33.64 76.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.104 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.8 m-85 -85.62 -2.57 58.31 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.694 -1.253 . . . . 0.0 109.433 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -99.35 145.76 27.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.623 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.0 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.17 155.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -98.65 92.94 5.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.92 144.07 41.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.44 -0.787 . . . . 0.0 109.737 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.409 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 13.7 m-70 -69.67 109.75 4.51 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.01 150.12 20.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.814 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -155.81 -178.08 7.03 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.12 -144.04 11.0 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -76.36 -19.8 57.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -1.073 . . . . 0.0 109.928 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.88 -58.92 3.76 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.035 -1.041 . . . . 0.0 108.675 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 27.5 tp -48.8 -56.23 9.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' B' ' 34' ' ' GLU . 28.6 t -50.09 -58.94 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.2 mt-10 -41.2 -40.98 1.71 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.97 -60.77 3.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.48 -46.08 63.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.596 -1.315 . . . . 0.0 108.361 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.36 -25.28 48.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.07 1.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 16' ' ' LEU . 30.7 t -53.16 -55.86 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.593 0.711 . . . . 0.0 110.099 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -73.34 -30.67 63.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.595 -0.69 . . . . 0.0 110.701 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.76 -115.27 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.634 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -84.08 -15.65 46.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.333 -1.098 . . . . 0.0 111.004 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -58.97 -18.22 31.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.851 -1.155 . . . . 0.0 109.779 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 69.18 128.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.8 p90 -121.14 177.43 5.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.454 -1.027 . . . . 0.0 109.199 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.491 ' CE1' ' OD1' ' A' ' 21' ' ' ASN . 36.2 m-85 -125.52 119.85 29.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.2 t80 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.782 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.875 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.7 tt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.527 0.679 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.6 t -55.66 -39.75 56.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.622 -0.674 . . . . 0.0 109.904 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.96 -20.16 60.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.483 -0.76 . . . . 0.0 110.344 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -91.11 -37.98 13.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.993 -1.067 . . . . 0.0 110.705 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.2 m -96.59 -24.15 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.99 -1.069 . . . . 0.0 111.929 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.23 -55.57 3.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.518 -1.364 . . . . 0.0 109.25 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -65.61 -18.66 65.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -154.6 173.21 16.66 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.968 HD11 ' CE1' ' B' ' 26' ' ' HIS . 66.5 mt -91.13 133.4 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.738 -1.226 . . . . 0.0 109.407 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 33.5 m -92.72 172.97 8.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.9 m -118.49 145.98 44.87 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.3 tp -43.54 -34.38 1.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 110.12 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.59 80.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.0 108.928 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -76.56 -36.81 57.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.838 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -69.71 -50.95 38.75 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.616 -0.678 . . . . 0.0 109.257 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.37 -25.51 65.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.4 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.19 -33.99 77.05 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.962 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.875 ' CD2' HD12 ' A' ' 2' ' ' ILE . 91.9 m-85 -84.44 2.15 42.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.725 -1.234 . . . . 0.0 109.105 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.1 t -106.34 146.04 30.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.17 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.383 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.43 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.4 p -75.93 156.77 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.43 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -102.23 92.87 4.92 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.17 141.69 47.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.968 ' CE1' HD11 ' A' ' 10' ' ' ILE . 1.8 m80 -69.23 109.85 4.3 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.408 -0.807 . . . . 0.0 109.512 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.1 mt -92.64 150.18 20.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 110.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.7 m -156.65 177.37 11.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.51 -145.54 18.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -74.17 -21.21 59.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.084 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.91 -53.19 16.64 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 0.0 108.62 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 21.8 tp -56.36 -56.48 20.54 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 34' ' ' GLU . 24.1 t -47.82 -60.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.26 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 33' ' ' VAL . 38.6 mt-10 -41.1 -42.93 2.11 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.707 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -54.74 -61.02 2.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 26.6 mt -52.67 -47.58 67.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.473 -1.392 . . . . 0.0 108.146 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -53.57 -26.1 20.03 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.5 tp -85.07 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.838 HG21 HD23 ' A' ' 16' ' ' LEU . 42.3 t -54.24 -56.91 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.716 0.77 . . . . 0.0 109.721 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.8 t -70.34 -29.96 66.79 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.724 -0.61 . . . . 0.0 110.662 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.56 -125.67 22.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.6 -9.04 59.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -1.14 . . . . 0.0 110.804 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -55.46 -42.15 73.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.903 -1.123 . . . . 0.0 109.587 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 101.64 126.62 5.88 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -130.84 165.65 22.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.567 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -120.5 114.29 21.55 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.932 0.873 . . . . 0.0 109.584 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 85.4 t80 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.445 0.64 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 8.4 t -56.05 -38.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 110.581 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 6.9 tp-100 -91.42 -33.13 15.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 0.0 110.543 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 m -96.78 -29.76 13.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.938 -1.101 . . . . 0.0 111.404 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.8 t -92.83 -63.33 1.24 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.758 -1.214 . . . . 0.0 109.584 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -4.84 1.09 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 39.7 t -161.07 -148.92 0.16 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.51 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.5 mt -127.71 140.96 47.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 69.4 m -109.31 164.71 12.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.37 -0.832 . . . . 0.0 110.417 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 61.1 m -114.68 146.33 41.01 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.8 tp -43.13 -34.16 1.03 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.758 . . . . 0.0 110.315 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.54 -33.92 77.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.746 -1.221 . . . . 0.0 108.706 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.4 mt-30 -79.22 -30.56 43.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.82 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -75.3 -49.83 17.96 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.67 -23.26 65.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.6 m-20 -64.78 -34.56 78.63 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.0 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.51 -4.57 59.02 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.678 -1.264 . . . . 0.0 109.151 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.9 t -100.23 145.95 27.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 109.566 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.6 p30 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -65.3 157.95 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.789 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -101.6 93.18 5.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.06 144.68 45.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.782 . . . . 0.0 110.04 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.51 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.3 m-70 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.482 -0.761 . . . . 0.0 109.666 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.6 mt -92.52 150.78 20.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 109.347 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.4 m -155.7 -177.85 6.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.3 -144.11 11.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -77.23 -18.82 57.37 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.47 -58.48 4.14 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.086 -1.009 . . . . 0.0 108.715 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 29.4 tp -48.67 -55.91 10.0 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.6 t -52.19 -58.96 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.012 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 33' ' ' VAL . 15.4 mt-10 -41.47 -41.87 2.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.87 -60.8 3.04 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.74 -48.87 58.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.0 108.318 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.84 -24.42 22.97 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.3 tp -85.25 -55.78 3.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -61.51 -59.58 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.605 0.716 . . . . 0.0 110.061 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.1 t -70.11 -30.22 67.37 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.649 -0.657 . . . . 0.0 110.711 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.52 -119.32 5.54 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.347 -1.406 . . . . 0.0 109.856 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.68 -12.64 55.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -1.133 . . . . 0.0 110.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 74.8 mtt180 -58.14 -31.87 67.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 87.52 126.49 2.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -119.22 177.23 4.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -1.091 . . . . 0.0 109.341 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -125.66 115.48 20.18 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.853 -0.529 . . . . 0.0 109.715 -179.63 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.2 tt . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.594 0.711 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.6 t -61.26 -38.8 80.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.591 0.71 . . . . 0.0 109.869 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.93 -20.07 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 109.995 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -90.71 -27.98 18.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.987 -1.071 . . . . 0.0 110.708 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' SER . 59.1 m -103.4 -30.45 10.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.043 -1.036 . . . . 0.0 111.082 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.0 t -93.65 -63.78 1.16 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.879 -1.138 . . . . 0.0 109.777 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -62.03 -10.05 8.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -162.93 164.15 25.95 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.358 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 67.0 mt -85.59 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 0.0 109.049 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.47 160.32 17.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.46 -0.775 . . . . 0.0 110.053 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' GLN . 44.9 m -103.39 147.71 26.78 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 13' ' ' LEU . 7.7 tp -43.46 -35.1 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.494 -0.754 . . . . 0.0 110.242 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.1 -35.3 79.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.768 -1.208 . . . . 0.0 108.566 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.1 mt-30 -77.85 -26.96 49.72 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 HG21 ' B' ' 39' ' ' VAL . 7.2 tp -78.81 -47.97 15.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.446 -0.784 . . . . 0.0 108.947 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -62.59 -21.39 65.58 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.476 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 4.0 m-20 -65.43 -34.53 78.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.145 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 83.7 m-85 -84.76 1.78 45.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.562 -1.336 . . . . 0.0 109.044 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -109.67 146.1 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 2.9 p30 . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.318 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.6 p -63.53 157.34 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.83 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -103.85 92.62 4.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -137.39 144.19 42.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 109.809 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 15.2 m-70 -69.1 109.51 4.06 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.149 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.0 mt -90.89 149.51 21.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.133 -0.98 . . . . 0.0 109.708 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 47.3 m -155.91 -178.08 7.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.12 -145.55 16.4 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.15 -19.99 57.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -47.43 -60.62 2.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.074 -1.016 . . . . 0.0 108.658 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 22.7 tp -47.29 -56.46 6.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' B' ' 34' ' ' GLU . 35.2 t -50.78 -59.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.261 -0.899 . . . . 0.0 108.903 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.9 mt-10 -41.43 -39.58 1.53 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.687 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.68 -59.88 4.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -45.41 66.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.5 -1.375 . . . . 0.0 108.069 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -56.27 -25.93 49.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -84.77 -58.32 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.868 HG21 HD23 ' A' ' 16' ' ' LEU . 46.9 t -57.36 -56.73 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -72.83 -31.03 64.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.652 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -112.94 1.3 Allowed Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.794 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.03 -20.35 32.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 111.226 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -52.41 -50.81 61.78 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.799 -1.188 . . . . 0.0 109.665 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.57 127.73 6.15 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -125.3 170.23 11.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.86 114.09 19.38 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.948 0.88 . . . . 0.0 109.544 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 73.3 t80 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.773 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.407 0.622 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.69 -40.58 19.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.735 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -75.4 -19.65 59.39 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.769 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -88.89 -41.17 12.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.144 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.5 m -91.2 -30.41 16.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 111.75 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.5 t -92.91 -66.72 0.9 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.647 -1.283 . . . . 0.0 110.508 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -57.21 -10.17 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.976 -1.077 . . . . 0.0 108.498 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -163.12 176.64 9.83 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.113 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.0 mt -97.09 135.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.997 -1.064 . . . . 0.0 108.901 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 p -103.06 158.29 16.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.487 -0.758 . . . . 0.0 110.275 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.8 m -100.25 146.54 26.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.8 tp -43.45 -34.4 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.25 79.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 108.702 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.8 mt-30 -77.58 -29.47 52.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.878 HD23 HG21 ' B' ' 39' ' ' VAL . 8.3 tp -76.9 -49.09 16.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.509 -0.745 . . . . 0.0 109.068 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.44 -23.53 66.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.478 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.7 m-20 -61.62 -35.56 78.24 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.149 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.773 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.1 m-85 -84.5 -3.84 58.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.716 -1.24 . . . . 0.0 109.395 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.5 t -100.55 146.37 27.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.442 -0.786 . . . . 0.0 109.671 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' B' ' 43' ' ' ARG . 2.2 p30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 13' ' ' LEU . 4.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.42 152.19 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 93.68 7.31 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.17 144.46 42.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.434 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.3 m-70 -73.87 109.97 7.8 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.0 mt -92.26 148.77 21.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 109.773 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.8 m -155.41 -177.79 6.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.24 -143.57 15.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.73 -18.17 54.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -1.173 . . . . 0.0 109.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -48.18 -57.07 6.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.002 -1.061 . . . . 0.0 108.447 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.5 t -51.32 -59.03 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.898 . . . . 0.0 108.972 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.1 mt-10 -42.49 -40.19 2.52 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.48 -60.18 4.27 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -51.65 -45.95 63.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.675 -1.265 . . . . 0.0 108.103 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.44 -24.95 48.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.08 -62.98 1.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 16' ' ' LEU . 58.7 t -52.41 -57.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.748 0.785 . . . . 0.0 109.749 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.477 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.7 t -70.13 -29.53 66.49 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.662 -0.649 . . . . 0.0 110.564 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.75 -126.3 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.369 -1.396 . . . . 0.0 109.758 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -83.18 -5.96 59.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.244 -1.151 . . . . 0.0 110.649 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.45 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.6 mtt180 -61.63 -37.21 83.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.943 -1.098 . . . . 0.0 109.666 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.477 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 95.19 126.07 4.74 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.417 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.4 p90 -121.53 177.6 5.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.472 -1.016 . . . . 0.0 109.181 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -127.03 118.59 24.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.9 t80 . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.366 0.603 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.3 t -54.51 -38.89 43.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.869 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -76.31 -25.87 55.23 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.467 -0.77 . . . . 0.0 110.261 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.523 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.2 tt0 -91.35 -29.69 16.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.888 -1.132 . . . . 0.0 110.441 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.6 m -93.39 -30.96 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 111.187 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.9 t -94.57 -63.74 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.859 -1.15 . . . . 0.0 110.174 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 m -57.68 -7.42 0.67 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 108.248 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 7' ' ' CYS . 35.7 t -156.65 -148.89 0.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.856 0.836 . . . . 0.0 109.44 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' B' ' 26' ' ' HIS . 80.1 mt -130.95 144.97 36.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.69 154.91 29.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.242 -0.911 . . . . 0.0 110.064 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -98.75 149.4 22.9 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.22 -33.41 1.55 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.84 -34.67 78.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.706 -1.246 . . . . 0.0 108.752 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.523 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.3 mt-30 -78.82 -30.34 45.31 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -75.53 -50.17 16.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.54 -26.18 66.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -61.35 -35.03 76.32 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.161 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 92.2 m-85 -83.62 -4.5 58.64 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.652 -1.28 . . . . 0.0 109.322 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -100.23 146.28 27.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 0.0 109.58 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 4.0 p30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.381 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.41 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.4 p -81.86 155.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.97 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.41 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -99.62 91.33 4.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 26' ' ' HIS . 0.3 OUTLIER -133.83 142.6 47.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.531 -0.731 . . . . 0.0 109.863 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.976 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.7 m80 -67.8 109.75 3.5 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.509 -0.744 . . . . 0.0 110.491 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.522 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -92.96 149.06 21.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.802 . . . . 0.0 109.339 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.3 m -155.71 -178.12 7.06 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.71 -143.37 18.59 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -78.77 -18.62 53.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -1.114 . . . . 0.0 109.815 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -47.64 -58.37 4.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.06 -1.025 . . . . 0.0 108.636 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 18.6 tp -48.84 -55.71 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' B' ' 34' ' ' GLU . 19.9 t -52.2 -59.07 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.257 -0.902 . . . . 0.0 108.839 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' B' ' 33' ' ' VAL . 18.0 mt-10 -42.36 -41.63 2.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.59 -60.39 3.74 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.69 -47.67 63.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.618 -1.301 . . . . 0.0 108.194 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -54.68 -25.46 27.3 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -84.89 -62.83 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.865 HG21 HD23 ' A' ' 16' ' ' LEU . 40.7 t -53.24 -58.43 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.703 0.763 . . . . 0.0 109.706 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.69 -28.69 66.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.682 -0.636 . . . . 0.0 110.585 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.19 -132.49 48.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.75 -4.91 58.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -57.65 -43.26 84.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 127.09 6.0 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.444 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.2 p90 -122.98 177.36 5.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.484 -1.01 . . . . 0.0 108.87 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -122.54 113.48 19.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 72.5 t80 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.27 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.852 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.351 0.596 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.455 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.39 -39.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.48 -24.39 50.19 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.508 -0.745 . . . . 0.0 110.139 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.97 -22.14 20.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.943 -1.098 . . . . 0.0 110.113 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' SER . 56.5 m -104.62 -30.43 9.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.987 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.2 t -98.51 -66.13 0.92 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.947 -1.095 . . . . 0.0 109.855 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -57.63 -9.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.3 m -161.72 -176.48 5.3 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.965 HD11 ' CE1' ' B' ' 26' ' ' HIS . 57.4 mt -106.64 137.81 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.063 -1.023 . . . . 0.0 108.849 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.44 156.86 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.472 -0.767 . . . . 0.0 109.947 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.1 m -99.78 147.94 24.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 tp -43.44 -34.26 1.27 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.492 -0.755 . . . . 0.0 110.16 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.55 -34.7 78.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.723 -1.236 . . . . 0.0 108.75 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -78.82 -28.76 44.51 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 8.9 tp -76.8 -49.53 15.65 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.68 -25.29 67.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -60.56 -35.83 77.01 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.173 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.1 m-85 -83.43 0.35 46.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.626 -1.296 . . . . 0.0 109.094 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.81 146.36 31.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.736 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.81 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.401 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.6 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.463 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.1 p -47.77 158.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.747 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -107.07 89.47 3.01 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.18 141.89 51.63 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.573 -0.705 . . . . 0.0 109.671 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.965 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -66.24 110.66 3.11 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.406 -0.809 . . . . 0.0 110.555 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -90.94 149.72 21.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -156.09 -178.13 7.09 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.31 -144.23 14.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.19 -18.94 54.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -47.32 -56.87 5.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.086 -1.009 . . . . 0.0 108.62 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.3 tp -50.14 -56.29 11.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.5 t -51.34 -60.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.276 -0.89 . . . . 0.0 109.113 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 17.7 mm-40 -41.42 -42.39 2.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.373 0.606 . . . . 0.0 109.378 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.31 -60.3 3.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.2 mt -51.17 -49.02 61.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.628 -1.295 . . . . 0.0 108.083 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -53.07 -26.18 15.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.2 -62.96 1.41 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 56.4 t -51.06 -55.71 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.438 0.637 . . . . 0.0 110.175 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -75.37 -30.83 60.29 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 110.94 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.8 -111.94 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.184 -1.484 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -83.87 -23.89 31.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.343 -1.092 . . . . 0.0 110.947 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -52.25 -28.16 17.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.91 -1.119 . . . . 0.0 110.008 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 79.39 129.75 0.69 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.407 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 27.6 p90 -123.07 177.01 5.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.571 -0.958 . . . . 0.0 108.944 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.01 122.19 33.76 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 78.0 t80 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.919 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.891 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.354 0.597 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.453 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.9 t -54.33 -39.94 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -75.29 -19.54 59.62 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.465 -0.772 . . . . 0.0 110.472 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.8 mt-30 -90.67 -40.48 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 110.711 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -92.67 -24.27 18.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.916 -1.115 . . . . 0.0 111.944 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.1 t -94.91 -66.65 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.638 -1.289 . . . . 0.0 109.485 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.492 ' C ' ' HG ' ' A' ' 9' ' ' SER . 9.1 m -57.77 -8.84 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' A' ' 8' ' ' THR . 1.4 m -160.84 -159.07 0.64 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.497 HD11 ' NE2' ' B' ' 26' ' ' HIS . 78.1 mt -119.03 139.76 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.28 -0.888 . . . . 0.0 109.198 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 90.6 m -104.39 171.67 7.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.439 -0.788 . . . . 0.0 110.097 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 48.2 m -118.46 145.67 45.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.7 tp -43.65 -33.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.437 -0.789 . . . . 0.0 110.214 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.85 -34.98 79.16 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.742 -1.223 . . . . 0.0 108.491 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.8 mt-30 -77.04 -34.69 57.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.833 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -71.5 -50.52 30.62 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.596 -0.69 . . . . 0.0 109.212 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.32 -23.56 65.81 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.413 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.1 m-20 -65.76 -33.82 76.74 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.125 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.891 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.0 m-85 -84.42 -4.65 59.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.674 -1.266 . . . . 0.0 109.398 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -98.9 145.99 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.404 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.6 p-10 . . . . . 0 C--N 1.303 -1.445 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.453 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.3 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.68 154.35 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.0 110.083 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.22 96.02 10.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -137.18 144.28 42.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.188 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.497 ' NE2' HD11 ' A' ' 10' ' ' ILE . 9.8 m-70 -74.37 108.78 7.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -94.52 150.77 19.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.082 -1.011 . . . . 0.0 109.775 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 56.6 m -155.77 -177.97 6.95 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.31 -144.75 10.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -76.24 -19.89 57.93 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.259 -1.142 . . . . 0.0 109.798 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -47.19 -57.73 4.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.061 -1.024 . . . . 0.0 108.804 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 28.1 tp -50.92 -55.85 15.19 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.0 t -50.74 -59.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' VAL . 45.8 mt-10 -41.1 -42.36 1.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.62 -60.53 3.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.15 -48.67 61.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.595 -1.316 . . . . 0.0 108.276 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -53.9 -25.68 21.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.07 -62.91 1.43 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.833 HG21 HD23 ' A' ' 16' ' ' LEU . 30.2 t -53.62 -58.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.601 0.715 . . . . 0.0 109.909 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.95 -28.38 65.51 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 110.476 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 -130.32 46.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -82.76 -10.4 58.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -1.139 . . . . 0.0 109.971 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -52.93 -45.09 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 128.24 6.3 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.432 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 21.9 p90 -122.68 177.41 5.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -1.018 . . . . 0.0 109.121 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.57 117.74 25.0 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.709 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.924 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.3 tt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.347 0.594 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 9.4 t -52.39 -38.91 26.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.26 -27.71 59.53 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.177 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.3 tt0 -91.66 -28.78 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.841 -1.162 . . . . 0.0 110.594 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' SER . 18.3 m -92.98 -28.94 16.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 0.0 111.2 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.447 ' C ' ' N ' ' A' ' 9' ' ' SER . 14.1 t -96.43 -66.32 0.91 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.891 -1.13 . . . . 0.0 109.985 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -56.41 -12.71 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.4 m -154.93 -179.28 7.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 54.3 mt -105.83 138.78 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.136 -0.978 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.48 157.03 17.44 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 36.1 m -99.02 147.94 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.6 tp -43.71 -33.14 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.445 -0.784 . . . . 0.0 110.092 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -65.01 -34.72 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.782 -1.199 . . . . 0.0 108.75 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.526 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.0 mt-30 -78.57 -31.82 47.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.09 -50.17 20.73 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.75 -25.5 66.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.3 m-20 -63.1 -34.63 78.01 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.21 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.924 ' CD2' HD12 ' A' ' 2' ' ' ILE . 93.2 m-85 -83.14 -2.22 54.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.617 -1.302 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.28 146.57 28.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.539 -0.726 . . . . 0.0 109.789 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.395 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.405 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.2 p -73.02 153.68 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.815 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.405 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -100.63 92.69 5.22 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.46 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.1 tm0? -134.18 139.87 46.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.387 -0.821 . . . . 0.0 109.555 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -65.53 110.2 2.62 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.299 -0.876 . . . . 0.0 110.172 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -91.21 148.63 22.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.684 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.5 m -155.4 -177.87 6.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.3 -144.2 20.07 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.31 -18.94 54.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 109.677 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.1 m-20 -47.54 -57.83 4.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 108.686 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.9 tp -49.47 -55.54 12.89 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.2 t -52.65 -59.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.234 -0.916 . . . . 0.0 108.757 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -42.0 -41.21 2.45 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.15 -60.36 3.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -51.73 -45.74 63.73 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.761 -1.212 . . . . 0.0 108.281 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -56.05 -25.64 45.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -84.96 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 41.7 t -53.48 -56.98 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.645 0.736 . . . . 0.0 109.568 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.8 t -70.43 -29.42 66.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.72 -0.613 . . . . 0.0 110.781 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.92 -129.26 38.63 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.371 -1.395 . . . . 0.0 109.695 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.12 -3.69 57.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -1.139 . . . . 0.0 110.526 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -62.38 -34.08 76.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.961 -1.087 . . . . 0.0 109.629 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.0 128.01 4.27 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.451 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 17.0 p90 -123.06 177.77 5.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.42 -1.047 . . . . 0.0 109.059 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.3 114.26 19.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.1 t80 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 -179.751 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.904 HD12 ' CD2' ' A' ' 19' ' ' TYR . 14.5 tt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.844 0.831 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.8 t -68.4 -36.42 74.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.619 0.724 . . . . 0.0 110.018 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.82 -20.14 58.39 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.19 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.9 mt-30 -91.04 -34.98 14.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.53 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -95.48 -30.35 13.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.814 -1.179 . . . . 0.0 111.385 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.2 t -92.96 -64.14 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.816 -1.177 . . . . 0.0 109.911 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -60.1 -5.79 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 7' ' ' CYS . 42.6 t -159.74 -145.84 0.13 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.963 HD11 ' CE1' ' B' ' 26' ' ' HIS . 91.9 mt -130.05 142.44 43.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 60.4 m -109.18 151.05 26.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.283 -0.886 . . . . 0.0 110.628 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLN . 59.3 m -101.23 146.0 28.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.6 tp -43.54 -34.02 1.28 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.01 -34.76 78.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.718 -1.239 . . . . 0.0 108.698 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.3 mt-30 -77.58 -33.01 54.07 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.847 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -72.95 -50.26 24.45 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.621 -0.674 . . . . 0.0 109.237 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -61.61 -20.79 63.74 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.4 m-20 -69.2 -32.74 72.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.904 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.6 m-85 -85.83 -6.98 59.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.588 -1.32 . . . . 0.0 109.283 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 t -93.61 142.6 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.891 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.477 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.1 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.411 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -82.34 154.64 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.85 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.58 90.28 4.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -132.45 145.1 50.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.614 -0.679 . . . . 0.0 109.599 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.963 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.1 m80 -68.32 110.5 4.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.514 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.76 150.87 20.36 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.19 -178.11 7.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.62 -142.07 12.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.05 -18.07 54.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.355 -1.086 . . . . 0.0 109.92 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -48.3 -55.42 10.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.99 -1.069 . . . . 0.0 108.693 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 35.1 tp -51.04 -56.2 13.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.3 t -51.65 -59.84 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 6.0 mm-40 -40.94 -41.56 1.66 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.422 0.63 . . . . 0.0 109.378 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.647 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.55 -60.3 3.88 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.7 mt -51.05 -48.87 61.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.693 -1.254 . . . . 0.0 108.127 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -53.65 -25.41 17.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.28 -62.86 1.43 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 16' ' ' LEU . 33.7 t -54.16 -57.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.8 -30.06 67.51 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.676 -0.64 . . . . 0.0 110.453 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 -121.25 8.0 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.61 -8.76 59.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -1.162 . . . . 0.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -62.79 -17.6 61.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.875 -1.141 . . . . 0.0 109.846 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 70.69 129.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -119.7 177.67 4.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.412 -1.052 . . . . 0.0 110.192 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -121.63 115.82 23.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 87.4 t80 . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.482 0.658 . . . . 0.0 110.317 -179.146 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.994 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.854 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.1 tt -60.16 -25.73 34.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.353 -1.086 . . . . 0.0 109.311 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.42 ' H ' HG23 ' A' ' 3' ' ' VAL . 5.5 t -58.93 -40.14 79.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 CA-C-O 121.457 0.646 . . . . 0.0 110.58 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.2 -54.07 16.74 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.448 -0.782 . . . . 0.0 110.879 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.8 mt-30 -61.06 -33.87 73.98 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.234 -0.916 . . . . 0.0 111.72 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 m -96.17 -30.63 13.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.691 -1.256 . . . . 0.0 112.372 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 t -91.65 -58.2 2.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.625 -1.297 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -66.22 -11.17 48.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -161.22 166.31 27.96 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.217 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.4 mt -82.29 137.65 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.877 -1.139 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 5.9 m -98.93 171.64 7.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.416 -0.803 . . . . 0.0 110.041 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 m -118.6 144.9 45.81 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.8 tp -44.19 -35.09 2.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 110.135 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -61.24 -36.83 81.03 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.79 -1.164 . . . . 0.0 108.621 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.497 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 16.3 mt-30 -74.21 -41.62 61.09 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.848 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -64.35 -49.59 71.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.598 -0.689 . . . . 0.0 109.621 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -63.06 -25.31 68.31 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.943 0.878 . . . . 0.0 108.745 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.12 -32.31 73.68 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.854 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.3 m-85 -87.75 -0.34 56.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.686 -1.259 . . . . 0.0 109.119 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -94.33 146.3 24.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' B' ' 44' ' ' GLY . 38.7 t-20 . . . . . 0 C--N 1.299 -1.594 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.778 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.424 ' HB2' HD13 ' A' ' 13' ' ' LEU . 4.7 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.465 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.31 159.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.122 -0.987 . . . . 0.0 109.797 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.465 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.1 92.78 4.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -139.55 144.64 37.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.425 -0.797 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.42 ' H ' ' CD2' ' B' ' 26' ' ' HIS . 15.6 m-70 -68.59 109.59 3.84 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.343 -0.848 . . . . 0.0 109.133 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.2 mt -92.01 149.23 21.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.928 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.0 m -156.4 -178.13 7.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.9 -143.87 18.6 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.49 -20.37 54.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.831 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -47.28 -59.03 3.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.087 -1.008 . . . . 0.0 108.732 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.96 -54.72 14.39 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' B' ' 34' ' ' GLU . 31.1 t -52.63 -59.02 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -0.87 . . . . 0.0 109.212 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -40.99 -41.79 1.73 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.78 -60.5 3.6 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.79 -46.17 64.11 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.646 -1.284 . . . . 0.0 108.359 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -55.73 -25.57 41.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.4 tp -85.25 -63.3 1.35 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -53.48 -56.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.603 0.716 . . . . 0.0 110.004 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.4 t -71.71 -30.36 65.56 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.667 -0.646 . . . . 0.0 110.665 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -120.58 6.69 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.3 pm0 -84.36 -12.56 54.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.259 -1.142 . . . . 0.0 110.959 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -54.91 -33.36 62.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.85 -1.156 . . . . 0.0 109.989 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.76 126.86 4.18 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -128.25 172.93 10.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.058 -1.26 . . . . 0.0 108.761 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.61 119.77 28.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.631 -0.668 . . . . 0.0 109.437 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -129.64 109.29 10.88 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.1 t -175.74 -129.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.537 ' N ' ' OG1' ' B' ' 48' ' ' THR . 33.1 mttp 42.76 51.58 6.79 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 26.8 Cg_exo -28.62 112.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.582 2.855 . . . . 0.0 112.674 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.427 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.917 0 N-CA-C 119.874 2.709 . . . . 0.0 119.874 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.908 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt -62.53 -32.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -1.115 . . . . 0.0 109.787 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 t -58.84 -38.35 72.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.47 -0.769 . . . . 0.0 110.037 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -67.94 -45.18 75.0 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.679 -0.638 . . . . 0.0 110.821 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -75.97 -31.81 59.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.139 -0.976 . . . . 0.0 111.598 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 9' ' ' SER . 12.0 m -94.27 -28.17 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.62 -1.3 . . . . 0.0 112.104 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' N ' ' A' ' 9' ' ' SER . 15.1 t -90.49 -62.38 1.47 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.508 -1.37 . . . . 0.0 109.598 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.38 -9.75 0.77 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.472 ' N ' ' C ' ' A' ' 7' ' ' CYS . 1.5 m -160.11 -147.18 0.15 Allowed 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.335 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.418 HD11 ' NE2' ' B' ' 26' ' ' HIS . 61.5 mt -128.09 141.88 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.259 -0.901 . . . . 0.0 108.931 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.56 174.12 6.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 54.0 m -118.31 146.69 44.14 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -43.8 -34.64 1.63 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.481 -0.762 . . . . 0.0 110.259 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.06 -35.46 80.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.77 -1.206 . . . . 0.0 108.521 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.9 mt-30 -76.73 -35.73 57.6 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.849 HD23 HG21 ' B' ' 39' ' ' VAL . 9.9 tp -70.49 -50.29 39.51 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.644 -0.66 . . . . 0.0 109.288 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -60.81 -26.85 67.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -61.89 -34.29 75.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.235 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.908 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.01 -4.4 58.71 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.602 -1.311 . . . . 0.0 109.334 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.2 t -100.69 146.47 27.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.407 -0.808 . . . . 0.0 109.691 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 3.7 p30 . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -57.54 157.37 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.699 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -106.32 88.94 2.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.04 151.8 48.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.524 -0.735 . . . . 0.0 109.539 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 10' ' ' ILE . 10.1 m-70 -74.59 110.42 8.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.183 -0.948 . . . . 0.0 109.925 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -92.03 148.69 22.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.784 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.3 m -155.81 -177.87 6.88 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.14 -142.77 16.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.84 -18.58 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -1.134 . . . . 0.0 109.792 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.82 -57.8 5.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.087 -1.008 . . . . 0.0 108.814 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.8 tp -49.29 -55.2 13.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 23.3 t -51.61 -59.49 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.115 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 29.0 mt-10 -41.31 -39.97 1.54 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.87 -60.49 3.77 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.1 mt -51.64 -46.45 63.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.547 -1.345 . . . . 0.0 108.186 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -55.03 -25.72 32.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -85.24 -63.07 1.39 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.849 HG21 HD23 ' A' ' 16' ' ' LEU . 39.8 t -54.15 -56.72 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.627 0.727 . . . . 0.0 109.943 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -71.47 -29.29 64.67 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.624 -0.672 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.55 -130.2 41.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -82.83 -6.91 59.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.213 -1.169 . . . . 0.0 110.152 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -56.95 -39.46 74.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.479 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 98.4 127.7 5.9 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -124.03 176.85 6.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -1.048 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.1 116.89 24.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -129.25 109.11 10.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 1.3 t -177.95 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 109.081 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' OG1' ' B' ' 48' ' ' THR . 70.3 tttt 45.22 49.75 6.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 26.7 Cg_exo -28.5 147.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.629 2.886 . . . . 0.0 112.659 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.939 0 N-CA-C 119.791 2.676 . . . . 0.0 119.791 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.8 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt -70.27 -38.41 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -1.108 . . . . 0.0 109.202 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.46 ' H ' HG23 ' A' ' 3' ' ' VAL . 7.2 t -49.72 -40.06 15.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.589 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.49 -61.33 2.05 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.377 -0.827 . . . . 0.0 111.056 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.66 -27.96 69.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 111.037 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 m -88.42 -31.55 18.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.698 -1.251 . . . . 0.0 110.866 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.6 t -101.89 -58.77 1.82 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -60.49 -7.04 1.86 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 7' ' ' CYS . 37.3 t -163.12 -144.28 0.09 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.626 0.727 . . . . 0.0 109.53 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.47 HD11 ' NE2' ' B' ' 26' ' ' HIS . 77.2 mt -130.02 156.46 42.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.52 147.33 50.68 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.264 -0.897 . . . . 0.0 109.486 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.6 m -90.84 148.0 22.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 HD13 ' CB ' ' B' ' 22' ' ' PHE . 7.2 tp -43.41 -34.31 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.533 -0.73 . . . . 0.0 110.145 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.88 -34.71 78.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.779 -1.201 . . . . 0.0 108.584 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 12' ' ' SER . 17.0 mt-30 -77.96 -28.04 49.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.88 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -78.17 -49.08 14.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.99 -23.03 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.481 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -62.85 -35.18 79.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.12 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.8 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -84.64 -2.73 57.9 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.685 -1.259 . . . . 0.0 109.232 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 t -101.42 145.92 28.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.425 -0.797 . . . . 0.0 109.892 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.304 -1.405 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.649 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.441 ' CB ' HD13 ' A' ' 13' ' ' LEU . 7.5 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.45 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.9 p -47.99 159.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.45 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -106.04 90.05 3.25 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -126.09 151.97 46.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.47 ' NE2' HD11 ' A' ' 10' ' ' ILE . 9.6 m-70 -75.45 110.3 9.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 16.2 mt -91.58 151.0 20.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.002 -1.061 . . . . 0.0 109.43 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 86.1 m -156.11 -177.95 6.95 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.33 -145.22 12.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -77.87 -17.67 57.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.31 -1.112 . . . . 0.0 109.714 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.71 -58.02 4.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.064 -1.022 . . . . 0.0 108.859 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -48.49 -54.38 14.5 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.28 -46.5 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.123 -0.986 . . . . 0.0 108.91 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.5 -41.25 29.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.66 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.63 -60.11 4.17 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 24.0 mt -52.17 -42.54 63.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.301 -1.5 . . . . 0.0 108.39 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -60.45 -25.01 65.67 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.5 -63.04 1.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.88 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -52.18 -56.31 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.529 0.68 . . . . 0.0 110.207 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.78 -30.52 61.47 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.55 -0.719 . . . . 0.0 110.925 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.86 -117.52 4.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -84.06 -15.13 48.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.296 -1.12 . . . . 0.0 111.035 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -57.25 -23.92 51.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.912 -1.118 . . . . 0.0 109.835 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 77.36 128.62 0.39 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.424 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 25.0 p90 -121.71 177.37 5.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.464 -1.021 . . . . 0.0 109.28 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 8.0 m-85 -125.19 120.23 30.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.435 ' OH ' HG22 ' A' ' 3' ' ' VAL . 77.4 t80 -129.26 107.39 9.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.5 OUTLIER 169.59 -116.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.551 ' N ' ' OG1' ' B' ' 48' ' ' THR . 31.8 ttmt 40.78 50.13 3.73 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 110.635 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 25.4 Cg_exo -28.27 91.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.566 2.844 . . . . 0.0 112.583 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 1' ' ' GLY . 41.7 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.051 -1.031 . . . . 0.0 109.466 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' H1 ' HG23 ' B' ' 51' ' ' THR . . . . . . . . 1 N--CA 1.53 4.911 0 N-CA-C 119.543 2.577 . . . . 0.0 119.543 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.886 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.9 tt -53.12 -36.56 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.259 -1.142 . . . . 0.0 109.655 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.1 t -49.77 -43.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 109.849 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.24 -59.23 3.93 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.341 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -49.79 -50.2 45.79 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.772 . . . . 0.0 110.838 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 m -81.36 -30.68 33.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.022 -1.049 . . . . 0.0 112.27 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 8.5 t -92.58 -60.53 1.8 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.542 -1.349 . . . . 0.0 109.521 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 m -55.38 -17.22 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.131 -0.981 . . . . 0.0 108.566 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' CYS . 5.9 m -157.85 -147.99 0.19 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.5 mt -123.17 137.09 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.307 -0.87 . . . . 0.0 109.087 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 58.4 m -98.68 170.33 8.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 110.349 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 15' ' ' GLN . 73.2 m -118.06 145.89 44.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.2 tp -43.4 -33.43 1.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.827 . . . . 0.0 110.205 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.68 -36.59 84.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.727 -1.233 . . . . 0.0 108.699 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.0 mt-30 -76.11 -36.06 59.03 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -70.5 -50.3 39.34 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.588 -0.695 . . . . 0.0 109.383 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -61.6 -23.23 65.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.22 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.886 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.8 m-85 -86.37 -3.8 59.06 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.659 -1.276 . . . . 0.0 109.269 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.3 t -99.06 145.67 26.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.426 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.59 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.427 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.2 t80 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.403 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.5 p -77.71 153.86 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.106 -0.997 . . . . 0.0 110.037 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -99.96 93.12 5.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -138.05 146.27 42.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.302 -0.873 . . . . 0.0 109.839 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.432 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.8 m-70 -71.08 109.54 5.22 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 11.8 mt -92.39 150.35 20.87 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.14 -0.975 . . . . 0.0 109.698 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 58.4 m -156.48 -177.75 6.83 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.25 -142.42 14.27 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.56 -18.63 54.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -1.081 . . . . 0.0 109.963 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -48.64 -59.07 3.82 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.966 -1.084 . . . . 0.0 108.509 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 33.9 tp -48.7 -56.79 7.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.9 t -50.05 -59.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 20.4 mt-10 -41.56 -42.23 2.37 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.62 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.44 3.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.04 -48.68 61.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.729 -1.232 . . . . 0.0 108.083 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -53.14 -25.97 15.21 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.31 -63.06 1.39 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 37.1 t -53.59 -57.07 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.693 0.758 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.2 t -70.24 -29.49 66.31 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.758 -0.589 . . . . 0.0 110.594 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.86 -124.67 16.93 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.265 -1.445 . . . . 0.0 109.603 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -83.35 -8.23 59.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.303 -1.116 . . . . 0.0 110.733 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -59.16 -33.03 70.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.884 -1.135 . . . . 0.0 109.717 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.67 125.66 2.52 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.415 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.6 p90 -119.86 177.66 4.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.395 -1.062 . . . . 0.0 109.341 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -125.13 115.27 20.2 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -130.32 106.82 8.82 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.523 ' H ' ' HD3' ' B' ' 50' ' ' PRO . 2.0 p -150.62 48.22 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.555 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 13.0 mmmt 44.81 45.4 2.14 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.733 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 34.9 Cg_exo -25.03 -48.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 123.846 3.031 . . . . 0.0 112.89 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.491 HG23 ' H1 ' ' A' ' 1' ' ' GLY . 8.1 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.375 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.846 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.9 tt -76.15 -39.45 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.284 -1.127 . . . . 0.0 109.579 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.485 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.6 t -48.54 -40.09 10.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -76.09 -23.82 55.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.993 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 21.9 mt-30 -91.16 -18.48 24.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.845 -1.159 . . . . 0.0 110.109 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -109.57 -30.6 7.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 110.819 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 t -100.33 -63.04 1.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.996 -1.065 . . . . 0.0 109.417 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 m -62.95 -11.03 15.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -163.73 159.86 21.92 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 55.8 mt -83.57 140.64 15.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 109.677 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.13 156.96 18.24 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.473 -0.767 . . . . 0.0 109.621 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . 50.2 m -100.49 147.48 25.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 tp -43.47 -34.39 1.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.433 -0.792 . . . . 0.0 110.118 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.13 -34.88 79.07 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.763 -1.211 . . . . 0.0 108.555 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.6 mt-30 -78.07 -30.98 49.95 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 HG21 ' B' ' 39' ' ' VAL . 8.8 tp -74.53 -49.16 23.09 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.535 -0.728 . . . . 0.0 109.122 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.53 -22.95 66.69 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.456 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.4 m-20 -65.06 -34.42 78.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.386 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.846 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.3 m-85 -83.65 -0.71 51.8 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.585 -1.322 . . . . 0.0 109.384 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -103.48 146.41 28.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.71 . . . . 0.0 109.838 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.486 ' OD1' ' CZ ' ' B' ' 46' ' ' PHE . 21.9 m-20 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.614 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.19 151.27 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.088 -1.008 . . . . 0.0 109.518 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -101.3 85.56 2.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.822 . . . . 0.0 109.354 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -125.36 147.65 49.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.344 -0.847 . . . . 0.0 110.166 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -69.05 111.01 4.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.312 -0.867 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.1 mt -90.59 150.93 21.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 63.6 m -155.96 -178.15 7.09 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.78 -143.47 10.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -78.91 -18.47 53.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 0.0 109.856 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -47.95 -49.57 29.99 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.045 -1.034 . . . . 0.0 108.49 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.7 tp -58.43 -56.63 19.7 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 16.4 t -51.15 -59.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 108.877 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 13.3 mm-40 -41.87 -42.94 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.43 -60.55 3.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.8 mt -51.67 -48.75 63.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.572 -1.33 . . . . 0.0 108.141 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -53.61 -25.73 18.87 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.8 tp -85.13 -63.01 1.4 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.867 HG21 HD23 ' A' ' 16' ' ' LEU . 41.8 t -53.09 -58.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.67 0.747 . . . . 0.0 109.579 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 2.0 t -69.57 -29.74 67.37 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.721 -0.612 . . . . 0.0 110.648 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.62 -125.57 26.48 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.23 -1.462 . . . . 0.0 109.487 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' B' ' 42' ' ' GLU . 1.5 pm0 -83.81 -6.28 59.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -1.12 . . . . 0.0 110.853 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.62 -28.51 69.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 85.88 128.01 2.08 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.458 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.6 p90 -124.62 177.12 6.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.441 -1.035 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' OD1' ' A' ' 21' ' ' ASN . 18.7 m-85 -122.91 114.6 20.67 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.54 ' C ' HG22 ' B' ' 48' ' ' THR . 82.5 t80 -129.87 109.72 11.14 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.621 HG23 ' H ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 177.3 -78.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.499 179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.621 ' H ' HG23 ' B' ' 48' ' ' THR . 33.6 mmtm -133.77 53.14 9.47 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.0 Cg_exo -30.66 -69.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.327 2.685 . . . . 0.0 112.497 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.44 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.965 0 N-CA-C 119.808 2.683 . . . . 0.0 119.808 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.913 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt -68.8 -34.6 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -1.119 . . . . 0.0 109.703 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -56.88 -39.1 62.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 109.818 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -75.66 -20.12 58.68 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.255 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.452 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 1.4 tp-100 -91.28 -35.04 14.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.942 -1.099 . . . . 0.0 110.744 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.529 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 6.1 m -96.24 -24.32 16.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.809 -1.182 . . . . 0.0 111.593 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.1 t -97.44 -67.97 0.82 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.857 -1.152 . . . . 0.0 109.66 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -56.69 -12.29 1.78 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -155.87 -163.41 1.49 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.951 HD11 ' CE1' ' B' ' 26' ' ' HIS . 62.4 mt -116.7 146.81 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.119 -0.988 . . . . 0.0 109.24 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 97.9 m -111.32 169.87 8.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.536 -0.728 . . . . 0.0 110.007 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.1 m -118.4 146.36 44.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -43.4 -34.46 1.28 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.339 -0.851 . . . . 0.0 110.28 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.88 -35.84 81.96 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.822 -1.174 . . . . 0.0 108.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 18.7 mt-30 -76.28 -34.86 59.1 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.8 tp -70.89 -50.51 34.19 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.623 -0.673 . . . . 0.0 109.263 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -60.31 -27.55 67.42 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.5 m-20 -61.99 -34.28 75.87 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.913 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.2 m-85 -84.13 -5.03 59.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.627 -1.295 . . . . 0.0 109.496 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -98.42 145.9 26.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 0.0 109.638 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.05 148.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.041 -1.037 . . . . 0.0 109.567 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -98.7 80.95 2.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.423 -0.798 . . . . 0.0 109.465 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' B' ' 25' ' ' GLN . 3.8 pt20 -120.27 148.89 43.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.806 . . . . 0.0 110.204 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.951 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.2 m80 -68.4 111.18 4.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -90.19 150.6 21.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 67.9 m -155.75 -178.3 7.19 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.86 -143.24 11.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.32 -18.61 54.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.303 -1.116 . . . . 0.0 109.905 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -47.68 -53.3 15.38 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.017 -1.052 . . . . 0.0 108.695 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 26.4 tp -53.55 -55.62 24.03 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.6 t -53.36 -58.66 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.26 -0.9 . . . . 0.0 109.085 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.3 mt-10 -41.11 -40.4 1.49 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.661 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -58.81 -60.59 3.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -51.54 -45.94 63.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.597 -1.315 . . . . 0.0 108.366 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.27 -25.4 48.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.24 -62.88 1.43 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 31.7 t -54.17 -57.47 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.583 0.706 . . . . 0.0 109.843 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -70.05 -28.46 65.47 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.596 -0.69 . . . . 0.0 110.327 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.58 -131.3 46.56 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.76 -7.33 59.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.279 -1.13 . . . . 0.0 110.136 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -55.63 -44.28 76.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.007 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 102.98 128.08 6.28 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.1 p90 -122.88 177.6 5.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.51 -0.994 . . . . 0.0 109.178 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.35 114.39 20.12 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -129.88 109.95 11.31 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.745 -0.597 . . . . 0.0 109.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.523 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.6 OUTLIER -168.9 -114.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.551 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' N ' ' OG1' ' B' ' 48' ' ' THR . 26.8 mmtp 44.78 50.38 7.19 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.979 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 30.9 Cg_exo -27.57 100.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.739 2.959 . . . . 0.0 112.812 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.418 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.909 0 N-CA-C 119.76 2.664 . . . . 0.0 119.76 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.821 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.7 tt -70.32 -34.79 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -1.15 . . . . 0.0 109.722 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.5 t -55.2 -40.94 58.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 110.044 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 121.445 -0.785 . . . . 0.0 111.011 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.446 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 16.2 mt-30 -59.73 -33.36 71.54 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 111.499 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.548 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.6 m -93.86 -30.34 14.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.68 -1.263 . . . . 0.0 112.062 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 9' ' ' SER . 12.2 t -93.45 -62.75 1.31 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.669 -1.27 . . . . 0.0 109.429 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m -56.12 -10.37 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.8 m -161.46 -150.5 0.2 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.2 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.487 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 72.1 mt -124.07 136.79 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 57.2 m -101.5 173.96 6.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.442 -0.786 . . . . 0.0 110.158 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.3 m -118.82 146.67 44.65 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.4 tp -43.55 -34.03 1.29 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.452 -0.78 . . . . 0.0 110.266 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.29 -35.19 80.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.737 -1.227 . . . . 0.0 108.83 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.7 mt-30 -77.14 -32.68 56.52 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.06 -50.31 20.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -61.72 -22.75 65.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.428 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.07 -33.69 76.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.267 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.821 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.0 m-85 -86.55 -1.27 57.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.622 -1.299 . . . . 0.0 109.204 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.2 t -104.22 146.56 28.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.593 -0.692 . . . . 0.0 109.827 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.276 179.721 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 13' ' ' LEU . 1.5 t80 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.54 151.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -101.84 91.87 4.57 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -136.61 147.62 47.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.423 -0.798 . . . . 0.0 110.014 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.487 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.9 m-70 -71.2 109.52 5.29 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.365 -0.834 . . . . 0.0 108.793 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.04 149.9 20.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.05 -1.031 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.88 -178.39 7.26 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.34 -144.74 10.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.01 -19.9 58.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -1.118 . . . . 0.0 109.87 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -47.53 -58.3 4.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.077 -1.015 . . . . 0.0 108.654 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -50.08 -55.2 15.82 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' B' ' 34' ' ' GLU . 20.1 t -51.54 -60.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.3 -0.875 . . . . 0.0 109.079 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' B' ' 33' ' ' VAL . 42.7 mt-10 -41.23 -42.43 2.11 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.7 -60.63 3.27 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.92 -48.85 60.61 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.8 -1.188 . . . . 0.0 108.177 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -53.69 -25.68 19.39 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.7 tp -85.1 -62.83 1.44 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.846 HG21 HD23 ' A' ' 16' ' ' LEU . 43.8 t -52.2 -55.95 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.555 0.693 . . . . 0.0 109.921 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 0.9 OUTLIER -73.55 -30.12 62.86 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.563 -0.711 . . . . 0.0 110.594 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.37 -119.78 7.65 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.158 -1.496 . . . . 0.0 109.633 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.6 -15.9 47.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.124 . . . . 0.0 110.954 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -52.94 -45.59 67.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.513 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.473 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 100.68 127.71 6.14 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.401 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 29.5 p90 -122.76 177.22 5.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.511 -0.993 . . . . 0.0 108.8 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 46' ' ' PHE . 24.1 m-85 -126.35 114.15 17.84 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.552 0.692 . . . . 0.0 109.388 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -130.5 107.29 9.11 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' B' ' 49' ' ' LYS . 1.3 t 175.54 120.95 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.459 -0.775 . . . . 0.0 109.594 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 69.3 mttt 38.49 50.09 2.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.606 -0.684 . . . . 0.0 110.626 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 33.9 Cg_exo -26.85 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.749 2.966 . . . . 0.0 113.028 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.541 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.927 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.899 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.5 tt -70.88 -33.68 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -1.114 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -58.8 -37.67 67.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.712 0.768 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.1 -47.48 74.04 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.692 -0.63 . . . . 0.0 111.092 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -77.23 -39.7 47.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.103 -0.998 . . . . 0.0 111.727 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' SER . 16.7 m -83.12 -27.3 30.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.535 -1.353 . . . . 0.0 112.23 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.9 -55.92 3.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.497 -1.377 . . . . 0.0 109.428 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -157.32 169.85 23.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.405 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 62.9 mt -85.75 140.32 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 110.072 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' SG ' ' NE2' ' A' ' 15' ' ' GLN . 12.4 m -102.61 174.87 5.7 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.492 -0.755 . . . . 0.0 109.517 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLN . 55.5 m -118.54 144.97 45.7 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tp -43.62 -34.73 1.52 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.451 -0.781 . . . . 0.0 110.199 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -62.76 -35.25 79.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.841 -1.162 . . . . 0.0 108.703 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.419 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 15.9 mt-30 -76.05 -34.15 59.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 HG21 ' B' ' 39' ' ' VAL . 9.5 tp -72.4 -50.07 29.16 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.575 -0.703 . . . . 0.0 109.324 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.3 -21.4 65.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' ND2' ' CE2' ' A' ' 14' ' ' TYR . 1.8 m-20 -66.89 -33.47 75.66 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.077 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.899 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.9 m-85 -84.53 -2.96 58.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.669 -1.269 . . . . 0.0 109.408 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.5 t -101.47 145.68 28.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.45 -0.781 . . . . 0.0 109.55 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.4 p30 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.3 p -77.43 153.75 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 109.675 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -102.81 91.13 4.03 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -137.09 146.44 45.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 109.933 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.518 ' N ' ' OE1' ' B' ' 25' ' ' GLN . 15.0 m-70 -68.78 110.03 4.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.369 -0.832 . . . . 0.0 109.602 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.515 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -92.66 149.3 21.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.053 -1.03 . . . . 0.0 109.804 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.51 -178.02 7.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.75 -144.1 12.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.2 m -76.68 -19.99 57.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -1.096 . . . . 0.0 109.851 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -47.75 -57.96 4.93 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.027 -1.046 . . . . 0.0 108.73 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.2 tp -50.67 -55.21 17.53 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.62 -60.02 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 0.0 109.213 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 25.4 mt-10 -41.12 -43.51 2.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -55.37 -60.83 2.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -51.37 -48.9 62.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.711 -1.243 . . . . 0.0 108.256 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.16 -25.87 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.3 tp -85.56 -63.14 1.37 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.843 HG21 HD23 ' A' ' 16' ' ' LEU . 39.5 t -52.72 -55.26 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.543 0.687 . . . . 0.0 110.129 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -74.03 -30.37 62.39 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.468 -0.77 . . . . 0.0 110.475 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.92 -117.62 4.28 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.338 -1.41 . . . . 0.0 109.702 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -83.85 -13.44 53.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.267 -1.137 . . . . 0.0 111.081 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 69.6 mtt180 -58.77 -29.35 66.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.847 -1.158 . . . . 0.0 109.858 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 83.34 128.02 1.33 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.414 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.7 p90 -121.98 175.83 6.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.335 -1.097 . . . . 0.0 109.406 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -123.02 116.85 24.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -129.61 109.08 10.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.576 -0.703 . . . . 0.0 109.644 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.439 ' O ' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 179.05 65.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.876 . . . . 0.0 109.417 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 14.6 ptmt 34.05 49.36 0.69 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 122.221 -0.3 . . . . 0.0 111.147 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 29.7 Cg_exo -26.2 -67.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.772 2.982 . . . . 0.0 113.005 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.423 HG22 ' H ' ' B' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.456 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.96 0 N-CA-C 119.819 2.688 . . . . 0.0 119.819 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.895 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt -71.7 -35.14 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -1.121 . . . . 0.0 109.72 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.05 -36.94 65.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.496 -0.753 . . . . 0.0 110.167 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.57 -23.21 60.94 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.54 -0.725 . . . . 0.0 110.92 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 8.0 tt0 -92.58 -53.56 4.14 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.758 -1.213 . . . . 0.0 110.89 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.3 m -72.4 -29.94 64.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 112.266 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' C ' ' N ' ' A' ' 9' ' ' SER . 10.0 t -89.53 -66.71 0.9 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.49 -1.381 . . . . 0.0 109.887 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 m -51.49 -14.84 0.34 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.913 -1.117 . . . . 0.0 108.538 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 7' ' ' CYS . 3.2 t -154.91 -138.73 0.07 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.496 HD11 ' NE2' ' B' ' 26' ' ' HIS . 93.3 mt -130.44 150.98 35.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.3 m -116.5 169.31 9.43 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.363 -0.836 . . . . 0.0 109.661 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLN . 58.7 m -117.52 145.59 44.13 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tp -42.98 -33.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.509 -0.745 . . . . 0.0 110.245 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.75 -35.74 82.04 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.683 -1.26 . . . . 0.0 108.857 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.7 mt-30 -76.54 -32.49 58.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.853 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -74.0 -51.0 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.3 -24.59 65.09 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.0 m-20 -62.97 -34.86 78.42 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.071 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.895 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.5 m-85 -84.62 -2.52 57.57 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.646 -1.284 . . . . 0.0 109.411 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.6 t -101.86 145.81 28.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.59 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.0 m-20 . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.575 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.82 142.41 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 109.673 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.9 OUTLIER -92.33 75.6 5.27 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.411 -0.806 . . . . 0.0 109.568 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -115.92 158.69 22.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.496 ' NE2' HD11 ' A' ' 10' ' ' ILE . 6.3 m-70 -77.28 110.79 12.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 109.91 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.509 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.8 mt -92.72 150.83 20.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.808 -1.182 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 68.6 m -156.28 -177.98 6.99 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.05 -144.22 10.55 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -76.99 -19.65 57.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -1.104 . . . . 0.0 109.874 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -47.28 -56.05 7.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.064 -1.023 . . . . 0.0 108.781 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.1 tp -51.19 -55.2 19.17 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.8 t -52.18 -58.8 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.137 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.7 mt-10 -41.17 -40.09 1.46 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.27 -60.53 3.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.8 -44.73 63.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.607 -1.308 . . . . 0.0 108.372 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -57.12 -25.5 58.93 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.06 1.39 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.853 HG21 HD23 ' A' ' 16' ' ' LEU . 38.9 t -53.34 -55.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.522 0.677 . . . . 0.0 110.215 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -74.74 -30.54 61.54 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.536 -0.727 . . . . 0.0 110.87 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.12 -115.23 2.25 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.327 -1.415 . . . . 0.0 109.759 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -83.68 -21.26 32.46 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.38 -1.071 . . . . 0.0 110.962 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -52.2 -28.69 19.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.869 -1.145 . . . . 0.0 109.901 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.492 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 80.58 129.34 0.86 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.5 p90 -123.54 177.16 5.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.463 -1.022 . . . . 0.0 109.118 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.06 120.25 29.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.463 ' C ' HG22 ' B' ' 48' ' ' THR . 82.8 t80 -129.82 109.77 11.19 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.587 HG23 ' H ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -178.93 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.587 ' H ' HG23 ' B' ' 48' ' ' THR . 18.2 pttp -131.46 53.22 11.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.5 Cg_exo -31.7 -62.95 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 123.151 2.567 . . . . 0.0 112.327 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.46 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.729 2.652 . . . . 0.0 119.729 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.911 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt -73.6 -35.75 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.215 -1.168 . . . . 0.0 109.596 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -54.34 -39.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.49 -0.756 . . . . 0.0 109.778 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -73.2 -20.44 60.88 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.533 -0.729 . . . . 0.0 110.339 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 9' ' ' SER . 20.9 mt-30 -91.29 -36.89 13.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.785 -1.197 . . . . 0.0 110.622 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 m -94.85 -27.36 15.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.02 . . . . 0.0 111.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 t -91.0 -59.57 2.13 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.753 -1.217 . . . . 0.0 109.715 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -65.61 -13.47 59.13 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.115 -0.991 . . . . 0.0 108.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -158.49 164.52 36.1 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.9 mt -81.94 137.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.842 -1.162 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 9.7 m -96.83 168.25 10.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 15' ' ' GLN . 75.4 m -118.46 144.68 45.81 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.3 tp -43.45 -33.65 1.13 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.347 -0.846 . . . . 0.0 110.272 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.77 -35.58 81.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.719 -1.238 . . . . 0.0 108.776 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.1 mt-30 -76.84 -32.55 57.63 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.851 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.26 -50.14 20.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.66 -0.65 . . . . 0.0 109.292 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -61.65 -23.39 66.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -63.57 -34.71 78.4 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.945 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.911 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.4 m-85 -84.83 -6.63 59.35 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.7 -1.25 . . . . 0.0 109.263 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -98.99 145.89 26.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.52 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 5.1 p30 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.7 t80 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -78.55 152.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.049 -1.032 . . . . 0.0 110.067 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -97.78 93.92 6.64 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -141.89 144.98 34.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 109.975 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' B' ' 26' ' ' HIS . 13.9 m-70 -68.92 109.86 4.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.518 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.27 150.5 20.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.07 -1.019 . . . . 0.0 109.949 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.5 m -155.92 -178.24 7.16 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.9 -145.3 8.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -75.22 -19.52 59.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -1.162 . . . . 0.0 109.95 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -48.09 -57.65 5.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.039 -1.038 . . . . 0.0 108.751 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 31.2 tp -49.99 -55.77 13.33 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.7 t -50.24 -59.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.312 -0.868 . . . . 0.0 109.39 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' B' ' 33' ' ' VAL . 23.1 mt-10 -41.24 -42.15 2.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.69 -60.78 3.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.2 -48.37 62.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.685 -1.259 . . . . 0.0 108.228 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.95 -25.58 21.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -85.41 -63.0 1.4 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.851 HG21 HD23 ' A' ' 16' ' ' LEU . 40.8 t -52.58 -56.45 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.505 0.669 . . . . 0.0 110.022 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 0.7 OUTLIER -73.28 -30.37 63.37 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.527 -0.733 . . . . 0.0 110.585 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.76 -118.71 5.15 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.279 -1.439 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.72 -11.55 57.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.274 -1.133 . . . . 0.0 110.894 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -59.8 -34.65 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.927 -1.108 . . . . 0.0 109.806 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.497 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 88.75 127.16 2.85 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 22.3 p90 -119.62 177.2 5.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.8 114.58 19.43 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -129.47 109.52 11.12 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.3 62.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' B' ' 51' ' ' THR . 79.0 mttt -152.36 55.73 1.6 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 23.7 Cg_exo -30.26 -31.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.325 2.683 . . . . 0.0 112.935 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.536 ' N ' ' O ' ' B' ' 49' ' ' LYS . 5.3 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.03 . . . . 0.0 109.697 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.93 0 N-CA-C 119.799 2.679 . . . . 0.0 119.799 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 19' ' ' TYR . 18.9 tt -65.13 -35.47 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.34 -1.094 . . . . 0.0 109.717 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 t -55.8 -38.96 53.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.42 -0.8 . . . . 0.0 109.949 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -75.34 -20.32 59.1 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.507 -0.745 . . . . 0.0 110.294 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -91.38 -36.99 13.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.944 -1.098 . . . . 0.0 110.771 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 4.8 m -95.76 -26.07 15.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.965 -1.084 . . . . 0.0 111.882 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -90.19 -58.78 2.38 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.614 -1.304 . . . . 0.0 109.366 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.407 ' C ' ' HG ' ' A' ' 9' ' ' SER . 7.1 m -65.22 -12.34 50.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 108.59 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.3 m -159.67 172.83 17.04 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 75.2 mt -89.91 135.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.735 -1.228 . . . . 0.0 109.558 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 21.2 m -96.8 171.48 8.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 109.846 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 60.5 m -118.53 144.83 45.79 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.18 -33.64 1.59 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.328 -0.857 . . . . 0.0 110.289 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.43 -34.87 78.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.702 -1.248 . . . . 0.0 108.66 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -76.92 -34.27 57.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.841 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -72.54 -50.41 25.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.631 -0.668 . . . . 0.0 109.241 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.44 -22.18 64.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -66.56 -33.64 76.12 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.104 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 2' ' ' ILE . 94.8 m-85 -85.62 -2.57 58.31 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.694 -1.253 . . . . 0.0 109.433 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -99.35 145.76 27.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.623 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.0 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.407 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -81.17 155.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.407 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -98.65 92.94 5.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.92 144.07 41.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.44 -0.787 . . . . 0.0 109.737 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.409 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 13.7 m-70 -69.67 109.75 4.51 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.9 mt -93.01 150.12 20.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.814 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -155.81 -178.08 7.03 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.12 -144.04 11.0 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -76.36 -19.8 57.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -1.073 . . . . 0.0 109.928 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.88 -58.92 3.76 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.035 -1.041 . . . . 0.0 108.675 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 27.5 tp -48.8 -56.23 9.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' B' ' 34' ' ' GLU . 28.6 t -50.09 -58.94 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.2 mt-10 -41.2 -40.98 1.71 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.699 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.97 -60.77 3.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -51.48 -46.08 63.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.596 -1.315 . . . . 0.0 108.361 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.36 -25.28 48.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.3 -63.07 1.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 16' ' ' LEU . 30.7 t -53.16 -55.86 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.593 0.711 . . . . 0.0 110.099 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.6 t -73.34 -30.67 63.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.595 -0.69 . . . . 0.0 110.701 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.76 -115.27 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.349 -1.405 . . . . 0.0 109.634 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -84.08 -15.65 46.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.333 -1.098 . . . . 0.0 111.004 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -58.97 -18.22 31.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.851 -1.155 . . . . 0.0 109.779 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 69.18 128.98 0.05 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.8 p90 -121.14 177.43 5.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.454 -1.027 . . . . 0.0 109.199 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.491 ' CE1' ' OD1' ' A' ' 21' ' ' ASN . 36.2 m-85 -125.52 119.85 29.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -129.39 107.82 9.8 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 173.92 -107.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' N ' ' OG1' ' B' ' 48' ' ' THR . 44.6 tttm 43.31 49.43 4.91 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.52 -0.737 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.9 Cg_exo -27.47 83.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.744 2.963 . . . . 0.0 112.723 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 49' ' ' LYS . 2.4 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.98 -1.075 . . . . 0.0 109.456 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.94 0 N-CA-C 119.824 2.689 . . . . 0.0 119.824 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.875 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.7 tt -58.02 -33.41 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.233 -1.157 . . . . 0.0 109.438 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.6 t -55.66 -39.75 56.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.622 -0.674 . . . . 0.0 109.904 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -73.96 -20.16 60.44 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.483 -0.76 . . . . 0.0 110.344 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -91.11 -37.98 13.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.993 -1.067 . . . . 0.0 110.705 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 5.2 m -96.59 -24.15 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.99 -1.069 . . . . 0.0 111.929 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.23 -55.57 3.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.518 -1.364 . . . . 0.0 109.25 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 m -65.61 -18.66 65.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.2 m -154.6 173.21 16.66 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.968 HD11 ' CE1' ' B' ' 26' ' ' HIS . 66.5 mt -91.13 133.4 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.738 -1.226 . . . . 0.0 109.407 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 33.5 m -92.72 172.97 8.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.145 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.9 m -118.49 145.98 44.87 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.3 tp -43.54 -34.38 1.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 110.12 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.59 80.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.0 108.928 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -76.56 -36.81 57.39 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.838 HD23 HG21 ' B' ' 39' ' ' VAL . 9.7 tp -69.71 -50.95 38.75 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.616 -0.678 . . . . 0.0 109.257 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.37 -25.51 65.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.4 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -64.19 -33.99 77.05 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.962 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.875 ' CD2' HD12 ' A' ' 2' ' ' ILE . 91.9 m-85 -84.44 2.15 42.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.725 -1.234 . . . . 0.0 109.105 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.1 t -106.34 146.04 30.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.503 -0.748 . . . . 0.0 109.17 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.383 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.43 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.4 p -75.93 156.77 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.43 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -102.23 92.87 4.92 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.17 141.69 47.17 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.575 -0.703 . . . . 0.0 109.442 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.968 ' CE1' HD11 ' A' ' 10' ' ' ILE . 1.8 m80 -69.23 109.85 4.3 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.408 -0.807 . . . . 0.0 109.512 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.1 mt -92.64 150.18 20.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 110.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.7 m -156.65 177.37 11.56 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.51 -145.54 18.37 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -74.17 -21.21 59.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.084 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.91 -53.19 16.64 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 0.0 108.62 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 21.8 tp -56.36 -56.48 20.54 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 34' ' ' GLU . 24.1 t -47.82 -60.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.26 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 33' ' ' VAL . 38.6 mt-10 -41.1 -42.93 2.11 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.707 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -54.74 -61.02 2.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 26.6 mt -52.67 -47.58 67.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.473 -1.392 . . . . 0.0 108.146 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -53.57 -26.1 20.03 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' B' ' 35' ' ' ALA . 4.5 tp -85.07 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.838 HG21 HD23 ' A' ' 16' ' ' LEU . 42.3 t -54.24 -56.91 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.716 0.77 . . . . 0.0 109.721 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.8 t -70.34 -29.96 66.79 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.724 -0.61 . . . . 0.0 110.662 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.56 -125.67 22.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -83.6 -9.04 59.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -1.14 . . . . 0.0 110.804 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -55.46 -42.15 73.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.903 -1.123 . . . . 0.0 109.587 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.462 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 101.64 126.62 5.88 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -130.84 165.65 22.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.567 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -120.5 114.29 21.55 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.932 0.873 . . . . 0.0 109.584 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -119.38 113.1 20.28 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -158.63 -166.44 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.121 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.563 ' N ' ' OG1' ' B' ' 48' ' ' THR . 44.8 mttp 55.06 50.33 6.07 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.155 -0.966 . . . . 0.0 109.505 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.2 Cg_exo -28.17 -39.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.75 2.967 . . . . 0.0 112.901 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.444 ' N ' ' O ' ' B' ' 49' ' ' LYS . 11.4 t . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.346 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.967 0 N-CA-C 119.677 2.631 . . . . 0.0 119.677 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt -74.41 -35.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.682 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 3' ' ' VAL . 8.4 t -56.05 -38.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.011 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 110.581 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 6.9 tp-100 -91.42 -33.13 15.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 0.0 110.543 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 m -96.78 -29.76 13.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.938 -1.101 . . . . 0.0 111.404 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.8 t -92.83 -63.33 1.24 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.758 -1.214 . . . . 0.0 109.584 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -60.85 -4.84 1.09 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 39.7 t -161.07 -148.92 0.16 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.51 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 93.5 mt -127.71 140.96 47.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 69.4 m -109.31 164.71 12.22 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.37 -0.832 . . . . 0.0 110.417 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 61.1 m -114.68 146.33 41.01 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.8 tp -43.13 -34.16 1.03 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.758 . . . . 0.0 110.315 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.54 -33.92 77.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.746 -1.221 . . . . 0.0 108.706 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.4 mt-30 -79.22 -30.56 43.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.82 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -75.3 -49.83 17.96 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.67 -23.26 65.97 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.6 m-20 -64.78 -34.56 78.63 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.0 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 96.9 m-85 -84.51 -4.57 59.02 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.678 -1.264 . . . . 0.0 109.151 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.9 t -100.23 145.95 27.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 109.566 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 3.6 p30 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 9.6 p -65.3 157.95 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.789 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -101.6 93.18 5.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.06 144.68 45.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.782 . . . . 0.0 110.04 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.51 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 10.3 m-70 -71.92 110.21 6.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.482 -0.761 . . . . 0.0 109.666 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.6 mt -92.52 150.78 20.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 109.347 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.4 m -155.7 -177.85 6.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.3 -144.11 11.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -77.23 -18.82 57.37 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.47 -58.48 4.14 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.086 -1.009 . . . . 0.0 108.715 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 29.4 tp -48.67 -55.91 10.0 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.6 t -52.19 -58.96 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.012 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 33' ' ' VAL . 15.4 mt-10 -41.47 -41.87 2.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.87 -60.8 3.04 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 mt -50.74 -48.87 58.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.721 -1.237 . . . . 0.0 108.318 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.84 -24.42 22.97 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.3 tp -85.25 -55.78 3.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.82 HG21 HD23 ' A' ' 16' ' ' LEU . 37.6 t -61.51 -59.58 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.605 0.716 . . . . 0.0 110.061 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.1 t -70.11 -30.22 67.37 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.649 -0.657 . . . . 0.0 110.711 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.52 -119.32 5.54 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.347 -1.406 . . . . 0.0 109.856 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.68 -12.64 55.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -1.133 . . . . 0.0 110.895 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.453 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 74.8 mtt180 -58.14 -31.87 67.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 87.52 126.49 2.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -119.22 177.23 4.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -1.091 . . . . 0.0 109.341 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' B' ' 48' ' ' THR . 17.1 t80 -125.66 115.48 20.18 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -129.79 108.28 10.04 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.853 -0.529 . . . . 0.0 109.715 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.55 ' CG2' ' CE2' ' B' ' 46' ' ' PHE . 1.3 t 174.06 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 40.7 mtpt -145.23 52.95 1.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.5 Cg_exo -28.34 109.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.605 2.87 . . . . 0.0 112.642 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.454 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.976 0 N-CA-C 119.716 2.647 . . . . 0.0 119.716 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.631 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.2 tt -57.53 -26.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.392 -1.063 . . . . 0.0 109.4 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.6 t -61.26 -38.8 80.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.591 0.71 . . . . 0.0 109.869 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.93 -20.07 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 109.995 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -90.71 -27.98 18.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.987 -1.071 . . . . 0.0 110.708 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' SER . 59.1 m -103.4 -30.45 10.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.043 -1.036 . . . . 0.0 111.082 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.0 t -93.65 -63.78 1.16 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.879 -1.138 . . . . 0.0 109.777 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -62.03 -10.05 8.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' CYS . 1.1 m -162.93 164.15 25.95 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.358 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 67.0 mt -85.59 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.136 -0.978 . . . . 0.0 109.049 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.47 160.32 17.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.46 -0.775 . . . . 0.0 110.053 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 15' ' ' GLN . 44.9 m -103.39 147.71 26.78 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 13' ' ' LEU . 7.7 tp -43.46 -35.1 1.5 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.494 -0.754 . . . . 0.0 110.242 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -63.1 -35.3 79.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.768 -1.208 . . . . 0.0 108.566 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.1 mt-30 -77.85 -26.96 49.72 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 HG21 ' B' ' 39' ' ' VAL . 7.2 tp -78.81 -47.97 15.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.446 -0.784 . . . . 0.0 108.947 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -62.59 -21.39 65.58 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.476 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 4.0 m-20 -65.43 -34.53 78.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.145 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 2' ' ' ILE . 83.7 m-85 -84.76 1.78 45.12 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.562 -1.336 . . . . 0.0 109.044 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -109.67 146.1 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 2.9 p30 . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.318 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.432 HG22 ' N ' ' B' ' 24' ' ' ASN . 10.6 p -63.53 157.34 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.83 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.432 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -103.85 92.62 4.49 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -137.39 144.19 42.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 109.809 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 15.2 m-70 -69.1 109.51 4.06 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.401 -0.812 . . . . 0.0 109.149 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.0 mt -90.89 149.51 21.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.133 -0.98 . . . . 0.0 109.708 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 47.3 m -155.91 -178.08 7.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.12 -145.55 16.4 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -76.15 -19.99 57.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -47.43 -60.62 2.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.074 -1.016 . . . . 0.0 108.658 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 22.7 tp -47.29 -56.46 6.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' B' ' 34' ' ' GLU . 35.2 t -50.78 -59.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.261 -0.899 . . . . 0.0 108.903 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' B' ' 33' ' ' VAL . 1.9 mt-10 -41.43 -39.58 1.53 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.687 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.68 -59.88 4.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 mt -52.45 -45.41 66.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.5 -1.375 . . . . 0.0 108.069 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -56.27 -25.93 49.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.2 tp -84.77 -58.32 2.76 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.868 HG21 HD23 ' A' ' 16' ' ' LEU . 46.9 t -57.36 -56.73 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' B' ' 44' ' ' GLY . 1.0 OUTLIER -72.83 -31.03 64.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.652 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.43 -112.94 1.3 Allowed Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.794 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -84.03 -20.35 32.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.324 -1.104 . . . . 0.0 111.226 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -52.41 -50.81 61.78 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.799 -1.188 . . . . 0.0 109.665 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.57 127.73 6.15 Favored Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -125.3 170.23 11.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.556 ' CD2' ' N ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -123.86 114.09 19.38 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.948 0.88 . . . . 0.0 109.544 179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.406 ' C ' HG22 ' B' ' 48' ' ' THR . 73.3 t80 -124.69 107.63 11.17 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER 173.45 -175.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' OG1' ' B' ' 48' ' ' THR . 20.2 mmmt 41.78 50.97 5.24 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.636 -0.665 . . . . 0.0 110.622 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.1 Cg_exo -30.08 152.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.425 2.75 . . . . 0.0 112.577 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.468 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 4.984 0 N-CA-C 119.769 2.668 . . . . 0.0 119.769 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.773 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.8 tt -75.57 -37.63 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -1.138 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.69 -40.58 19.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.735 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -75.4 -19.65 59.39 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.769 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -88.89 -41.17 12.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.144 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 9' ' ' SER . 80.5 m -91.2 -30.41 16.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 111.75 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.5 t -92.91 -66.72 0.9 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.647 -1.283 . . . . 0.0 110.508 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -57.21 -10.17 1.18 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.976 -1.077 . . . . 0.0 108.498 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.4 m -163.12 176.64 9.83 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.113 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' CG1' ' CD2' ' B' ' 26' ' ' HIS . 71.0 mt -97.09 135.65 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.997 -1.064 . . . . 0.0 108.901 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 p -103.06 158.29 16.4 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.487 -0.758 . . . . 0.0 110.275 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.8 m -100.25 146.54 26.78 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' B' ' 22' ' ' PHE . 6.8 tp -43.45 -34.4 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.39 -35.25 79.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.694 -1.254 . . . . 0.0 108.702 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' SER . 14.8 mt-30 -77.58 -29.47 52.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.878 HD23 HG21 ' B' ' 39' ' ' VAL . 8.3 tp -76.9 -49.09 16.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.509 -0.745 . . . . 0.0 109.068 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -62.44 -23.53 66.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.478 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.7 m-20 -61.62 -35.56 78.24 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.149 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.773 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.1 m-85 -84.5 -3.84 58.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.716 -1.24 . . . . 0.0 109.395 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.5 t -100.55 146.37 27.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.442 -0.786 . . . . 0.0 109.671 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' B' ' 43' ' ' ARG . 2.2 p30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 13' ' ' LEU . 4.6 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.42 152.19 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 93.68 7.31 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -137.17 144.46 42.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.316 -0.865 . . . . 0.0 110.261 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.434 ' CD2' ' CG1' ' A' ' 10' ' ' ILE . 9.3 m-70 -73.87 109.97 7.8 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.514 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 12.0 mt -92.26 148.77 21.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 109.773 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 57.8 m -155.41 -177.79 6.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.24 -143.57 15.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -78.73 -18.17 54.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -1.173 . . . . 0.0 109.825 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -48.18 -57.07 6.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.002 -1.061 . . . . 0.0 108.447 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 20.7 tp -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.5 t -51.32 -59.03 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.898 . . . . 0.0 108.972 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.1 mt-10 -42.49 -40.19 2.52 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -59.48 -60.18 4.27 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -51.65 -45.95 63.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.675 -1.265 . . . . 0.0 108.103 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.44 -24.95 48.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.8 tp -85.08 -62.98 1.41 Allowed 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.878 HG21 HD23 ' A' ' 16' ' ' LEU . 58.7 t -52.41 -57.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.748 0.785 . . . . 0.0 109.749 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.477 ' SG ' ' C ' ' B' ' 44' ' ' GLY . 1.7 t -70.13 -29.53 66.49 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.662 -0.649 . . . . 0.0 110.564 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.75 -126.3 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.369 -1.396 . . . . 0.0 109.758 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -83.18 -5.96 59.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.244 -1.151 . . . . 0.0 110.649 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.45 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.6 mtt180 -61.63 -37.21 83.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.943 -1.098 . . . . 0.0 109.666 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.477 ' C ' ' SG ' ' B' ' 40' ' ' CYS . . . 95.19 126.07 4.74 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.417 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 23.4 p90 -121.53 177.6 5.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.472 -1.016 . . . . 0.0 109.181 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -127.03 118.59 24.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.533 ' C ' HG22 ' B' ' 48' ' ' THR . 76.9 t80 -129.44 107.64 9.65 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.533 HG22 ' C ' ' B' ' 47' ' ' TYR . 0.0 OUTLIER 166.63 84.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.668 . . . . 0.0 109.279 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 31.5 ttmt -160.23 50.88 0.36 Allowed Pre-proline 0 C--N 1.3 -1.573 0 O-C-N 121.086 -1.009 . . . . 0.0 109.961 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.6 Cg_exo -29.06 109.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.567 2.844 . . . . 0.0 112.602 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.515 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.898 0 N-CA-C 119.717 2.647 . . . . 0.0 119.717 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.905 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.5 tt -74.44 -36.47 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.3 t -54.51 -38.89 43.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.36 -0.838 . . . . 0.0 109.869 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -76.31 -25.87 55.23 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.467 -0.77 . . . . 0.0 110.261 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.523 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.2 tt0 -91.35 -29.69 16.97 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.888 -1.132 . . . . 0.0 110.441 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.6 m -93.39 -30.96 14.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 111.187 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 9' ' ' SER . 11.9 t -94.57 -63.74 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.859 -1.15 . . . . 0.0 110.174 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 m -57.68 -7.42 0.67 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 108.248 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 7' ' ' CYS . 35.7 t -156.65 -148.89 0.23 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.856 0.836 . . . . 0.0 109.44 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.976 HD11 ' CE1' ' B' ' 26' ' ' HIS . 80.1 mt -130.95 144.97 36.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.69 154.91 29.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.242 -0.911 . . . . 0.0 110.064 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -98.75 149.4 22.9 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.5 tp -44.22 -33.41 1.55 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.84 -34.67 78.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.706 -1.246 . . . . 0.0 108.752 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.523 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.3 mt-30 -78.82 -30.34 45.31 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 39' ' ' VAL . 9.2 tp -75.53 -50.17 16.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.54 -26.18 66.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -61.35 -35.03 76.32 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.161 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.905 ' CD2' HD12 ' A' ' 2' ' ' ILE . 92.2 m-85 -83.62 -4.5 58.64 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.652 -1.28 . . . . 0.0 109.322 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -100.23 146.28 27.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 0.0 109.58 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' B' ' 44' ' ' GLY . 4.0 p30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.381 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.448 ' HB2' HD13 ' A' ' 13' ' ' LEU . 5.1 t80 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.41 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.4 p -81.86 155.12 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.97 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.41 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.0 OUTLIER -99.62 91.33 4.83 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 26' ' ' HIS . 0.3 OUTLIER -133.83 142.6 47.91 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.531 -0.731 . . . . 0.0 109.863 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.976 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.7 m80 -67.8 109.75 3.5 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.509 -0.744 . . . . 0.0 110.491 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.522 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.2 mt -92.96 149.06 21.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.802 . . . . 0.0 109.339 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 61.3 m -155.71 -178.12 7.06 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.71 -143.37 18.59 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -78.77 -18.62 53.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -1.114 . . . . 0.0 109.815 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -47.64 -58.37 4.35 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.06 -1.025 . . . . 0.0 108.636 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 18.6 tp -48.84 -55.71 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' B' ' 34' ' ' GLU . 19.9 t -52.2 -59.07 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.257 -0.902 . . . . 0.0 108.839 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' B' ' 33' ' ' VAL . 18.0 mt-10 -42.36 -41.63 2.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.59 -60.39 3.74 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.4 mt -51.69 -47.67 63.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.618 -1.301 . . . . 0.0 108.194 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -54.68 -25.46 27.3 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -84.89 -62.83 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.865 HG21 HD23 ' A' ' 16' ' ' LEU . 40.7 t -53.24 -58.43 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.703 0.763 . . . . 0.0 109.706 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.69 -28.69 66.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.682 -0.636 . . . . 0.0 110.585 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.19 -132.49 48.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.75 -4.91 58.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -57.65 -43.26 84.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 127.09 6.0 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.444 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 18.2 p90 -122.98 177.36 5.54 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.484 -1.01 . . . . 0.0 108.87 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -122.54 113.48 19.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.579 ' C ' HG22 ' B' ' 48' ' ' THR . 72.5 t80 -130.85 107.63 9.26 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.579 HG22 ' C ' ' B' ' 47' ' ' TYR . 0.0 OUTLIER 167.43 75.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.469 -0.769 . . . . 0.0 109.423 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.494 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 31.3 tttm -142.95 50.64 1.5 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 24.3 Cg_exo -29.21 100.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.579 2.852 . . . . 0.0 112.635 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.407 HG22 ' O ' ' B' ' 49' ' ' LYS . 15.2 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.529 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 5.024 0 N-CA-C 119.719 2.647 . . . . 0.0 119.719 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.852 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.1 tt -80.3 -38.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 109.754 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.455 ' N ' HG23 ' A' ' 2' ' ' ILE . 7.3 t -50.39 -39.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.363 -0.836 . . . . 0.0 109.857 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -77.48 -24.39 50.19 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.508 -0.745 . . . . 0.0 110.139 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -90.97 -22.14 20.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.943 -1.098 . . . . 0.0 110.113 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' SER . 56.5 m -104.62 -30.43 9.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.987 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.2 t -98.51 -66.13 0.92 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.947 -1.095 . . . . 0.0 109.855 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 m -57.63 -9.3 1.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 7' ' ' CYS . 1.3 m -161.72 -176.48 5.3 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.965 HD11 ' CE1' ' B' ' 26' ' ' HIS . 57.4 mt -106.64 137.81 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.063 -1.023 . . . . 0.0 108.849 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.44 156.86 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.472 -0.767 . . . . 0.0 109.947 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 46.1 m -99.78 147.94 24.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 tp -43.44 -34.26 1.27 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.492 -0.755 . . . . 0.0 110.16 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD2' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -64.55 -34.7 78.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.723 -1.236 . . . . 0.0 108.75 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 15.2 mt-30 -78.82 -28.76 44.51 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 8.9 tp -76.8 -49.53 15.65 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.68 -25.29 67.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.7 m-20 -60.56 -35.83 77.01 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.173 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 2' ' ' ILE . 98.1 m-85 -83.43 0.35 46.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.626 -1.296 . . . . 0.0 109.094 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.81 146.36 31.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.662 -0.649 . . . . 0.0 109.736 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 C--N 1.304 -1.38 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.81 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.401 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.6 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.463 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.1 p -47.77 158.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.747 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.496 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -107.07 89.47 3.01 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.18 141.89 51.63 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.573 -0.705 . . . . 0.0 109.671 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.965 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -66.24 110.66 3.11 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.406 -0.809 . . . . 0.0 110.555 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -90.94 149.72 21.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 109.799 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.9 m -156.09 -178.13 7.09 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.31 -144.23 14.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.19 -18.94 54.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -47.32 -56.87 5.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.086 -1.009 . . . . 0.0 108.62 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 19.3 tp -50.14 -56.29 11.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.5 t -51.34 -60.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.276 -0.89 . . . . 0.0 109.113 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 33' ' ' VAL . 17.7 mm-40 -41.42 -42.39 2.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.373 0.606 . . . . 0.0 109.378 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -57.31 -60.3 3.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.2 mt -51.17 -49.02 61.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.628 -1.295 . . . . 0.0 108.083 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -53.07 -26.18 15.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.2 -62.96 1.41 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 56.4 t -51.06 -55.71 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.438 0.637 . . . . 0.0 110.175 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -75.37 -30.83 60.29 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 110.94 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.8 -111.94 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.184 -1.484 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -83.87 -23.89 31.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.343 -1.092 . . . . 0.0 110.947 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -52.25 -28.16 17.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.91 -1.119 . . . . 0.0 110.008 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 79.39 129.75 0.69 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.407 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 27.6 p90 -123.07 177.01 5.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.571 -0.958 . . . . 0.0 108.944 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -127.01 122.19 33.76 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.82 110.52 11.79 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -175.18 56.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.993 . . . . 0.0 109.622 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.435 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 0.4 OUTLIER -138.23 53.06 5.41 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.509 -0.744 . . . . 0.0 109.273 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 35.7 Cg_exo -26.28 -47.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 124.054 3.169 . . . . 0.0 113.569 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 3.0 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.946 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.891 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.6 tt -75.23 -37.06 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.887 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' H ' HG23 ' A' ' 3' ' ' VAL . 6.9 t -54.33 -39.94 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -75.29 -19.54 59.62 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.465 -0.772 . . . . 0.0 110.472 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.8 mt-30 -90.67 -40.48 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.872 -1.142 . . . . 0.0 110.711 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -92.67 -24.27 18.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.916 -1.115 . . . . 0.0 111.944 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 9' ' ' SER . 10.1 t -94.91 -66.65 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.638 -1.289 . . . . 0.0 109.485 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.492 ' C ' ' HG ' ' A' ' 9' ' ' SER . 9.1 m -57.77 -8.84 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' A' ' 8' ' ' THR . 1.4 m -160.84 -159.07 0.64 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.497 HD11 ' NE2' ' B' ' 26' ' ' HIS . 78.1 mt -119.03 139.76 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.28 -0.888 . . . . 0.0 109.198 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 90.6 m -104.39 171.67 7.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.439 -0.788 . . . . 0.0 110.097 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 15' ' ' GLN . 48.2 m -118.46 145.67 45.07 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.7 tp -43.65 -33.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.437 -0.789 . . . . 0.0 110.214 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -63.85 -34.98 79.16 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.742 -1.223 . . . . 0.0 108.491 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.8 mt-30 -77.04 -34.69 57.23 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.833 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -71.5 -50.52 30.62 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.596 -0.69 . . . . 0.0 109.212 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.32 -23.56 65.81 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.1 m-20 -65.76 -33.82 76.74 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.125 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.891 ' CD2' HD12 ' A' ' 2' ' ' ILE . 95.0 m-85 -84.42 -4.65 59.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.674 -1.266 . . . . 0.0 109.398 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -98.9 145.99 26.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.404 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 22.6 p-10 . . . . . 0 C--N 1.303 -1.445 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.453 ' HB2' HD13 ' A' ' 13' ' ' LEU . 2.3 t80 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.68 154.35 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.0 110.083 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.22 96.02 10.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -137.18 144.28 42.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 110.188 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.497 ' NE2' HD11 ' A' ' 10' ' ' ILE . 9.8 m-70 -74.37 108.78 7.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.513 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.5 mt -94.52 150.77 19.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.082 -1.011 . . . . 0.0 109.775 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 56.6 m -155.77 -177.97 6.95 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.31 -144.75 10.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -76.24 -19.89 57.93 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.259 -1.142 . . . . 0.0 109.798 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -47.19 -57.73 4.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.061 -1.024 . . . . 0.0 108.804 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 28.1 tp -50.92 -55.85 15.19 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' B' ' 34' ' ' GLU . 21.0 t -50.74 -59.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' VAL . 45.8 mt-10 -41.1 -42.36 1.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -56.62 -60.53 3.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.15 -48.67 61.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.595 -1.316 . . . . 0.0 108.276 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -53.9 -25.68 21.29 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.1 tp -85.07 -62.91 1.43 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.833 HG21 HD23 ' A' ' 16' ' ' LEU . 30.2 t -53.62 -58.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.601 0.715 . . . . 0.0 109.909 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.95 -28.38 65.51 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 110.476 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.82 -130.32 46.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -82.76 -10.4 58.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.264 -1.139 . . . . 0.0 109.971 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -52.93 -45.09 67.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 103.27 128.24 6.3 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.432 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 21.9 p90 -122.68 177.41 5.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -1.018 . . . . 0.0 109.121 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.57 117.74 25.0 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.422 ' C ' HG22 ' B' ' 48' ' ' THR . 79.5 t80 -129.46 108.37 10.21 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 174.68 179.87 0.12 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.114 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' OG1' ' B' ' 48' ' ' THR . 17.5 ttpp 44.66 50.58 7.35 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.485 -0.76 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 31.1 Cg_exo -27.46 -62.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.721 2.948 . . . . 0.0 112.6 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 50' ' ' PRO . 27.1 p . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.289 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.92 0 N-CA-C 119.86 2.704 . . . . 0.0 119.86 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.924 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.3 tt -73.91 -37.69 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' N ' HG23 ' A' ' 2' ' ' ILE . 9.4 t -52.39 -38.91 26.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.26 -27.71 59.53 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.177 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 7.3 tt0 -91.66 -28.78 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.841 -1.162 . . . . 0.0 110.594 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' SER . 18.3 m -92.98 -28.94 16.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.915 . . . . 0.0 111.2 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' C ' ' N ' ' A' ' 9' ' ' SER . 14.1 t -96.43 -66.32 0.91 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.891 -1.13 . . . . 0.0 109.985 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.9 m -56.41 -12.71 1.8 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' CYS . 1.4 m -154.93 -179.28 7.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.969 HD11 ' CE1' ' B' ' 26' ' ' HIS . 54.3 mt -105.83 138.78 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.136 -0.978 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -104.48 157.03 17.44 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' GLN . 36.1 m -99.02 147.94 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 13' ' ' LEU . 6.6 tp -43.71 -33.14 1.16 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.445 -0.784 . . . . 0.0 110.092 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -65.01 -34.72 79.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.782 -1.199 . . . . 0.0 108.75 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.526 ' NE2' ' OE1' ' A' ' 5' ' ' GLN . 15.0 mt-30 -78.57 -31.82 47.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.858 HD23 HG21 ' B' ' 39' ' ' VAL . 9.4 tp -74.09 -50.17 20.73 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.75 -25.5 66.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 3.3 m-20 -63.1 -34.63 78.01 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.21 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.924 ' CD2' HD12 ' A' ' 2' ' ' ILE . 93.2 m-85 -83.14 -2.22 54.89 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.617 -1.302 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.28 146.57 28.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.539 -0.726 . . . . 0.0 109.789 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.395 179.805 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.405 HG22 ' N ' ' B' ' 24' ' ' ASN . 11.2 p -73.02 153.68 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.815 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.405 ' N ' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER -100.63 92.69 5.22 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.46 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.1 tm0? -134.18 139.87 46.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.387 -0.821 . . . . 0.0 109.555 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.969 ' CE1' HD11 ' A' ' 10' ' ' ILE . 3.0 m80 -65.53 110.2 2.62 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.299 -0.876 . . . . 0.0 110.172 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.517 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.3 mt -91.21 148.63 22.22 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.684 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 60.5 m -155.4 -177.87 6.86 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.3 -144.2 20.07 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -78.31 -18.94 54.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 109.677 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 1.1 m-20 -47.54 -57.83 4.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.106 -0.996 . . . . 0.0 108.686 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 17.9 tp -49.47 -55.54 12.89 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' B' ' 34' ' ' GLU . 25.2 t -52.65 -59.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.234 -0.916 . . . . 0.0 108.757 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' B' ' 33' ' ' VAL . 2.7 mt-10 -42.0 -41.21 2.45 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 38' ' ' LEU . . . -58.15 -60.36 3.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 mt -51.73 -45.74 63.73 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.761 -1.212 . . . . 0.0 108.281 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -56.05 -25.64 45.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.0 tp -84.96 -63.09 1.39 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.858 HG21 HD23 ' A' ' 16' ' ' LEU . 41.7 t -53.48 -56.98 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.645 0.736 . . . . 0.0 109.568 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.8 t -70.43 -29.42 66.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.72 -0.613 . . . . 0.0 110.781 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.92 -129.26 38.63 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.371 -1.395 . . . . 0.0 109.695 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.12 -3.69 57.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -1.139 . . . . 0.0 110.526 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -62.38 -34.08 76.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.961 -1.087 . . . . 0.0 109.629 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 92.0 128.01 4.27 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.451 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 17.0 p90 -123.06 177.77 5.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.42 -1.047 . . . . 0.0 109.059 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 0.1 OUTLIER -124.3 114.26 19.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -130.02 110.61 11.78 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.699 -0.626 . . . . 0.0 109.477 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.522 ' OG1' ' N ' ' B' ' 49' ' ' LYS . 2.1 t -173.32 -128.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.522 ' N ' ' OG1' ' B' ' 48' ' ' THR . 30.6 ttmt 45.99 49.71 6.98 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.946 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 27.4 Cg_exo -28.78 103.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 123.704 2.936 . . . . 0.0 112.722 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.449 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.954 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.904 HD12 ' CD2' ' A' ' 19' ' ' TYR . 14.5 tt -72.52 -20.58 19.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.414 -1.051 . . . . 0.0 109.035 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 3' ' ' VAL . 6.8 t -68.4 -36.42 74.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.619 0.724 . . . . 0.0 110.018 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.82 -20.14 58.39 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.19 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' C ' ' SG ' ' A' ' 11' ' ' CYS . 22.9 mt-30 -91.04 -34.98 14.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.53 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 3.9 m -95.48 -30.35 13.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.814 -1.179 . . . . 0.0 111.385 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 9' ' ' SER . 8.2 t -92.96 -64.14 1.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.816 -1.177 . . . . 0.0 109.911 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -60.1 -5.79 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 7' ' ' CYS . 42.6 t -159.74 -145.84 0.13 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.963 HD11 ' CE1' ' B' ' 26' ' ' HIS . 91.9 mt -130.05 142.44 43.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 6' ' ' CYS . 60.4 m -109.18 151.05 26.99 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.283 -0.886 . . . . 0.0 110.628 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLN . 59.3 m -101.23 146.0 28.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' B' ' 22' ' ' PHE . 6.6 tp -43.54 -34.02 1.28 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' C ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -64.01 -34.76 78.74 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.718 -1.239 . . . . 0.0 108.698 -179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' SER . 16.3 mt-30 -77.58 -33.01 54.07 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.847 HD23 HG21 ' B' ' 39' ' ' VAL . 9.6 tp -72.95 -50.26 24.45 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.621 -0.674 . . . . 0.0 109.237 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -61.61 -20.79 63.74 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 2.4 m-20 -69.2 -32.74 72.22 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.316 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.904 ' CD2' HD12 ' A' ' 2' ' ' ILE . 97.6 m-85 -85.83 -6.98 59.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.588 -1.32 . . . . 0.0 109.283 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 t -93.61 142.6 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.973 -1.013 . . . . 0.0 108.891 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.477 ' HB2' HD13 ' A' ' 13' ' ' LEU . 6.1 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.411 HG22 ' N ' ' B' ' 24' ' ' ASN . 12.6 p -82.34 154.64 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.129 -0.982 . . . . 0.0 109.85 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.58 90.28 4.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' B' ' 26' ' ' HIS . 1.2 tm0? -132.45 145.1 50.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.614 -0.679 . . . . 0.0 109.599 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.963 ' CE1' HD11 ' A' ' 10' ' ' ILE . 2.1 m80 -68.32 110.5 4.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.514 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.511 ' O ' ' SG ' ' B' ' 28' ' ' CYS . 13.4 mt -92.76 150.87 20.36 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.369 -0.832 . . . . 0.0 109.425 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 64.4 m -156.19 -178.11 7.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.62 -142.07 12.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.05 -18.07 54.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.355 -1.086 . . . . 0.0 109.92 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -48.3 -55.42 10.67 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.99 -1.069 . . . . 0.0 108.693 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 35' ' ' ALA . 35.1 tp -51.04 -56.2 13.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' B' ' 34' ' ' GLU . 22.3 t -51.65 -59.84 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.172 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' B' ' 33' ' ' VAL . 6.0 mm-40 -40.94 -41.56 1.66 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.422 0.63 . . . . 0.0 109.378 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.647 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -57.55 -60.3 3.88 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' B' ' 40' ' ' CYS . 22.7 mt -51.05 -48.87 61.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.693 -1.254 . . . . 0.0 108.127 178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -53.65 -25.41 17.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 35' ' ' ALA . 5.4 tp -85.28 -62.86 1.43 Allowed 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.847 HG21 HD23 ' A' ' 16' ' ' LEU . 33.7 t -54.16 -57.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' B' ' 44' ' ' GLY . 1.5 t -69.8 -30.06 67.51 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.676 -0.64 . . . . 0.0 110.453 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 -121.25 8.0 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.321 -1.419 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -83.61 -8.76 59.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -1.162 . . . . 0.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -62.79 -17.6 61.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.875 -1.141 . . . . 0.0 109.846 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' B' ' 40' ' ' CYS . . . 70.69 129.46 0.07 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' B' ' 45' ' ' TYR . 19.2 p90 -119.7 177.67 4.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.412 -1.052 . . . . 0.0 110.192 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -121.63 115.82 23.46 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -129.79 118.2 21.43 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.482 0.658 . . . . 0.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 75.8 p -133.18 -170.67 2.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.572 ' N ' ' CD ' ' B' ' 50' ' ' PRO . 18.1 ptmt -144.06 46.82 0.68 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.964 -1.085 . . . . 0.0 110.42 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 12.6 Cg_exo -35.98 -48.3 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.836 2.357 . . . . 0.0 111.266 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.444 HG22 ' H ' ' B' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.377 179.996 . . . . . . . . 2 2 . 1 stop_ save_